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ABSTRACT 
Toward a better understanding of urinary fistula repair prognosis:  
Results from a multi-country prospective cohort study 
 
Veronica M. Frajzyngier 
This dissertation addresses several critical gaps in the evidence-base with regard to urinary 
fistula care and treatment in developing countries.  First, I systematically reviewed and 
synthesized the small but growing body of literature examining the patient, fistula and facility-
level factors that influence repair outcomes in developing countries.  There was insufficient 
evidence to support a role of patient characteristics in influencing repair outcomes.  In contrast, 
the weight of evidence suggested that some fistula characteristics, particularly scarring and 
urethral involvement, may influence the risk of failure to close the fistula, residual incontinence 
following closure and any incontinence.  Results from randomized controlled trials examining 
prophylactic antibiotic use and repair outcomes were inconclusive, and observational studies 
examining the influence of peri-operative procedures were limited by small sample sizes and 
lack of statistical adjustment for potential confounding factors.   
 
Secondly, using data from a multi-country facility-based prospective cohort study, I examined 
the prognostic value of five existing classification systems – those developed by Lawson, 
Tafesse, Goh, the World Health Organization (WHO) and Waaldijk – for predicting fistula 
closure, and evaluated the prognostic value of a score derived empirically from the data from this 
study.  The scoring systems representing the Tafesse, Goh and WHO and empirically-derived 
classification systems were similar, and had the highest predictive values.  However, none of the 
scores evaluated achieved good discriminatory ability (AUC > 0.70), suggesting that other 
factors unrelated to fistula characteristics may be equally or more important in predicting repair 
outcomes.    
 
Finally, I examined several issues surrounding two peri-operative procedures related to fistula 
surgery: abdominal versus vaginal route of repair, and catheterization duration greater than 14 
days (compared to 14 days or less).  Specifically, I explored the factors influencing the choice of 
these procedures, the influence of each of these procedures on repair outcomes independent of 
indication for repair or repair prognosis, and whether indication for the procedure or fistula 
prognosis moderates the influence of each of these procedures on repair outcomes.   Abdominal 
route of repair was independently associated with site, parity > 3, and having a fistula that met 
indications for an abdominal route of repair (limited vaginal access due to extensive scarring or 
tissue loss, genital infibulation, ureteric involvement, or trigonal, supra-trigonal, vesico-uterine 
or intracervical location, or other abdominal pathology).  Surgeon experience conducting 
complex repairs and mid-vaginal location were inversely associated with abdominal route of 
repair.  Increased prognostic score was independently associated with catheterization > 14 days, 
as were site and surgeon experience doing complex repairs.  Vaginal route of repair was 
independently associated with increased risk of failure to close the fistula, relative to abdominal 
route of repair; however, stratified analyses suggested that the risk of failed repair among those 
repaired vaginally may be particularly elevated among women who met common indications for 
abdominal route of repair.  Duration of catheterization > 14 days was associated with failure to 
close the fistula, after adjusting for repair prognosis and surgeon experience; however, residual 
confounding by indication and reverse causation cannot be excluded as explanations for this 
finding. 
 
Additional research is needed to confirm our findings regarding the discriminatory value of the 
classification systems evaluated.  Further, since the value of a classification system lies not only 
in its discriminatory ability but also its reliability and ease of use, tests of inter- and intra-rater 
reliability of these systems are priority area for future research.  Given the cost and health 
implications associated with abdominal route of repair and longer duration catheterization, 
additional studies examining the influence of these procedures on repair outcomes are warranted.  
Such studies must ensure adequate control of confounding by indication and prognosis of repair. 
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Chapter 1 : Introduction 
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Vaginal fistula is a devastating condition.  The immediate manifestation of the condition is 
persistent leakage of urine or feces, or both; secondary consequences include a range of co-
morbidities, and social marginalization.  While the exact prevalence of the condition is unknown, 
it is estimated to affect thousands, if not millions, of women in developing countries.  The 
primary cause of a vaginal fistula is prolonged obstructed labor; such cases are termed 
“obstetric” fistula.  Obstetric fistula can be prevented through adequate access to emergency 
obstetric care; indeed, the condition does not occur in developed countries, where such care is 
readily accessible.   Where surgical repair services are available and financially accessible, 80-
95% of vaginal fistula can be closed surgically.1  However, factors such as lack of provider 
expertise and the complexity of the repair can hinder the successful closure of a fistula.  
Moreover, up to 33% of women may suffer residual incontinence even after successful closure of 
the fistula,2, 3 and an unknown percentage suffer complications or health-care associated 
infections related to intra- and post-operative procedures.   
 
The issue of vaginal fistula has recently begun to garner worldwide attention, as well as funding 
from bilateral (e.g. USAID) and multilateral (e.g. UNFPA) donors.  Nonetheless, a paucity of 
research on the topic remains, including research on effective treatment for the condition and 
factors influencing the prognosis of the repair.  In this introductory chapter, I first describe the 
epidemiology and consequences of fistula and the context in which fistula repair takes place.  I 
next illustrate the importance of developing an evidence-based standardized system for 
classifying the prognosis of fistula repair for both research and clinical purposes, and briefly 
review current gaps in knowledge with regard to two peri-operative procedures: route of surgical 
repair, and duration of catheterization.  
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Epidemiology and social consequences of vaginal fistula 
 
The leading cause of fistula in the developing world is obstructed labor.   The pressure of the 
fetus’s head causes ischemic pressure necrosis and a slough of tissue, giving way to a hole 
between the vagina and bladder, or between the vagina and rectum.  While less common, vaginal 
fistulas are also caused by sexual violence, particularly the insertion of foreign objects into a 
woman’s vagina.  Finally, vaginal fistula can occur as a result of malignant disease, radiation 
therapy or surgical injury (most often to the bladder during hysterectomy); the latter is the 
predominant type of vaginal fistula seen in industrialized countries.  Fistula resulting after 
surgical injury is a relatively simple injury in comparison with fistula produced by obstructed 
labor: it is characterized by discrete wounding of otherwise normal tissue, whereas obstructed 
labor results in a massive injury with an area of central necrosis, surrounded by dense scarring.4   
 
A vaginal fistula can occur in various areas of the reproductive tract, with the location depending 
on the point at which labor became obstructed.  Most commonly, fistulas occur at the bladder; 
these are termed vesico-vaginal fistulas (VVF).  Fistulas can also occur at the uterus (termed 
utero-vesico fistulas), in the cervix (cervico-vaginal fistulas), at the urethra (urethra-vaginal 
fistulas) or at the ureter (uretero-vaginal fistulas); diagrams of vesico-vaginal and uretero-vaginal 
fistulas are shown in Appendix A.  Each of the above locations is associated with urinary 
incontinence, and the overarching term “urinary fistula” is often used to describe them.  Finally, 
fistulas affecting the rectum are termed recto-vaginal fistula (RVF), and these manifest in fecal 
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incontinence.  As will be discussed in this dissertation, the location and characteristics of the 
fistula may determine the difficulty and the outcome of the surgical repair. 
 
While the primary cause of vaginal fistula in developing countries is obstructed labor, the 
underlying causes include poverty, malnutrition, lack of access to emergency obstetric care and 
family planning, lack of education, early marriage, and low social status of women.5  
Malnutrition and early childbearing in particular both lead to increased risk of cephalo-pelvic 
disproportion, a primary cause of obstructed labor.6  Indeed, surveys conducted in Nigeria,7-9 
Ghana10  and Ethiopia3 have shown that fistula patients are predominantly young, married at an 
early age, are of short stature, and receive very little education.  Once a woman experiences an 
obstructed labor, the problem can be solved by caesarean delivery; however, timely access to 
emergency obstetric services is rare in developing countries.11  Without access to such services, 
women with obstruction may labor for up to 5 days without effective intervention.1, 9, 12   
 
To date only one large-scale, prospective, population-based study examining incidence of fistula 
in a developing country setting has been conducted, and the results of this study (124 cases of 
fistula per 100,000 deliveries, 95%CI 15-446) are difficult to interpret, as information about how 
the outcome was measured was not provided, and the sampling error is wide.13  Recently, 
questions regarding lifetime experience of fistula symptoms have been included in Demographic 
and Health Surveys, and estimates of lifetime prevalence have ranged from 0.2% in Mali14 and 
Niger15 to 4.7% in Malawi.16  However, these estimates must be interpreted with caution, due to 
problems related to questionnaire design (inappropriate contingency questions or lack of 
specificity in the definition of fistula), or underreporting of fistula symptoms (due to the social 
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stigma associated with the condition).17  Model-based estimates have also been developed, using 
assumptions about obstructed labor rates in developing countries; using this method, it is 
estimated that there are 82,000 fistula cases annually (8.68 per 100,000 women), and 654,000 
prevalent cases (51.35 per 100,000 women) in developing countries.18   
 
While the prevalence of the condition is unknown, the physical, social, and economic 
consequences of fistula are indisputably dire.  The majority of women with fistula develop 
painful rashes as a result of the constant leakage of urine.  In addition, women with fistula may 
develop amenorrhea, vaginal stenosis (narrowing of the vagina due to a build-up of scar tissue), 
infertility, bladder stones, and infection; they may also suffer concomitantly from leg weakness 
and footdrop (paralysis or weakness of the dorsiflexor muscles of the foot and ankle, resulting 
from compression of the sacral nerves by the fetal head as well as damage to the perineal nerve).4  
Women with fistula are often deemed to have an offensive odor, due to the constant leakage of 
urine and / or feces.  As a result, they are often abandoned by their husbands, and are ostracized 
by their families and communities.  In some contexts, community members may not understand 
the cause of fistula, may view the smell as resulting from poor personal hygiene, or may even 
view the injuries as punishment from God or as a form of sexually transmitted infection, further 
contributing to the woman’s marginalization.4  After development of the fistula, married women 
are frequently sent back to their parents’ home, where they are precluded from cooking food, 
participating in social events or performing religious rituals.19  For these reasons, women with 
vaginal fistula have been deemed “the most dispossessed, outcast, powerless group of women in 
the world.”20 
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Treatment of vaginal fistula 
 
The majority (80-95%) of fistulas can be closed surgically.1  The method of treating obstetric 
fistula varies according to how soon a patient presents for care after obstructed labor.  Early 
catheterization of women who start leaking after obstructed labor is increasingly being 
employed, and has been shown to cure up to one-fifth of early stage fistulas.8  However, the 
majority of women present months or even years after a fistula has fully developed;1, 9, 21 in this 
case, surgical closure is the only therapeutic option.   
 
While many fistula surgeons have developed their own methods through experience,22 the 
following methods described by John Kelly (1994), a fistula surgeon, are an example of typical 
procedures used for the repair of a simple vesico-vaginal fistula.  The repair is approached either 
abdominally or vaginally, often depending on the surgeon’s preference (gynecologists often 
prefer vaginal approaches, and urologists abdominal approaches) and the site of the fistula (low 
vesico-vaginal fistulas and urethra-vaginal fistulas are most often approached vaginally).  For a 
vaginal approach, patients are placed in a lithotomy or knee-chest position.  In the context of 
scarring and limited access, an episiotomy and division of scar tissue may provide better 
exposure for the repair.  The fistula is mobilized, scar tissue is excised, and then the repair is 
performed with two layers of sutures.  A catheter is inserted for 14 days to allow for continuous 
bladder drainage, and a dye test is performed to test whether the fistula has been closed, and that 
another fistula has not been missed.23 Women are counseled to avoid sexual activity and 
inserting anything into the vagina for three months, and are generally discharged soon after 
catheter removal.   
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A number of challenges are associated with providing fistula repair services in developing 
countries.  Specialized training and skills are necessary, especially to handle more complex 
cases, and this limits the availability of services. Women with the condition are predominantly 
poor and from rural areas, and often cannot pay for surgery or transport to a service site.  Thus, 
fistula repair services must be provided free of charge.  Fistula services are few and far between 
in Africa and Asia: the availability of services depends not only on the availability and 
motivation of surgeons with specialized skills, but also the availability of operating rooms, 
equipment, and funding from local or international donors to support both surgeries and lengthy 
post-operative care.  In most contexts, the need for repair services exceeds the available human 
and infrastructural capacity.  Moreover, the prolonged bladder catheterization that is frequently 
employed after surgery translates into a need for longer hospitalization, more intensive nursing 
care, increased costs, and thus decreased capacity for treating other patients. In light of these 
challenges, finding ways of providing services in a more efficient and cost-effective manner, 
without compromising surgical outcomes and the overall health of the patient, is paramount.  To 
this end, further research on factors predicting successful repair, particularly those factors 
contributing to increased hospital stay and risk of infection, is needed.   
 
Importantly, any research efforts examining the comparative effectiveness of different modes of 
service delivery (facility-level factors) must account for potential confounding by patient and 
fistula characteristics; moreover, the influence of facility-level factors may vary across different 
levels of fistula severity or prognosis, as characterized by patient and fistula characteristics 
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(Figure 1.1). A standardized evidence-based system for classifying the prognosis of a fistula 
repair surgery, as described below, would facilitate the conduct of such research.   
 
Classifying fistula prognosis 
 
Efforts have been made to develop a schema for classifying fistulas since the work of J. Marion 
Sims in the mid-19th century.24  Currently at least 25 systems for classifying fistula are being 
used.25  These classification systems have been developed through the efforts of individual 
surgeons, informed by their clinical expertise and experience.  Fistula surgeons often use the 
classification system used or developed by the individual by whom they were trained.  For 
instance, Nigerian surgeons who have been trained by Kees Waaldijk, a prominent fistula 
surgeon who primarily works in Nigeria, may use the Waaldijk classification system, while 
surgeons trained at Addis Ababa Fistula Hospital in Ethiopia may use the Goh or Tafesse 
classification systems.  These classification systems may be used for didactic purposes, as well 
as for patient triage at the time of the patient’s admission examination: for instance, classification 
systems can help determine if cases should be referred to specialized facilities, or which cases 
can be repaired by less experienced fistula surgeons.   
 
Fistula classification systems vary in the type and amount of information collected, with some 
systems simply describing the location of the fistula, and other more detailed systems describing 
the anatomical structures affected and the extent to which these structures are affected, the 
location of the fistula described by fixed reference points, as well as other factors, such as 
bladder size, the size of the fistula and the amount of scarring involved.  Disagreement remains 
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with regard to which anatomical structures and fistula characteristics should be captured within a 
classification system.  While most of the recently developed systems assess the presence of 
circumferential injury (complete separation of the urethra from the bladder), fewer assess other 
involvement of the urethra.  Similarly, not all classification systems assess the size of the fistula, 
scarring, involvement of the bladder, and whether or not a prior repair was conducted; even 
fewer assess the degree of tissue loss, whether or not the vesico-vaginal fistula was accompanied 
by a recto-vaginal fistula, or the number of fistulas.  For prognostic purposes as well as to further 
research in the field, a standardized classification, whereby each component of the system has 
been empirically demonstrated to independently predict repair outcomes, is needed.  No 
commonly used classification systems are scoring systems, and none have clear thresholds 
defining a “simple” versus “complex” repair.  
 
Rationale for a standardized evidence-based classification system 
 
A standardized evidence-based system for classifying fistula prognosis would have a number of 
advantages.  While extant classification systems may currently be used for triage purposes, an 
evidence-based system of classifying fistula prognosis may facilitate this process in terms of 
improving the accuracy of surgeon triage decisions.  A prognostic scoring system would be 
particularly useful.  Such a score could provide clear thresholds to guide triage decisions.  For 
research and evaluation purposes, such a scoring system would facilitate the comparison of 
surgical outcomes across facilities, would provide a method of adjusting for confounding by 
prognosis of repair, and would facilitate comparative analyses of studies that examine treatment 
outcomes.  Moreover, since clinical trials on fistula management may use fistula complexity as 
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criteria for trial inclusion, an evidence-based index of complexity index will assist with 
participant selection.   
 
There are several steps required in order to develop an evidence-based score for predicting the 
prognosis of fistula repair prognosis.  First, it is necessary to determine which fistula 
characteristics are independently predictive of surgical outcomes.  Identifying the minimal set of 
variables required for an accurate prognosis is also important, since the simpler a classification 
system is, the more likely it is to be adopted and used.  This set of variables can then be 
transformed into an index or score.  A commonly used method of creating a prognostic score is 
that developed by Hutchinson and Thomas,26 whereby effect estimates calculated from beta 
coefficients are used to create a single variable prognostic of future risk.  In Chapter 2, I evaluate 
the predictive value of classification systems developed by Waaldijk,27 Lawson,28 Tafesse,29 
Goh,30 and a system presented by the World Health Organization (WHO) in their 2006 manual 
Obstetric Fistula: Guiding principles for clinical management and programme development;31 in 
order to do so, I first transform each of these systems into prognostic scores.  I also develop an 
empirically-derived prognostic score informed by the above systems.  In chapter 4, I use this 
score to statistically adjust for confounding by prognosis of repair in the evaluation of the 
influence of duration of catheterization on repair outcomes. 
 
The influence of route of repair and duration of catheterization on urinary fistula repair 
outcomes 
 
 
Evidence with regard to the influence of peri- operative procedures on repair outcomes is 
lacking.  Two procedures are of particular interest: abdominal route of repair, and duration of 
  
11
catheterization.  Each of these procedures is associated with longer-term hospitalization, and 
therefore a potentially elevated risk of nosocomial infection (particularly urinary tract infection, 
or UTI32) and increased financial and human resource requirements.33  
 
There are conflicting recommendations regarding whether a vaginal or abdominal surgical 
approach should be taken in the context of a complex repair.  The vaginal approach may be 
associated with less blood loss and pain, fewer complications, and a shorter hospital stay; 
however, it may also be associated with vaginal shortening and scarring.25  While certain fistula 
characteristics may indicate an abdominal repair, the choice of surgical approach remains to 
some extent a matter of surgeon preference or training. Though three studies34-36 have examined 
whether surgical approach influences fistula repair outcomes, each were underpowered to detect 
small differences, and did not account for a range of potential confounding factors, such as the 
prognosis of, or indication for, repair. 
 
There is similar disagreement regarding the optimal duration of catheterization following 
surgery.  While surgical publications state that bladder drainage through catheterization should 
continue between 10 and 14 days post-operatively,23, 37 this practice is based on tradition, rather 
than empirical evidence.4  Indeed, a recent survey of 49 fistula surgeons conducted by 
Arrowsmith and colleagues38 found that catheterization durations ranged from 5 to 21 days. Only 
one study on duration of bladder catheterization following obstetric fistula surgery has been 
published to-date.  Nardos et al.’s (2008)33 retrospective study of 212 obstetric fistula patients 
found no difference in the proportion of repair breakdown between those catheterized for 10 days 
(group 1), 12 days (group 2), and 14 days (group 3) at the Bahir Dar Hamlin Fistula Center in 
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Ethiopia.  While the authors suggest that catheterization for 10 days may be sufficient for 
management of simpler fistulas (and certain types of more complicated fistulas), the conclusions 
that can be drawn from this study are limited, as the duration of bladder catheterization was not 
randomized, and may have been influenced by the complexity of the fistula: women catheterized 
for 10 days were significantly more likely to have an intact urethra (p=0.009), smaller size fistula 
(p<0.001), and little or no vaginal scarring (p<0.001).33   
 
Duration of bladder catheterization has important implications in terms of both cost and hospital-
borne infection.  Nardos and colleagues illustrate the cost implications of catheterization duration 
using the example of the Addis Ababa Fistula Hospital, where approximately 1200 fistula repairs 
are performed annually.  Assuming no compromise in patient outcomes, if postoperative 
hospitalization were to be decreased by four days by removing the bladder catheter at 10 days 
rather than 14, the number of patients who could receive surgical care could be increased by 
20%.33 Results of a recent Cochrane review of urinary catheter policies following urogenital 
surgery in adults suggested that shorter-term catheterization was associated with fewer UTIs.32  
Thus, in Chapter 4, I evaluate 1) factors influencing the duration of catheterization and route of 
repair, 2) the influence of longer duration of catheterization and abdominal route of repair on 
fistula closure three months following surgery, and 3) whether prognosis of the repair or 
indication for the procedure moderates the influence of each of these procedures on fistula 
closure.   
 
Summary and conclusion 
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While global attention to the issue of vaginal fistula has increased markedly in the past decade,  a 
dearth of research on the topic remains, including research to support the development of a 
standardized, evidence-based classification system, as well to support effective treatment of the 
condition.  In this dissertation, I review the state of the evidence with regard to patient 
characteristics, fistula characteristics and peri-operative procedures that influence fistula repair 
outcomes (Chapter 2).  I evaluate the predictive value of five existing classification systems in 
terms of predicting fistula closure, as well as develop an empirically-derived prognostic score 
informed by these systems and including factors found to predict fistula repair outcomes in my 
dataset (Chapter 3).  Additionally I evaluate the influence of vaginal (versus abdominal) route of 
repair, and catheterization duration longer than 14 days, on fistula closure; for these analyses, I 
explore the role of repair prognosis and indication as both a confounder and effect modifier of 
these relationships (Chapter 4). Finally I summarize the results, and discuss their implications 
and future research directions in Chapter 5, the conclusion. 
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Figure 1.1: Interrelationships between patient and fistula characteristics, intra- and post-
operative procedures, and repair outcomes 
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Chapter 2 : Factors influencing urinary fistula repair outcomes in developing country 
settings: a systematic review of the literature 
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Abstract 
 
The objective of this study was to review and synthesize extant literature examining factors 
influencing fistula repair outcomes in developing country settings, including fistula and patient 
characteristics, as well as facility-level factors, such as peri-operative procedures used and other 
aspects of service delivery.   We conducted a systematic review of English and French language 
literature cited in the Medline database between January 1970 and December 2010, using search 
terms “obstetric fistula,” “vaginal fistula,” “urinary bladder fistula,” “vesicovaginal fistula” and 
“fistula.”  Articles were excluded if they were 1) case reports, cases series or contained 20 or 
fewer subjects; 2) focused on fistula in industrialized countries; and 3) did not include a 
statistical analysis of the association between facility or individual-level factors and surgical 
outcomes.  Nineteen articles were included, of which 16 were observational studies.  Surgical 
outcomes included fistula closure, residual incontinence following closure, and closure with no 
remaining incontinence (dry vs. wet).  The presence of scarring and urethral involvement was 
associated with poor prognosis across the range of outcomes, with some evidence suggesting an 
association between greater fistula size and smaller bladder size on poor repair prognosis.  
Evidence regarding the influence of ureteric involvement and prior repair on repair outcomes 
was insufficient.  Results from randomized controlled trials examining prophylactic antibiotic 
use and repair outcomes were inconclusive, and few observational studies examining peri-
operative interventions accounted for confounding of results by fistula severity.   We conclude 
that while a growing number of empirical studies have examined the relationship between 
surgical outcomes and both patient and fistula characteristics and peri-operative procedures used, 
there remains a lack of unified, standardized evidence on which to base practice.  Further 
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research is urgently needed to improve the care and treatment of fistula patients in developing 
countries.  
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Introduction 
 
Vaginal fistula, or an abnormal opening between the vagina and either the bladder or rectum, is a 
devastating condition.   The immediate consequence is urinary or fecal incontinence, or both.  
Secondary conditions may include painful rashes resulting from constant leakage of urine, 
amenorrhea, vaginal stenosis, infertility, bladder stones, and infection.1  Women suffering from a 
vaginal fistula often have an odor considered offensive due to the constant leakage of urine 
and/or feces.  As a result, they may be abandoned by their husbands and ostracized by their 
families and communities.  For these reasons, women with this condition have been deemed “the 
most dispossessed, outcast, powerless group of women in the world.”2  While the number of 
prevalent cases is unknown, estimates in developing countries have ranged from 654,0003 to 2 
million.4  
 
The primary cause of vaginal fistula is prolonged obstructed labor; such fistulas are termed 
“obstetric fistulas.”  During prolonged obstructed labor, the fetus’s head compresses soft tissues 
of the bladder, vagina and rectum against the woman’s pelvis, cutting off blood supply, causing 
these tissues to die and slough away.  Less frequently, vaginal fistula may result from sexual 
violence, malignant disease, radiation therapy, or surgical injury (most often to the bladder 
during hysterectomy or Caesarean section (C-section)).  Malignant disease, radiation therapy and 
surgical injury are the predominant cause of vaginal fistula in industrialized countries; indeed, 
obstetric fistula does not occur in settings where emergency obstetric care is readily accessible.  
The injury resulting from obstructed labor is unique in comparison with fistulas resulting from 
surgical injury: obstructed labor may cause extensive ischemic injury with an area of central 
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necrosis, surrounded by dense scarring, while fistulas resulting from surgical injury are 
characterized by discrete wounding of otherwise normal tissue.1   
 
Treatment of obstetric fistula varies according to how soon a patient presents for care after 
obstructed labor.  Catheterization of women who start leaking after obstructed labor is 
increasingly used, and cures up to one-fifth of early cases.5  Unfortunately, most women present 
months or years after their fistula occurred;6 surgical closure is then the only option.  While the 
majority (80-95%) of fistulas can be closed surgically,6 reported success rates range from 56-
100%;7,8 varying by case-mix, number of patients included, and other factors.  Up to 33% of 
women may suffer residual incontinence after successful closure,9, 10 and an unknown number 
suffer complications related to intra- and post-operative procedures.   
 
Challenges to providing fistula repair services in developing countries are numerous.  Because 
the vast majority of women with fistula are poor, repair services must be free of charge.  Most 
repairs are conducted within special units (with a dedicated operating theatre and wards) of 
district hospitals (e.g. primary referral facilities for rural populations) or within specialist fistula 
centers, and are supported by international donors.  Generally, the need for services exceeds 
available human and infrastructural capacity.  In this context, finding ways of providing services 
in a more cost-effective manner, without compromising surgical outcomes and patients’ overall 
health, is paramount.  Despite this need, the current body of published evidence on obstetric 
fistula has been termed “woefully inadequate by the standards of 21st Century evidence-based 
medicine.”1   
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One priority research need is development of a standardized evidence-based system for 
classifying fistulas.  Currently at least 25 systems are used11 and parameters measured by these 
classification systems vary greatly.  Early systems described the location of the fistula, while 
others are more detailed, describing the anatomical structures affected and the extent to which 
they are affected, as well as factors such as bladder size, fistula size and the amount of scarring 
involved.  To-date, only Goh’s and Waaldijk’s classification systems have been tested to 
determine the extent to which their components predict repair outcomes; these analyses were 
conducted following the adoption of these systems, rather than for the purpose of creating 
them.12, 13  In order to develop a single classification system that is prognostic for outcome of 
repair surgery, it is necessary to determine which fistula characteristics independently predict 
outcomes, and to identify the minimal parameters required for accurate prognosis, since the 
simpler a classification system, the more likely it is to be used.    
 
A second research priority is the evaluation of peri-operative techniques and procedures most 
effective and efficient for fistula repair.  Many fistula surgeons have developed their own 
methods through experience14 and thus there are a wide variety of pre-, intra- and post-operative 
procedures/techniques commonly used.  For instance, surgeons agree that tissues should be 
widely mobilized and sutures tension free.  However, disagreement remains regarding other 
interventions such as surgical route, timing of repair, use of interpositional grafts or flaps, and 
duration of bladder catheterization.  Further research to identify optimal interventions would 
benefit from the availability of a standard system for classifying fistula prognosis, which could 
be used to adjust for confounding by case-mix and thereby facilitate comparison of results across 
studies.   
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In light of the above priorities, we systematically reviewed and synthesized the literature on 
factors that may influence fistula repair outcomes in developing countries, including fistula and 
patient characteristics, as well as facility-level factors (e.g. peri-operative procedures and other 
aspects of service delivery). We then suggest future research priorities in order to fill existing 
gaps in the literature.   
 
 Methods 
 
We conducted a systematic review of the Medline database to identify relevant publications, by 
searching for articles published from 1970-2010, using the following topic headings: “obstetric 
fistula,” “vaginal fistula,” “urinary bladder fistula,” “vesicovaginal fistula” and “fistula”; this 
yielded 6,589 articles.  The search was further refined by excluding the MeSH headings 
“infant,newborn,” “male,”  “kidney transplantation,” “adenocarcinoma,” “radiotherapy,” “penis,” 
“animals,” “prostatectomy,” “Crohn’s Disease” “child, preschool” “radiation injuries,” and 
“kidney diseases,” yielding 2,437 articles.  We reviewed titles of these articles excluding those 
clearly not meeting our eligibility criteria (below).  This resulted in 526 articles whose abstracts 
were reviewed to determine eligibility.   
 
Articles included in the final analysis met the following criteria: 1) peer reviewed; 2) original 
research; 3) focused on predictors of fistula repair outcomes; 4) published after 1970; and 5) 
written in French or English.  Articles were excluded if they 1) were case reports, cases series or 
contained 20 or fewer subjects; 2) focused on fistula in industrialized countries (since most of 
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these are secondary to surgery or malignancy, and results from such studies may not be 
generalizable to developing countries where obstetric fistula predominates); and 3) did not 
statistically analyze associations between facility or individual-level factors and surgical 
outcomes.  Review of references of published papers yielded no additional articles that met the 
inclusion criteria, nor any articles published prior to 1970 which statistically analyzed factors 
predicting surgical outcomes.  One additional article was identified via an internet search engine 
(Google).  No relevant articles in French were found. 
 
The heterogeneity of exposures and outcomes studied precluded the possibility of combining the 
results of the studies with meta-analysis.  We thus present a descriptive analysis of the articles 
identified.   
 
Results 
 
Overview of articles identified 
Nineteen articles examining predictors of fistula repair surgery outcomes were identified (Table 
2.1).  Of these, 13 reported results of retrospective record reviews,15-27 three were prospective 
studies,12, 13, 28 and three were randomized controlled trials (RCTs).29-31 Sample sizes ranged 
from 34-1045; slightly over half of the articles had samples over 10013, 15, 16, 18, 20, 24-26, 30, 32 and 
one-quarter had samples under 50.21-23, 31 These articles examined a variety of predictors (Table 
2.2):  seven examined patient or fistula characteristics,12-13, 15-17, 25, 28 six examined facility-level 
factors,18-22, 27, 30 and five examined both patient or fistula characteristics and facility-level 
factors.23-26, 31  Three studies were restricted to women undergoing primary repairs.13, 24, 30  
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Definition of “successful repair” varied, with studies defining successful repair as fistula closure, 
no residual incontinence among those with closed fistula, or no incontinence (i.e. fistula closure 
and no residual incontinence) (Table 2.2). Among those studies specifying the timing of outcome 
assessment, almost all assessed associations between predictors and repair outcomes at discharge 
from the facility (typically 2-3 weeks after surgery).  There were three exceptions. Bland and 
Gelfand assessed outcome at six weeks following surgery,28 although it was unclear whether this 
was also the time of discharge.  Safan and colleagues31 and Morhason-Bello and colleagues27 
examined outcome three months following repair. For those studies not specifying timing of 
outcome assessment15, 17, 19, 22, 23 we assumed that outcome was assessed around the time of 
discharge.   
 
We report results of both bivariate and multivariate analyses, since a minority of the 
observational studies12, 13, 16, 24-26 accounted for potential confounding with multivariate analysis. 
However, associations that did not persist after multivariable adjustment are noted when 
applicable. 
 
The relationship between patient characteristics and surgical outcomes  
Socio-demographic characteristics 
Patient age was the most common socio-demographic characteristic studied.  Six studies 
examined the association between age at repair and repair outcomes, two of which detected 
bivariate associations. Browning et al.’s study of 530 women in Ethiopia found that women with 
residual incontinence after successful closure were younger (22.5 years) than those without (25.9 
years; p<.001).  Similarly, Kirschner and colleagues found that among 926 patients in Nigeria, 
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younger age was significantly associated with any incontinence (risk difference (RD) -1.9, 
p=0.01).26 One study examined the association between patient age at fistula occurrence and 
continence. Lewis et al. found that among 435 patients (505 records; some patients had multiple 
repairs) in Sierra Leone, patient older age at fistula occurrence had a significant (p=.0192) 
positive association with complete continence, but this did not remain significant in the final 
multivariate model.16  Finally, only Kirschner and colleagues examined other socio-demographic 
characteristics, such as literacy, education and marital status.  The only significant difference 
found in bivariate analysis was across categories of marital status, with women who were 
abandoned, divorced or separated having the highest proportions of incontinence (45.2%) 
following repair.26  
 
Duration of the fistula 
Six studies examined the association between fistula duration and repair outcomes; three found 
an association.  Olusegun and colleagues found a marginally significant association (χ2=7.53, 
p=.06) between fistula duration and successful repair (undefined) among 37 patients in Nigeria, 
but the direction of the trend was not provided.22  Raassen and colleagues reported that among 
581 women repaired in Kenya, Tanzania and Uganda, patients operated within 3 months of 
fistula development were more likely to achieve fistula closure (93.9% versus 87.0%, 
respectively); this association did not hold in multivariate analysis.13 Similarly, Kirschner et al.’s 
unadjusted analysis found that longer fistula duration was associated with incontinence following 
the first surgery (RD 24.1 months, p<001).26   The remaining three studies did not find an 
association between duration of fistula and fistula closure,17 complete continence,23 and 
incontinence following successful repair.25 
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Fistula etiology 
Most studies in our review included predominantly obstetric fistula cases; however, a study by 
Kriplani and colleagues in India included fistula of differing origins and examined the influence 
of etiology on repair outcomes among 34 patients.  Fistulas resulted from vaginal delivery after 
prolonged labor (29.4%), cesarean section or post-cesarean hysterectomy (11.7%), surgical 
errors (32.3%), or other causes (26.3%).  No significant difference in complete continence 
following repair among fistulas of differing origins was found.23   
 
Obstetric history 
Five studies examined the influence of parity,16, 23, 25, 26, 31 two examined the effect of mode of 
delivery,25, 26 and one examined the duration of labor and place of delivery on repair outcomes.26  
In bivariate analysis, Kirschner et al. found that lower parity and fewer living children were 
associated with incontinence following first surgery (RD -1.0, p<.001 and RD -1.0, p<.001, 
respectively);26 Browning found a similar trend with regard to lower parity and residual 
incontinence following successful closure, though this relationship was not significant in 
multivariate analysis.25  In contrast, Lewis found that if the delivery that caused the fistula was 
the woman’s first pregnancy, it was significantly (p=.0061) associated with continence following 
repair, but this did not remain significant in the final multivariate model.16  Browning found that 
cesarean delivery offered some protection against residual stress incontinence following 
successful repair in bivariate analysis; this association did not remain significant in multivariate 
analysis;25 the second study found no association of mode of delivery with repair outcomes. 
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Finally, more days in labor (RD 0.40, p=.002) predicted incontinence following first surgery, 
while place of delivery did not, in Kirschner et al.’s study.26   
 
Patient comorbidities  
Only one study examined the association between patient comorbidities and fistula repair 
outcomes.  Bland and Gelfand examined the association between urinary bilharziasis due to 
Schistosoma haematobium and fistula closure six weeks post-surgery among 60 patients, with 
the hypothesis that fibrosis of the bladder wall caused by urinary bilharziasis may complicate 
closure and healing.  Indeed, 70% of those who were S. haematobium negative healed 
successfully, compared to 37.5% of those who were S. haematobium positive.28     
 
Summary: The role of patient characteristics 
The results of the reviewed studies do not suggest an important role of patient characteristics in 
predicting repair outcome.  While several studies found crude associations between younger age 
at repair and poor repair prognosis, neither this variable nor age at the time of fistula occurrence 
independently predicted repair prognosis.  Similarly, no evidence supported the independent role 
of parity, duration of leakage, and mode of delivery on repair outcomes.  Other factors related to 
the causative delivery or obstetric history were evaluated by only one study, and analyses were 
unadjusted.26  Finally, the only patient comorbidity evaluated was urinary bilharziasis; this was 
done among a small sample, and only unadjusted associations were assessed.28 
 
The relationship between fistula characteristics and surgical outcomes  
Tests of existing classification systems 
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Only two of the existing classification systems have been correlated (post-development) with 
patient outcomes.  Goh and colleagues tested the association of individual parameters included in 
the Goh classification system (Table 2.3) with both fistula closure and residual incontinence 
following closure, among 987 women in Ethiopia.  In bivariate analysis, women with “special 
considerations” (e.g. scarring or circumferential fistula) were significantly less likely to have 
their fistulas closed compared to those without special considerations, but fistula type was not 
associated with closure; the authors suggest that the latter finding may have been due to the small 
numbers of failed repairs.  No multivariate analyses were conducted to assess independent 
predictors of closure.  In contrast, when the authors examined incontinence following successful 
closure, multivariate analysis showed that women with Goh Type 1 fistulas were more likely to 
be continent than women with Type 4, with a trend towards decreasing continence from Type 2 
to 4.  Women with larger fistulas, and those with any special considerations, were less likely to 
be continent.12 Measures of association and 95% confidence intervals were not reported.   
 
Raassen and colleagues applied Waaldijk’s classification system (Table 2.3) to 581 fistula 
patients in Kenya, Tanzania and Uganda.  The authors found that fistula type and size did not 
significantly influence closure, adjusting for age and duration of leakage (measures of 
association were not presented).  In bivariate analysis, women with Waaldijk Type I fistulas 
(fistulas not involving the closing mechanism) were less likely to develop residual incontinence 
following repair.13  
 
Fistula size  
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Six studies examined the association between fistula diameter and repair outcomes.  As 
mentioned above, Goh et al. found that women with larger fistulas were less likely to be 
continent following successful closure, adjusting for location and scarring or other special 
considerations.33  Similarly, Browning found that each centimeter increase in diameter increased 
the odds of residual stress incontinence by 34% (OR 1.34, 95%CI: 1.16-1.56), after adjusting for 
patient and fistula characteristics.9  Lewis and colleagues found that women with larger fistulas 
were significantly more likely to have incontinence after successful repair in bivariate analysis 
only.16  While Kriplani and coauthors did not find a statistically significant difference between 
average fistula size and incontinence following surgery, cases with incontinence had a higher 
mean fistula volume than cases without (8.1 vs 2.8 square centimeters, p=.009).23 No other 
studies found an association between fistula size and repair outcomes.   
 
Bladder size  
Two studies examined the association between bladder size and repair outcomes.  Nardos and 
colleagues found that small bladder size independently predicted failure to close the fistula 
(OR=2.27, 95%CI: 1.36-3.75).24  Browning found small bladder size to independently predict 
incontinence following successful closure (OR=4.1, 95%CI: 1.2-13.8).9   
 
Vaginal scarring 
Each of the six studies examining the specific influence of vaginal scarring on fistula repair 
outcomes, including Goh’s examination of Type 3 fistula12 discussed above, detected a 
detrimental effect of scarring on repair outcomes.  Nardos and colleagues found severe vaginal 
scarring to predict failure to close fistula (OR=2.67, 95%CI: 1.36-3.75), adjusting for bladder, 
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fistula and vaginal characteristics and fistula closure techniques,24  and Holme and colleagues 
found presence of scarring to be correlated with failure to close the fistula (Spearman r=.412, 
p<.001).15  Browning found that women with scarring had 2.4 times the odds of residual stress 
incontinence following successful closure (95%CI: 1.5-4.0) adjusting for patient and fistula 
characteristics.9 In addition, Lewis and colleagues found moderate (OR=2.14, p=.01) and severe 
(OR=3.07, p<.001) scarring to progressively predict incontinence16 and Kirschner similarly 
found that severe scarring predicted incontinence compared to mild and moderate fibrosis (OR 
3.21, 95%CI: 2.10-4.89).26     
 
Prior fistula repair 
Four studies examined the association between prior repair and repair outcomes.  Browning 
found that women having a repeat procedure were more likely to experience residual 
incontinence than women undergoing primary repair in bivariate analysis (20% versus 10%, 
p=.006); however, having a repeat procedure did not predict residual incontinence in multivariate 
analysis.9  No other studies found an association between prior repair and repair outcomes.   
 
Location  
A number of studies have examined the association between fistula location and repair outcomes.  
As reviewed above, Goh and colleagues found that the greater the distance of fistulas from the 
urinary meatus, the increased likelihood of continence.12  Three studies examined the association 
between fistula location/type and any continence following surgery.  Lewis and colleagues found 
a statistically significant difference between various fistula locations/types (defined as juxta-
cervical, juxta-urethral, mid-vaginal, circumferential, secondary, extensive or vesicouterine) and 
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continence; women with mid-vaginal fistulas were more likely to be continent in bivariate 
analysis.16  Kirschner and colleagues similarly found that mid-vaginal fistulas were protective of 
repair failure, with low fistulas (urethrovaginal, circumferential, juxta-urethral, fistula behind the 
symphysis pubis) and large fistulas (defined as destruction of the entire anterior vagina) 
significantly associated with incontinence (OR 2.27, 95%CI: 1.37-3.76 and OR 4.63 (95%CI: 
2.50-8.57, respectively), adjusting for fistula duration, number of living children and 
characteristics of the causative delivery.26  Safan and colleagues found no association between 
fistula location and continence, where location was defined as urethrovesical, trigonal or 
supratrigonal.31    
 
Urethral involvement  
Five studies examined the specific influence of urethral status on repair outcomes.  Raassen et al. 
found that urethral closing mechanism involvement was not associated with fistula closure, 
adjusting for age and duration of leakage.  In bivariate analyses,  involvement of the closing 
mechanism was associated with residual incontinence.13  Similarly, Browning found that women 
whose fistulas involved the urethra had 8.4 times the odds of developing urinary incontinence 
following successful fistula closure (95%CI: 3.9-17.9), adjusting for other patient and fistula 
characteristics.9  Nardos et al.’s analysis of 1045 patients found that those with circumferential or 
urethral fistulas had 1.56 times the odds (95%CI: 0.94-2.59) of failure to close the fistula 
compared to those without, while women with complete urethral destruction had 2.29 times 
greater odds (95%CI: 1.06-4.75) of failure to close the fistula.24  Kirschner and colleagues found 
a similar dose-response relationship in terms of predicting any incontinence, whereby partial and 
complete loss of the urethra were associated with 3.58 (95%CI:2.42-5.31) and 8.04 
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(95%CI:3.18-20.31) times greater odds of incontinence, respectively, adjusting for fistula 
duration, number of living children and characteristics of the causative delivery.26  The same 
authors also examined circumferential fistula (defined as damage to the bladder neck), finding 
that women with circumferential defect had eight times higher odds of incontinence (OR 8.78, 
95%CI: 5.41-14.27) than women whose bladder neck was intact; partial damage to the bladder 
neck was associated with over twice the odds of incontinence (OR 2.48, 95%CI: 1.67-3.66).26  
Finally,  Lewis et al. found only a marginal association (OR 2.41, p=.08) between partial damage 
to the urethra and any incontinence post-repair, and no association between complete urethral 
destruction and any incontinence following repair.16   
 
Ureteric involvement  
Two studies examined ureteric involvement as a predictor of repair outcomes.  Raassen et al.13 
and Lewis et al.16 included ureteric fistulas as categories in omnibus tests of difference in repair 
outcome by fistula type/location; the specific influence of ureteric involvement was not 
evaluated in either study, and prevalence of ureteric involvement was low in both (Waaldijk 
Type 3 fistula represented 4.5% of Raassen’s et al.’s sample,13 and 1% of fistulas in Lewis et 
al.’s study were ureteric).16 
 
Combined vesicovaginal and rectovaginal fistulas and multiple urinary fistulas 
Several studies examined the influence of combined VVF/RVF on repair outcomes.  Raassen et 
al. found no difference in fistula closure between those with VVF/RVF and VVF alone.13 
Similarly Browning found that patients with combined fistulas did not have significantly more 
residual stress incontinence compared to those without RVF.25  In contrast, Kirschner et al. found 
  
35
that women with combined VVF/RVF had three times the odds of incontinence compared to 
those without (OR 3.05, 95%CI: 1.65-5.64), adjusting for number of living children and fistula 
duration.26 The influence of combined fistulas was evaluated by Lewis et al. in the omnibus test 
mentioned above; the specific influence of combined VVF/RVF on repair outcomes was not 
evaluated.  Two studies examined the association between multiple urinary fistulas and repair 
outcomes (residual incontinence after successful closure9 and any incontinence26).  Neither found 
the number of fistulas to significantly predict repair outcomes.   
 
Summary: The role of fistula characteristics 
There is relatively strong evidence to support the negative influence of fistula characteristics, 
particularly vaginal scarring and urethral involvement, on repair outcomes.  Each of the studies 
examining vaginal scarring found an association with repair outcome, including multivariate 
analyses demonstrating an independent effect of vaginal scarring on closure24 residual stress 
incontinence following closure25 and any incontinence;26  one study found a dose-response, with 
higher degree of scarring resulting in greater likelihood of any incontinence.16  Similarly, four of 
five large studies found a significant association between increased degrees of urethral 
involvement and failure to close the fistula,24 residual incontinence12, 25 and any incontinence.26  
Evidence to support the role of fistula size and bladder size, while suggestive, was based on 
fewer studies.  Two large studies found that as fistula size increases, the likelihood of continence 
following fistula closure decreases, after adjusting for other fistula and patient characteristics,12, 
25
  though the only study13 examining the association between fistula diameter and fistula closure 
found no association.  The two studies examining the association between bladder size and repair 
outcomes found evidence of an independent effect of bladder size on fistula closure24 and 
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incontinence following closure,25 with smaller size predicting failure to close the fistula or 
increased chances of incontinence after successful closure.  Finally, evidence was insufficient 
regarding the role of prior repair, ureteric involvement, combined VVF/RVF or multiple fistulas 
on repair outcomes. 
 
The relationship between facility-level factors and surgical outcomes 
Use of prophylactic antibiotics 
Two RCTs have examined prophylactic antibiotic use and repair outcomes.  Tomlinson and 
Thornton, in their study of 79 women in Benin, examined whether intra-operative intravenous 
ampicillin reduced the failure rate of VVF repair.  While the authors hypothesized that reducing 
surgical wound infections might improve fistula healing, they found a trend towards higher 
failure to heal and more incontinence in the intervention group (OR 2.1, 95%CI: 0.75-6.1);29 we 
understand heal to refer to fistula closure, since the proposed mediating mechanism between 
antibiotic use and surgical outcome is reduction of surgical wound infection.  More recently, 
Muleta and colleagues examined the effects of either 80 mg Gentamycin IV or extended use of 
Amoxicillin, Chloramphenicol or Cortimexazole on fistula closure, finding that the single-dose 
Gentamycin arm trended toward higher closure rates (94% versus 89.4%, p=.04).30   
 
Interpositional grafts or flaps  
Four studies examined the effects of Martius flap interpositioning, with mixed results.18  Safan 
and colleagues’ RCT among 38 patients compared fibrin glue versus Martius flap 
interpositioning for the repair of complicated obstetric fistula, finding no statistically significant 
difference in the proportion of patients who were continent after 3 months follow-up.31  Three 
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retrospective studies compared cases where the Martius flap was used to cases where it was not.  
One study of 46 women found a higher rate of successful closure among those with a Martius 
flap (95.2%) as compared to those without (72%, p=.038), particularly in recurrent fistulas.21  In 
contrast, a study of 440 women found no statistical difference between groups with regard to 
fistula closure; however, women with a Martius flap were significantly more likely to have 
residual incontinence.18 Finally, an analysis of 966 women found no difference in continence 
status between those receiving and not receiving Martius flap.26  
 
Surgical route 
Three retrospective studies examined unadjusted associations between surgical route and repair 
outcomes.  Chigbu and colleagues compared abdominal to vaginal routes for repair of juxta-
cervical fistulas among 78 women (65.4% of whom were repaired abdominally). They reported 
successful fistula closure in 84.3% of women repaired abdominally compared to 77.8% of those 
repaired vaginally; this difference was not statistically significant.  All of the failures in the 
vaginal group were in cases with difficult access and were subsequently repaired abdominally.19  
In contrast, among 28 repairs, Kriplani and colleagues found significantly lower incontinence 
(7.14%) using the vaginal approach compared to either the abdominal or combined approach 
(42.8%, p=.05).23  Finally, Morhason-Bello and colleagues27 found no statistically significant 
differences in continence across 71 cases of mid-vaginal fistula (with no fibrosis or evidence of 
infection, urethral or bladder neck involvement and without more than one previous repair) 
repaired either abdominally or vaginally; continence rates were 78.3% versus 80.0%, 
respectively. 
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Other peri-operative procedures 
Three separate retrospective studies examined single- versus double-layer closure, relaxing 
incision, and duration of bladder catheterization.  Nardos et al. (2009) found that single-layer 
closure was associated with failure to close the fistula among 1045 patients in bivariate analysis. 
However, the decision to use single-layer closure was influenced by bladder size, and after 
adjusting for this and other fistula characteristics, single-layer was no worse than double-layer 
closure.24  Kirschner and colleagues found that performance of a relaxing incision to improve 
exposure of the operative field was associated with twice the odds of incontinence at discharge 
(OR 1.91, 95%CI: 1.25-3.11), adjusting for number of living children, months with fistula, and 
place of delivery.26 Finally, a study conducted by Nardos and colleagues among 212 obstetric 
fistula patients found no difference in the proportion of repair breakdowns between those 
catheterized for 10, 12, or 14 days.20    
 
Summary: The role of facility-level factors 
In summary, there is sparse evidence with regard to the effectiveness of peri-operative 
procedures on repair outcomes.  The two RCTs examining antibiotic use29, 30 had indeterminate 
findings.  The only study21 finding a positive effect of Martius graft on fistula closure was small 
and reported only unadjusted associations.  While one study found the Martius Flap to be 
associated with significantly higher risk of residual incontinence after repair,18 analyses did not 
account for a range of potentially confounding factors.  All three retrospective studies examining 
route of repair19, 23, 27 were small, detected varying directions of effect, and reported only 
unadjusted associations.  The only study examining double- versus single-layer closure found no 
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association after adjusting for bladder size, and relaxing incision was found to be associated with 
incontinence, though analyses did not control for confounding by other fistula characteristics.26  
Finally, one small study found no difference across patients catheterized for durations ranging 
from 10-14 days.20  No other peri-operative procedures have been studied, nor have any studies 
examined the influence of context of repair or provider experience on repair outcomes. 
 
Discussion 
 
Overview of findings 
Most studies reviewed were observational, and few conducted analyses that would permit 
assessment of the independent effects of individual predictors.  Patient and fistula characteristics 
have been most frequently studied, with multiple studies examining the same predictors.  Studies 
of facility-level factors, such as use of antibiotic prophylaxis and duration of post-operative 
catheterization, have been less frequently replicated.   
 
The results of the reviewed studies do not support an independent role of patient characteristics 
in predicting repair outcome.  While several studies found crude associations between younger 
age at repair and poor repair prognosis, neither this variable nor age at the time of fistula 
occurrence independently predicted repair prognosis.  Indeed, it is possible that the relationship 
between patient age (at either time-point) and repair outcomes is mediated by fistula 
characteristics, since age is related to pelvic size and may thereby influence the degree of 
damage caused by the obstructed labor, in turn influencing the prognosis of the repair.    
Evidence supporting the independent role of parity, duration of leakage, and mode of delivery on 
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repair outcomes was similarly insufficient.  Finally, Bland and Gelfand’s finding regarding the 
association of s. haematobium and failure of healing is plausible given the association of s. 
haematobium with bladder damage, particularly fibrosis and tissue avascularity.  Nonetheless, 
the results were based on a small sample and only crude associations were tested.   
 
Unlike patient characteristics, the weight of evidence indicates that certain fistula characteristics, 
particularly scarring and urethral involvement, predict poor repair prognosis.   These findings are 
biologically plausible.  Extensive scarring not only inhibits access to the fistula, but also requires 
use of unhealthy tissue to close the defect.6  Vaginal scarring can also cause the urethra to be 
held open, preventing it from functioning normally.25  Similarly, urethral fistula repair is a 
complex procedure, whereby surviving tissues must be reassembled as a supple functional organ, 
which acts both as a passageway for urine, and as a “gatekeeper,” ensuring that passage of urine 
occurs at appropriate times.  Moreover, an injured, shortened, fibrotic or scarred urethra may be 
expected to lead to stress incontinence following successful closure.6   
 
The relationship between other fistula characteristics and repair outcomes is less clear. There is 
some evidence that fistula size and bladder size influence repair outcomes.  A number of studies 
examined the association between fistula diameter and repair outcomes. While two large studies 
found that as fistula size increases, the likelihood of continence following fistula closure 
decreases,12, 25  there may be some overlap in the study population in these two studies as they 
were conducted at the same facility during overlapping time periods. Nonetheless, these findings 
are not surprising, as it has been suggested that the more extensive dissection which may be 
required for larger fistulas can in turn cause post-operative scarring around the urethra, holding 
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the urethra open.25  The results of two studies examining the association between smaller bladder 
size and failure to close the fistula24 and incontinence following closure,25 are also biologically 
plausible. In the case of bladder size, loss of bladder tissue means the surgeon must try to close 
large defects in the bladder with only small remnants of (frequently damaged) bladder tissue; the 
small resulting bladder size may affect its capacity to retain urine.  While no studies detected an 
independent association of prior repair and repair outcomes, prior repair has been correlated with 
the degree of vaginal scarring.15  Thus, prior repair may be an indirect cause of negative repair 
outcomes, via vaginal scarring; this could explain the lack of an independent role of prior repair 
after adjusting for vaginal scarring, as was found by both Browning25 and Lewis and 
colleagues.16 Additional studies with sample sizes large enough to study relatively rare exposures 
such as ureteric involvement are needed.  
 
Few studies have examined the role of facility-level factors, such as peri-operative procedures, 
on repair outcomes, and all but three were observational study designs.  The results of both RCTs 
examining antibiotic use29, 30 are difficult to interpret.  The findings that prophylactic antibiotic 
use trended towards higher operative failure and more incontinence compared to no antibiotic 
use are surprising and counter-intuitive, given the expectation that reducing wound infections 
would promote fistula closure.  The results of a recent trial comparing single-dose versus 
extended antibiotic use demonstrate a marginally significant benefit in favor of single-dose 
antibiotics, though reasons for such a trend are unclear.  However, the confidence intervals for 
both results were compatible with a chance result.  The RCT comparing fibrin glue to Martius 
flap interpositioning was also inconclusive, due to its small sample size.   
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Observational studies examining medical interventions are subject to confounding by indication, 
or prognosis, whereby providers prescribe vigorous therapy when the outlook is poor.34  This 
applies to observational studies examining peri-operative interventions related to fistula surgery.  
For instance, Nardos et al.20 demonstrated that women catheterized for fewer days were 
significantly more likely to have fistula characteristics associated with a favorable repair 
prognosis, including an intact urethra and little or no vaginal scarring; this and the limited power 
of the study to detect clinically significant differences between catheterization groups limit the 
conclusions that can be drawn from the study. In contrast, while Kriplani and colleagues23 found 
a significantly higher proportion success among fistulas repaired vaginally, analyses did not 
account for the severity of the fistula, and it is possible that fistulas repaired abdominally may 
have been more difficult cases.  Similarly, while Kirschner and coauthors found that use of 
relaxing incision was associated with poorer prognosis, analyses did not adjust for scarring and 
stenosis, factors that the authors acknowledge may have indicated use of relaxing incision.26 
 
Several observational studies restricted their samples to women meeting specific characteristics, 
or conducted stratified analyses.  However, this approach does adjust for multiple confounding 
factors.  For instance, while two studies19, 27 examining route of repair restricted study samples to 
women with fistulas that can be repaired either abdominally or vaginally (juxta-cervical and mid-
vaginal fistulas, respectively), patients repaired abdominally may have exhibited other 
characteristics associated with both abdominal route and repair outcome.  Similarly, while 
Browning18 found that a significantly higher proportion of women experienced residual 
incontinence after repair, analyses stratified by components of the Goh classification system and 
other subgroups demonstrated that fistulas repaired with Martius flap may have been more 
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difficult cases.  While differences persisted within select subgroups (e.g. urethral fistulas), it is 
not possible to completely exclude the possibility of confounding by indication: for instance, 
among urethral fistulas, those repaired with Martius flap may have been larger.  Further, as 
acknowledged by the author, since repairs conducted with Martius flap were conducted at an 
earlier time point in the author’s surgical career, results may be confounded by his increased 
level of experience.18     
 
Implications and future directions 
Evidence to support existing classification systems 
There is wide agreement among those working in the field of fistula care and treatment that a 
single, evidence-based standardized system of classifying obstetric fistula is needed.6, 11, 35-37  
The development of such a system requires evidence demonstrating which fistula characteristics 
independently predict outcomes, and identification of the minimal parameters required for 
accurate prognosis.  The studies reviewed above which tested components of the Goh and 
Waaldijk classification systems to evaluate whether they predict repair outcomes12, 13 represent 
useful additions to the evidence-base regarding the relative importance of different fistula 
characteristics in predicting repair outcomes.  However, these studies cannot in and of 
themselves determine the sufficiency of either system in predicting repair outcomes, nor the 
superiority of one over another.  First, since these systems were not empirically derived, it is 
possible that other patient or fistula characteristics not included are also important in predicting 
repair outcomes.  Similarly, the inability of any component of these systems to predict fistula 
closure must not be interpreted to mean that these components or the systems themselves lack 
prognostic value.  Instead, these studies may have been underpowered to detect small 
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differences.  For instance, while these studies did not identify any independent predictors of 
fistula closure, Nardos and coauthors’24 larger study found that complete urethral destruction and 
severe vaginal scarring (approximations of parameters included in the Goh system) 
independently predicted fistula closure.24  It is also important to note that while the results 
suggesting aspects of Goh’s system predict residual incontinence12 were replicated by 
Browning,25 the additional evidence provided by the latter study is hard to interpret because of 
the possible overlap in study populations.     
 
Future research priorities 
In order to develop a single, standardized prognostic system for classifying fistulas, additional 
research confirming the prognostic value of parameters included in existing classification 
systems is needed.  In addition, it is necessary to explore if other parameters not included in the 
current classification systems predict repair outcomes, which may indicate that they should be 
incorporated into an existing or new system.  It is also important to compare existing 
classification systems to assess the discriminatory value of each as a whole in terms of predicting 
repair outcomes.  If it is determined that one system does indeed have higher discriminatory 
value, and if the system in question has not yet been validated, the system will need to be tested 
to ensure that it has both inter-rater and intra-rater reliability.  A classification system that is 
overly complicated or difficult to learn will have limited utility in practice, and is unlikely to be 
adopted.   
 
More research is required to assess which facility-level factors are associated with repair 
outcomes.  In particular, further research is required on factors such as duration of catheterization 
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and route of repair which may be associated with increased hospital stay and risk of infection.  
Nardos and colleagues20 illustrated the cost implications of duration of post-repair 
catheterization; assuming no compromise in patient outcomes, removing bladder catheters at 10 
days rather than 14 would decrease hospitalization by four days, increasing by 20% the number 
of patients who could receive surgical care.  Longer duration of bladder catheterization may also 
increase risk of UTIs.  A recent Cochrane review of urinary catheter policies following 
urogenital surgery in adults examined seven trials comparing shorter postoperative duration of 
catheter compared to longer; these trials suggested that shorter-term catheterization was 
associated with fewer UTIs.38  Given the potential benefits of short-term catheterization in terms 
of increasing capacity for treating additional patients and the potential reduced risk of 
nosocomial infection, further empirical evidence is needed to determine the non-inferiority of 
short-term catheterization compared to longer-term catheterization.  Similarly, the vaginal 
approach to fistula repair may be associated with less blood loss and pain, fewer complications, 
and a shorter hospital stay; however, it may also be associated with vaginal shortening and 
scarring.11  Further research examining the influence of route of repair on repair outcomes is 
warranted.  A standardized system of classifying fistula prognosis will facilitate the conduct of 
such studies.  
 
Conclusion 
 
A small, albeit growing, number of empirical studies has examined the relationship between 
fistula repair outcomes and patient characteristics, fistula characteristics and peri-operative 
procedures used.  Many of the studies we reviewed had relatively small sample sizes and did not 
use rigorous epidemiologic research methods.  This, together with the range of predictors studied 
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and variety of definitions of successful repair used, has resulted in lack of a unified evidence-
base on most predictor-repair outcome relationships and thus little evidence on which to base 
clinical practice.  Further research is urgently needed to improve the care and treatment of this 
most marginalized and neglected group of women.  
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Table 2.1: Publications examining predictors of fistula repair outcomes in developing country settings
Author,  
Year 
Study Design Population Sample 
size 
Outcome 
definition 
Exposures of interest Analytic 
approachi 
Statistically 
significant predictors 
of repair outcomesii 
Kirschner 
et al., 
201026 
Retrospective 
record review 
Patients with 
vesicovaginal 
fistula; where unit 
of analysis was 
individual patient, 
analyses were 
restricted to women 
undergoing first 
repair 
1084 
records 
from 
926 
patients 
Continence (dry vs 
wet), assessed at 
time of discharge 
Patient characteristics 
(age, education, parity, 
number of living 
children, literacy, 
language group and 
marital status), clinical 
data (cause of fistula and 
number of previous 
surgeries) and surgical 
data (type/location of 
fistula, degree of fibrosis, 
surgical approach, and 
procedures performed) 
Independent 
sample t-tests and 
Chi-square tests 
 
GEE bivariate and 
multivariate 
regression. 
Multivariate 
models adjusted 
for days in labor, 
number of living 
children, marital 
status, months with 
fistula and place of 
delivery   
Partial loss of the 
urethra, complete loss 
of the urethra, partial 
damage to the bladder 
neck, circumferential 
defect, relaxing 
incision, mixed VVF 
and RVF repair, 
severe fibrosis, lower 
fistula (protective), 
large fistula 
(protective) 
Muleta et 
al., 201030 
RCT Patients with 
obstetric fistula 
undergoing first 
repair 
722 
patients 
Fistula closure, 
assessed after 
catheter removal 
and prior to 
discharge 
Single-dose Gentamycin 
vs. extended (7-day) 
antibiotic use. Extended 
antibiotic use included 
any one or combination 
of Amoxicillin (500mg 
IV and oral 6 hourly), 
chloramphenicol (500 mg 
IV and oral 6 hourly), or 
cotrimexazole (800 mg 
orally every 12 hours)  
Chi-square, risk 
difference 
Single-dose 
Gentamycin 
significantly 
associated with fistula 
closure; confidence 
interval for risk 
difference marginally 
significant 
                                                 
i
 Only the analytic approach for the outcome of interest is reported 
ii
 Where bivariate and multivariate analyses were conducted, only multivariate results are reported  
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Author,  
Year 
Study Design Population Sample 
size 
Outcome 
definition 
Exposures of interest Analytic 
approachi 
Statistically 
significant predictors 
of repair outcomesii 
Nardos et 
al., 200924 
Retrospective 
record review 
Patients with 
obstetric 
vesicovaginal 
fistula undergoing 
first repairs via 
vaginal route 
1045 
patients 
Fistula closureiii, 
assessed after 
catheter removal 
and prior to 
discharge 
Fistula location, number 
of fistula, extent of 
urethral intactness, extent 
of scarring, residual 
bladder size, repair 
technique (single vs 
double layer closure)   
Logistic bivariate 
and multivariate 
regression 
Complete urethral 
destruction, severe 
vaginal scarring and 
small bladder size 
Lewis et al. 
200916 
Retrospective 
record review 
Patients with 
genitourinary 
fistula  
505 
records 
from 
435 
patients 
Continence (dry vs. 
wet), assessed via 
subjective appraisal 
after catheter 
removal and prior 
to discharge 
Patient demographics 
(age), obstetric history 
(index pregnancy), and 
fistula parameters 
(number of prior repairs, 
fistula 
type, site and size, degree 
of fibrosis, and urethral 
status  
Chi-square and 
Wilcoxon rank 
sum test; bivariate 
analyses stratified 
by primary vs. 
subsequent repair 
 
GEE multivariate 
regression   
Whether the 
patient presented for 
the 3-month follow-up 
appointment, degree 
of fibrosis 
surrounding 
the fistula  
Olusegun 
et al. 
200922 
Retrospective 
record review 
Patients with 
vesicovaginal 
fistula 
37 
patients 
Successful repair 
(undefined) 
Duration of fistula before 
repair 
Chi-square Duration of fistula 
(marginally 
significant) 
Safan et al. 
200931 
RCT Patients with 
complicated fistula 
(defined as 
recurrence, local 
moderate to severe 
fibrosis, fistula 
location involving 
the bladder neck, 
and or size of the 
fistula being more 
than 1.5 cm in 
largest diameter) 
38 
patients 
Continence (dry vs. 
wet), assessed at 
three months 
follow-up 
Primary exposures were 
fibrin glue vs martius flap 
as interpositioning layer.  
Also examined parity, 
patient age, attempts of 
previous repairs, fistula 
size, and fistula location 
 
Chi-square or 
Fisher’s Exact tests 
None 
                                                 
iii
 Unless otherwise specified, fistula closure was assessed using dye test if the patient reported urine leakage 
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Author,  
Year 
Study Design Population Sample 
size 
Outcome 
definition 
Exposures of interest Analytic 
approachi 
Statistically 
significant predictors 
of repair outcomesii 
Goh et al. 
200812 
Prospective Patients with 
genitourinary 
fistula (women 
with rectovaginal 
fistula only or no 
bladder tissue 
excluded) 
987 
patients 
Fistula closure and 
residual urinary 
incontinence 
following 
successful closure, 
assessed after 
catheter removal 
and prior to 
discharge 
Components of Goh’s 
classification system: 
Fistula type 
(characterized by 
distance of fistula from 
external urinary meatus), 
size, “special 
considerations” (extent of 
fibrosis and vaginal 
length, and special 
circumstances such as 
previous repair, ureteric 
involvement, etc) 
Chi-square test and 
logistic 
multivariate 
regression (residual 
incontinence only) 
Closure (bivariate 
only): “Special 
considerations” (e.g. 
scarring and 
circumferential 
fistulas) 
 
Residual 
incontinence:  
Greater distance from 
external urinary 
meatus (protective), 
fistula larger than 1.5 
cm, “special 
considerations”   
Morhason-
Bello et al. 
200827 
Retrospective 
record review 
Patients with mid-
vaginal fistulas 
with no fibrosis, 
evidence of 
infection, urethral 
or bladder neck 
involvement and 
more than one 
previous repair 
attempt 
71 
patients 
Continence three 
months following 
surgery 
Abdominal versus 
vaginal route of repair 
Fisher’s exact test None 
Nardos et 
al. 200820 
Retrospective 
record review 
Patients with 
obstetric fistula 
(women with 
rectovaginal fistula 
only excluded) 
212 
patients 
Fistula closure and 
residual 
incontinence, 
assessed after 
catheter removal 
and prior to 
discharge 
(differences at 6-
month follow-up 
not tested) 
3 duration of 
catheterization groups: 10 
days (group 1), 12 days 
(group 2), and 14 days 
(group 3) 
Unspecified (chi-
square assumed); 
bivariate analyses 
stratified by 
components of 
Goh classification 
system 
None 
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Author,  
Year 
Study Design Population Sample 
size 
Outcome 
definition 
Exposures of interest Analytic 
approachi 
Statistically 
significant predictors 
of repair outcomesii 
Raassen et 
al. 200813 
Prospective Patients with 
obstetric fistula 
undergoing first-
time repair 
581 
patients 
Fistula closure 
assessed via dye 
test prior to 
catheter removal 
(14-21 days 
following surgery) 
and residual 
urinary 
incontinence 
following 
successful closure 
assessed after 
catheter removal 
prior to discharge  
Patient characteristics 
(age and duration of 
leakage) and components 
of Waaldijk classification 
system (type of fistula 
characterized by extent of 
involvement of closing 
mechanism and presence 
of circumferential defect, 
exceptional fistulas and 
size)  
Chi-square and 
Fisher’s Exact tests 
and logistic 
multivariate 
regression (closure 
only) 
Closure: none 
 
Residual incontinence 
(bivariate only): lack 
of involvement of 
closing mechanism 
(protective) 
Holme et 
al. 200715 
Retrospective 
record review 
Patients with 
obstetric fistula 
259 
patients 
Closure, not closed, 
residual 
incontinence; time 
period unspecified 
Scarring Spearman 
correlation  
Scarring  
Browning 
200618 
Retrospective 
record review 
Patients with 
obstetric fistula 
(women with 
rectovaginal fistula 
only excluded) 
413 
repairs 
Fistula closure 
assessed via dye 
test prior to 
catheter removal 
(14-21 days 
following surgery) 
and residual 
urinary 
incontinence 
following 
successful closure 
assessed after 
catheter removal 
prior to discharge 
Martius graft Fisher’s Exact test 
or Chi-Square with 
continuity 
correction; 
bivariate analyses 
stratified by 
components of 
Goh classification 
system and other 
fistula 
characteristics 
Closure: none 
 
Residual 
incontinence:  
Martius graft (among 
all fistulas examined 
together, fistula > 6 
cm, Goh’s Type 2 
fistulas (distal edge 
2.5-3.5 cm from 
external meatus), and 
urethral fistulas 
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Author,  
Year 
Study Design Population Sample 
size 
Outcome 
definition 
Exposures of interest Analytic 
approachi 
Statistically 
significant predictors 
of repair outcomesii 
Browning 
200625 
Retrospective 
record review 
Patients with 
obstetric fistula 
(women with 
breakdown of 
repair, lack of 
bladder tissue and 
rectovaginal fistula 
only excluded) 
481 
women 
Residual 
incontinence 
following fistula 
closure, assessed 
following catheter 
removal and prior 
to discharge 
Urethral involvement, 
repeat surgery, size of 
fistula, size of bladder, 
location of ureter, 
scarring, flap required, 
presence of rvf, number 
of vvf, age, parity, 
duration labor, time since 
delivery, diameter of 
fistula, delivery method 
and outcome of delivery 
T-test, Mann-
Whitney U test, 
and logistic 
multivariate 
regression 
Urethral involvement, 
repeat repair, size of 
fistula, size of 
bladder, rvf present, 
younger age, lower 
parity and c-section 
delivery (protective) 
Chigbu et 
al. 200619 
Retrospective 
record review 
Patients with juxta-
cervical 
vesicovaginal 
fistula 
78 
women 
Fistula closure, 
time period of 
assessment 
unspecified 
Route of repair (vaginal 
vs. abdominal) 
 
T-tests and Chi-
square tests 
None 
Melah et 
al. 200617 
Retrospective 
record review 
Patients with 
vesicovaginal 
fistula 
80 
women 
Fistula closure and 
residual 
incontinence 
following closure; 
time period of 
assessment 
unspecified 
Early (less than 3 
months) vs. late (after 3 
months) closure 
Chi-square None 
Kriplani et 
al. 200523 
Retrospective 
record review 
Patients with 
genital fistula 
(radiation fistulas 
excluded) 
34 
women 
Continence 
following catheter 
removal 
Age, parity, duration of 
fistula, route of repair, 
cause of occurrence   
Levene’s test of 
equality of 
variances and Chi-
square with Yates 
correction 
Abdominal route of 
repair and volume of 
fistula 
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Author,  
Year 
Study Design Population Sample 
size 
Outcome 
definition 
Exposures of interest Analytic 
approachi 
Statistically 
significant predictors 
of repair outcomesii 
Rangnekar 
et al. 
200021 
Retrospective 
record review 
Patients with 
urinary-vaginal 
fistulas (excluded 
fistulas situated 
high on the 
posterior wall of 
the bladder and 
fistulas greater than 
1.5cm in size) 
46 
women 
Fistula closure 
assessed via dye 
test prior to 
catheter removal 
and residual 
incontinence 
following closure, 
assessed with 
urodynamic test 3 
weeks post-
operatively.   
 
Martius flap repair Fisher’s exact test Martius procedure 
(protective) 
Tomlinson 
and 
Thornton 
199829 
RCT Patients with 
obstetric vesico-
vaginal fistula 
79 
women 
Fistula closure and 
continued 
incontinence 
(positive pad test) 
at hospital 
discharge.  
500 mg ampicillin Mann-Whitney 
(non-parametric 
tests) 
None 
Bland and 
Gelfand 
197028 
Prospective Patients with 
vesicovaginal 
fistula 
60 
women 
Closed fistula 6 
weeks after repair 
Urinary bilharziasis 
defined by presence of 
ova on bladder biosopsy 
or urine examination or 
rectal snip 
Chi square with 
Yates correction 
Presence of urinary 
bilharziasis 
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Table 2.2: Predictors studied across the articles reviewed, by outcomeiv  
Predictor Closure Residual incontinence Any incontinence Not specified 
Patient Characteristics 
Comorbidities (s. haematobium) 28    
Age at fistula repair  13 25, 13 16, 23, 26, 31  
Age at fistula occurrence   16, 26  
Duration of fistula  17, 13 17, 25,13 23, 26 22 
Parity  25 16, 23, 26, 31  
Number living children   26  
Mode of delivery  25 26  
Days in labor   26  
Education   26  
Literacy   26  
Place of delivery   26  
Fistula characteristics 
Etiology   21  
Number of fistulas  25 26  
Fistula size 12, 13 25, 12, 13 16, 23, 26, 31  
Bladder size 24 25   
Bladder neck   26  
Scarring 15, 24, 12 15, 25, 12 16, 26  
Location of the fistula 24, 12 25, 12 16, 26, 31  
Extent of urethral involvement / 
circumferential fistula  
24, 13 13, 25 16, 26  
Ureteric involvement 13 13 16  
Combined vvf/rvf 13 25,13 16, 26  
Previous repair   25 16, 23, 31  
Goh type 3 fistula 12 12   
Facility-level factors 
Surgical route 19  23, 27v  
Duration catheterization 20 20   
Single vs. double layer closure 24    
Relaxing incision   26  
Fibrin glue vs. Martius 
flap/graft  
  31  
Martius fibrofatty flap/graft 18, 21 25 26  
Antibiotic prophylaxis   30, 29 29   
 
                                                 
iv
 Articles indicated by reference number 
v
 Outcome examined confirmed via personal communication with primary author 
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Table 2.3: Waaldijk and Goh fistula classification systems 
Classification 
system 
Type and / or description of fistula 
Waaldijk 199539 Classification 
Type 1  Not involving the closing 
mechanism 
Type 2  Involves closing mechanism 
A          Without (sub)total urethra 
involvement 
B          With (sub)total urethra involvement 
a           Without circumferential defect 
b           With circumferential defect 
Type 3  Ureteric and other exceptional 
fistula 
Size 
Small <2 
Medium 2-3 
Large 4-5 
Extensive> 6 
Goh 200440  Type: distance from fixed reference point 
Type 1  Distal edge of the fistula >3.5 cm from external urinary meatus 
Type 2  Distal edge of the fistula 2.5-3.5 cm from external urinary meatus 
Type 3  Distal edge of the fistula 1.5-<2.5 cm from external urinary meatus 
Type 4  Distal edge of the fistula <1.5 cm from external urinary meatus 
Size: largest diameter in centimetres 
a           Size <1.5 cm in the largest diameter 
b           Size 1.5-3 cm in the largest diameter 
c           Size >3 cm in the largest diameter 
Special considerations 
i.           None or only mild fibrosis (around fistula and/or vagina) and/or vaginal length 
>6cm, normal bladder capacity 
ii.          Moderate or severe fibrosis (around fistula and/or vagina) and/or reduced 
vaginal length and/or bladder capacity 
iii.         Special circumstances, e.g. post-radiation, ureteric involvement, 
circumferential fistula, previous repair  
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Chapter 3 : Development and test of prognostic scoring systems for surgical urinary fistula 
closure 
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Abstract 
 
Although over 25 systems exist for classifying vaginal fistula, no studies have examined the 
comparative value of different systems in predicting surgery outcomes. We tested the 
discriminatory value of five existing classification systems - those developed by Lawson, 
Tafesse, Goh, World Health Organization (WHO) and Waaldijk - to predict fistula closure. We 
also devised a scoring system using patient comorbidities and fistula characteristics found to 
independently predict fistula closure. We analyzed data for 1274 women with urinary fistula who 
presented for repair at 11 study sites in Uganda, Guinea, Niger, Nigeria and Bangladesh and 
returned for follow-up three months following surgery.  Using one-half the sample we created 
multivariate generalized estimating equation models to derive weighted prognostic scores for 
variables included in each classification system.  Using the second half of the sample and the 
prognostic scores derived above, we developed Receiver Operating Characteristic curves and 
calculated areas under the curves (AUCs) and corresponding 95% confidence intervals (CI) for 
each classification system.  The scoring systems representing Tafesse’s, Goh’s and WHO’s 
classification systems had the highest predictive values: AUC 0.60 (95%CI: 0.55-0.65), AUC 
0.62 (95%CI: 0.57- 0.68), and AUC 0.63 (95%CI: 0.57-0.68), respectively, compared to the 
other existing systems; there was no statistically significant difference in the AUCs of these 
scores.  Our proposed empirically-derived prognostic score combined significant predictors of 
closure in the above classification systems; this score achieved a similar discriminative ability 
(AUC 0.62, 95%CI: 0.56-0.67) to the scores representing Tafesse’s, Goh’s and WHO’s systems, 
and contained only few, non-overlapping, components.  Further evaluation of the reliability and 
  
60
validity of existing classification systems is warranted.  Consideration should be given to a 
prognostic score that is evidence-based, simple and easy to use. 
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Introduction 
 
While only garnering worldwide attention in the past decade, vaginal fistula, or an abnormal 
opening between the vagina and bladder or between the vagina and rectum, is an ancient 
condition.  Predominantly caused by obstructed labor (in which case it is referred to as “obstetric 
fistula”), evidence of the injury was found in the mummified remains of an 11th dynasty 
pharaoh’s wife, whose reign dated around the year 2050 BCE.1   From the mid 19th century, 
when the first surgical techniques for repairing vaginal fistulas were developed, efforts have been 
made to develop a schema for classifying them.2  Currently at least 25 such systems exist,3 and 
the reliability and validity of the majority of them have not been empirically tested.  While there 
is widespread acknowledgement that a single, standardized classification system is needed,3-7 
there remains disagreement with regard to which fistula characteristics this system should 
include, and what purposes (e.g. prognostic or descriptive) the classification system should serve.  
 
The purposes of existing systems for classifying vaginal fistula, and their characteristics, vary.  
These classification systems are used for didactic purposes, as a means of facilitating 
communication and learning.  Such systems are also used for planning and executing fistula 
repair, including assessing the prognosis of repair, and determining the need for referral.  For 
instance, a classification assigned to a fistula during the initial examination at admission to the 
facility may be used by the examining surgeon to determine whether the fistula would be most 
appropriately repaired by a highly experienced fistula surgeon, or whether it would be 
appropriate for a trainee.   The majority of systems classify urinary fistulas, or vaginal fistulas 
that result in urinary incontinence (as opposed to fistulas resulting in fecal incontinence, or 
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rectovaginal fistulas).  However, the components measured by different classification systems 
vary.  Some (particularly older) systems describe the location of the fistula only; examples of 
these are the systems developed by Sims (1852)2 and Lawson (1968).8  Other systems such as 
those developed by Goh,9 Tafesse10 and Waaldijk11 are more detailed, describing the anatomical 
structures affected and the extent to which these structures are affected, as well as other factors, 
such as bladder size, the size of the fistula and the amount of scarring involved.  Components of 
these more detailed systems can be variously combined to allow for a precise description of the 
fistula.  The implicit assumption is that as the type increases by number or letter combination 
(e.g. Type 2Bb versus Type 2A), the worse the prognostic rating, or “grade.”  Indeed, two of 
these systems, those developed by Goh and Waaldijk, have been empirically tested to determine 
the extent to which parameters included in the systems predict repair outcomes.12, 13  An 
additional classification presented by the World Health Organization (WHO) in their manual 
Obstetric fistula: Guiding principles for clinical management and programme development,14 
aims to classify fistula on the degree of difficulty of the repair (simple or complex).  However, 
this system has not been validated, nor (to our knowledge) is it currently used in a clinical 
setting.  No systems currently in use are prognostic scoring systems and none include patient 
characteristics, including comorbidities.   
 
Importantly, each of these systems were developed using clinical judgment, rather than empirical 
evidence.  Indeed, few studies have examined the ability of individual patient or fistula 
characteristics to predict fistula repair outcomes,12, 13, 15-23 and due to the relatively small sample 
sizes of many of these studies and the variety of definitions of successful repair used, the 
evidence-base on most predictor-repair outcome relationships remains thin.  No study to-date has 
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examined the comparative value of the different classification systems for predicting surgical 
outcomes.   
 
A standardized evidence-based system of classifying the prognosis of fistula repair surgery 
would have a number of advantages.  First, such a system would facilitate communication and 
learning across fistula surgeons worldwide.  In clinical practice, an evidence-based classification 
system would assist with the appropriate triage or selection of clients.5  An evidence-based 
prognostic scoring system in particular would have unique advantages.  A scoring system could 
facilitate surgeons’ decisions regarding patient referral, by providing thresholds for what 
constitutes a “good” or “poor” prognosis.  In the research setting, a prognostic score would 
facilitate the evaluation of surgical success rates across facilities, and the effectiveness of 
interventions independent of patient or fistula characteristics which may be associated with both 
the intervention and repair prognosis.  Such a score would also facilitate the comparative 
analysis of studies that examine treatment outcomes.  In order to be clinically and analytically 
useful, such a system must be both simple and sufficient.  In clinical practice, a simple and 
sufficient system will facilitate use and increase accuracy of prognostic prediction.  For analytic 
purposes, a prognostic score should accurately adjust for confounding, decreasing opportunities 
for residual confounding, yet not over-adjusting, which may unnecessarily increase variance.24 
 
Using data collected as part of a multi-country prospective cohort study, we first aimed to test 
the discriminatory value of five existing vaginal fistula classification systems (Lawson’s,8 
Waaldijk’s,11 Tafesse’s,10 Goh’s9 and the system proposed by WHO14) with regard to predicting 
fistula closure, the primary goal of fistula repair surgery.  These systems were selected because 
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we were able to measure their components using our study instruments, and are either commonly 
used in clinical settings (Waaldijk, Goh and Tafesse), or represent a range of detail, from the 
more sparse and descriptive (the Lawson system) to the more exhaustive (the system presented 
by the WHO).  Further, with the exception of the WHO system, all have been explicitly 
presumed to have prognostic value.  Our secondary aim was to evaluate whether the inclusion of 
patient characteristics or fistula characteristics not included in other classification systems 
represents an improvement over existing classification systems in terms of predicting fistula 
closure.  These analyses will thus provide an important contribution to efforts spearheaded by the 
WHO and other international agencies towards the development and acceptance of a single, 
standardized, evidence-based fistula classification system.   
 
Methods 
 
Study participants 
1389 women presenting for fistula repair services at 11 study sites in Uganda, Guinea, Niger, 
Nigeria and Bangladesh were enrolled between September 2007 and September 2010.  Since our 
primary outcome was urinary fistula closure, 25 women were excluded because they underwent 
repair for recto-vaginal repair only; an additional 35 women were excluded because they were 
either referred to other facilities, did not have surgery for medical/safety reasons, or were treated 
by catheterization; these women were distributed across all facilities.  The majority of those 
undergoing surgery (95.9%) returned for a follow-up visit; these 1274 women constitute the 
study sample for these analyses.   Most of those not retained (70.4%) came from two sites; 
women not retained were more likely to be malnourished, anemic, and have a failed repair at 
discharge (39.4% versus 14.9%).  The study received national institutional review board (IRB) 
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approval in Nigeria, Uganda, Guinea, and Niger; local (facility-based) ethical review was 
conducted at two of three facilities in Bangladesh; one of the three study sites chose not to 
subject the study protocol to ethical review.  All patients provided signed informed consent (if 
the patient was not literate, consent was indicated via thumbprint). 
 
Study procedures  
Prior to surgery, facility staff trained in study procedures and interview techniques interviewed 
women on their socio-demographic characteristics and obstetric history using standardized study 
questionnaires.  All clinical information was collected by either the attending surgeons or nurses 
using standardized case report forms; in the case of missing information, facility staff were asked 
to obtain the information (when available) from the patient’s clinical records.   Prior to surgery, 
information was collected on comorbidities and any medical care provided for these 
comorbidities.  At the time of surgery, detailed information was collected about characteristics of 
the fistula, intra-operative procedures performed and surgical outcomes.  Following the surgery 
but prior to discharge, women were queried about post-operative care provided, and at discharge, 
information about surgical outcomes was once again collected.  Participants were asked to return 
three months following the surgery, at which point a clinical evaluation was conducted to assess 
surgical outcomes.  Surgical repair protocols, including surgical procedures employed and pre- 
and post-operative care provided, varied across sites, as per routine practice. 
 
Measures  
The primary outcome is urinary fistula closure three months following the surgery, whereby the 
fistula is characterized dichotomously as either “closed” or “open.”  The primary mechanism of 
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assessing closure was through a pelvic exam and dye test.  For 186 women (14.6% of cases) in 
which no pelvic exam was conducted, fistula closure was determined using the question “does 
the client have continuous and uncontrolled leakage of urine,” asked of every client at the three-
month follow-up visit; this question has been used to differentiate between fistulas and other 
forms of incontinence, which are unlikely to be continuous and uncontrolled, in household-based 
Demographic and Health (DHS) surveys.25  At the two sites where pelvic exams were not 
routinely conducted at follow-up, any patient complaining of leakage of urine underwent a pelvic 
exam; since women with continued urinary leakage are eager to report their experiences to the 
surgeon in order for the condition to be rectified, misclassification of outcomes was unlikely.  
All cases where the dry test was negative but the patient reported continuous and uncontrolled 
leakage of urine were verified to exclude the possibility of an unclosed ureteric fistula or 
otherwise misclassified outcome.  In the event that a participant had multiple urinary fistulas 
(n=74), closure refers to closure of all fistulas.  For two women with multiple urinary fistulas, the 
surgery represented the first of a staged repair, and their fistulas were thus considered “closed” 
despite continued leakage from the remaining fistulas.  We also conducted sensitivity analyses 
using fistula closure at discharge from the facility (Appendix E); fistula closure at discharge was 
assessed the same way as closure at follow-up. 
 
In order to compare the predictive value of several existing classification systems, we first 
transformed these systems into scoring systems.  Using data collected as part of our study we 
created variables representing the components of the four classification systems we aimed to 
compare.   The components of Lawson’s classification were measured directly in our dataset, 
with the exception of “massive combination fistula.”  Massive combination fistulas were defined 
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by Lawson8 as those that are juxta-urethral, mid-vaginal and juxta-cervical; these three measures 
in our dataset were thus combined to create the variable “massive combination fistula.” 
 
In terms of Waaldijk’s classification system, non-involvement of the closing system (Type 1 
fistulas) was defined as those fistulas that were either explicitly stated in the study questionnaire 
to not involve the closing mechanism or did not involve complete destruction of the bladder 
neck.  Type 1 fistulas served as a reference category for the various Type 2 fistula subtypes.  
Subtype 2A fistulas (“without (sub)total urethra involvement”) were equated with an intact or 
partially damaged urethra in our questionnaire, and subtype 2B fistulas (“with (sub)total urethra 
involvement”) were considered to be urethras that were characterized as completely destroyed in 
the questionnaire.  These Type 2 subtypes were further subdivided into four categories, with 
Type2Ab and Type2Bb fistulas involving circumferential injury (urethra completely separated 
from the bladder).  We defined Type 3 (“ureteric or other exceptional fistula”) fistulas to include 
mixed vesicovaginal and rectovaginal fistulas, cervical and ureteric fistulas; urethral fistulas 
were excluded since the urethral closing mechanism and circumferential fistulas are measured as 
part of the Type 2 category.   
 
With regard to Tafesse’s classification system, the study questionnaire did not objectively 
measure bladder length, so it was not possible to create variables exactly representing Tafesse’s 
categorizations of longitudinal bladder diameter greater than 7 centimeters, 4-7 centimeters and 
less than 4 centimeters.  Instead, we equated bladder diameter less than 7 centimeters with the 
measured category “small” bladder.  Similarly, we considered involvement of less than 50% of 
the anterior vagina to equate with “minimal” tissue loss, greater than 50% involvement to equate 
with “moderate” tissue loss, and the category obliterated vagina to equate with either “extensive” 
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tissue loss or obliterated vagina according to response categories in the study questionnaire.  
Urethral involvement was measured by surgeons’ estimates of the length of the urethra, in 
centimeters, categorized according to Tafesse’s specifications. 
 
For Goh’s classification system, urethral length in centimeters was used to estimate the location 
of the distal edge of the urethra relative to the external urinary meatus; urethral length was 
categorized according to Goh’s specifications.  Classification subtypes i and ii were 
operationalized by creating a variable representing the presence of moderate or severe fibrosis 
and / or a small bladder; no measure of vaginal length or bladder capacity was available.  Finally, 
we created a variable representing the classification subtype “special considerations,” which 
included the presence of ureteric involvement, a circumferential fistula, or previous repair. 
 
In order to measure components of the WHO classification, the number of fistulas was 
dichotomized as one or greater than one, an indication that the urethra was intact was considered 
to mean absence of urethral involvement, and mild or greater scarring of the vagina was used to 
indicate presence of scarring.  The WHO system does not allow for a “moderate” degree of 
tissue loss, so we grouped moderate and minimal tissue loss into a single category as a proxy for 
minimal tissue loss in the WHO system.  Since there is considerable overlap between the WHO 
categories “site” (vesico-vaginal versus non vesico-vaginal fistulas) and “ureter/bladder 
involvement” (ureters are inside the bladder versus one or both ureters are draining into the 
vagina or are at the edge of the fistula), we excluded ureteric fistulas from the WHO category 
“site” and instead created a new variable “ureter involvement” comprising either ureteric 
location or drainage of ureters into the vagina or at the edge of the fistula.  Urethral fistulas are 
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also excluded from the category “site” since urethral involvement is captured by the component 
“involvement of the urethra / continence mechanism.” Similarly, we did not include the 
component “circumferential damage” in multivariate analyses, since circumferential injury was 
included in the variable above. 
 
In order to measure fistula size as characterized in Waaldijk’s, Goh’s and WHO’s system, we 
categorized this variable in three different ways: we created a categorical variable corresponding 
to Waaldijk’s four categories of size (<2, 2-3, 4-5 and >6 centimeters), another representing 
Goh’s three size categories (<1.5, 1.5-3, >3), as well as a dichotomous variable with a cut-off at 
4 centimeters, corresponding to the categorization of size in the WHO system.  The original 
components of the classification systems and the way they were operationalized for this analysis 
are summarized in Appendix C. 
 
Finally, we also evaluated whether other variables measured in our dataset, and not included in 
existing classification systems, merited inclusion in a revised classification system. In particular, 
we evaluated individual characteristics including patient age, duration of the fistula, and the 
presence of comorbidities prior to the surgery.  Age and duration of the fistula were measured as 
continuous variables.  Comorbidities assessed included presence of malnutrition (yes versus no, 
as determined through either a skin fold measurement, body mass index or visual assessment), 
anemia (yes versus no, as determined through either hemoglobin level, hematocrit or visual 
assessment), UTI (measured using physician and / or nurse reports of UTI), and parasitic 
infections, including malaria and helminthiasis (surgeon reports).  The variable helminthiasis 
captured both non-specific reports of helminthiasis, as well as Schistosoma mansoni, hookworm, 
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and ascariasis; there were no reports of Schistosoma haematobium. We also evaluated the 
presence of female genital cutting (any versus none).  In addition, we examined the distributions 
of ordinal variables included in existing classification systems to determine whether cut-points 
should be revised. 
 
Statistical analyses 
Comparison of derivation and validation cohorts.  A split-sample design was employed, 
whereby one-half of the sample (the derivation cohort) was used to create the complexity scoring 
systems, and the second (the validation cohort) was used to test these systems.  Pre-operative 
characteristics of patients in the two cohorts were compared using t-tests for continuous variables 
and Chi-square tests or Fisher’s exact tests (where cell sizes were less than 5) for ordinal or 
dichotomous variables. 
 
Bivariate analyses.  Characteristics of patients whose fistulas were closed at the 3 month follow-
up visit were compared to those whose fistulas were not closed using risk ratios (RRs) and 
corresponding 95% confidence intervals (CIs).  Risk ratios and 95% CIs were derived using 
Generalized Estimating Equations (GEE), using an exchangeable correlation structure with a 
robust standard error estimator.  GEE allows for the combination of the effects of variables at 
different levels into one model, while accounting for the non-independence of observations 
within higher level units.26  We present analyses which account for clustering of patient 
outcomes by facility, rather than surgeon, since facility is the highest level cluster and therefore 
should provide unbiased results;27 however, results accounting for clustering by primary surgeon 
(defined as attending surgeon, n=51) were similar, and are shown in Appendix D.  Risk ratios 
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were generated using the logarithm link function and binomial distribution specification in SAS 
PROC GENMOD.28  The multivariate model used to develop an empirically-informed 
classification system included variables associated with repair failure at a p-value < .20 in 
bivariate analysis that were conceptually associated with repair outcome and not highly 
correlated with other variables.  In the event that two candidate variables are highly correlated, 
the variable with the most clinical significance was selected for inclusion in the model. 
 
Creating classification scoring systems (multivariate analyses).  Using the derived cohort, we 
constructed separate multivariate GEE models for each of the classification systems to be 
compared. As above, RRs were generated using log-binomial models; in two models where the 
log-binomial model failed to converge, SAS PROC GENMOD’s Poisson regression capability 
with a log link function and robust variance was used.29  Each model contained variables from 
our dataset that closely represented each component of the particular classification system (as 
described above).  In the case of the existing classification systems, variables were included in 
the multivariate model even if they were not statistically significant predictors of repair outcome 
in bivariate analyses and were highly inter-correlated.  Weighted scores for individual 
classification system components were derived from adjusted RRs; scores were only assigned to 
those fistula characteristics significant at p-value<.05.  Weights were rounded to the nearest 
whole number.     
 
Comparing classification system scoring systems.  Among the validation cohort, sensitivity (the 
proportion of true positives) and specificity (the proportion of true negatives) were calculated for 
each scoring system.  Receiver Operating Characteristic (ROC) curves depicting the relationship 
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between the proportion of true-positives and false-positives (i.e. the accuracy of predictions) 
were drawn for each classification system score.  Areas under the ROC curves (AUCs) measured 
by the C-statistic and 95% confidence intervals were calculated for each curve.  Curves for each 
classification system score were compared visually, and, using methods for paired data, AUCs 
for each curve were statistically compared by calculating the contrast chi-square and 
corresponding p-value for the difference between the AUCs.  All analyses were done using SAS 
version 9.2; AUCs were calculated using the %roc macro (SAS Institute, Cary, North Carolina), 
and ROC curves were constructed using the %rocplot macro.30  
 
Results 
 
Comparison of derivation and validation cohorts 
There were few statistically significant differences between the derivation and validation cohorts 
with regard to baseline characteristics and repair outcomes.  A smaller proportion of women in 
the derived cohort had a mixed urinary and recto-vaginal fistula (1.7% versus 4.1%) and had 
piped water in their residence (20.3% versus 25.0%).  The proportion of successful fistula 
closure at the three-month follow-up visit was similar across both cohorts: 81.5% and 82.0% in 
the derived and validation cohorts, respectively (Table 3.1).  
 
Development of complexity scores 
Results of bivariate and multivariate analyses of existing classification systems are shown in 
Table 3.2.  One component of the Lawson classification system, mid-vaginal location, was found 
to be significantly protective of failure to close the fistula after adjusting for other components of 
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the Lawson classification system (RR .55, 95%CI: 0.33-0.90).  Given the lack of operating points 
available for the creation of an ROC curve no score was developed to represent the Lawson 
classification system.      
 
The majority of patients (93%) in our sample fell into Waaldijk’s “Type 1” category (fistulas not 
involving the closing mechanism).  Thus, only a small proportion of patients comprised the Type 
2Aa, Type2Ab, Type2Ba, Type2Bb categories.  Patients with Type 2Aa fistulas (fistulas 
involving the closing mechanism, none or partial urethral involvement and without 
circumferential defect) had over twice the risk of not having a closed fistula compared to patients 
with fistulas that did not involve the closing mechanism (RR 2.70, 95%CI: 1.79-4.08).   While 
representing a very small proportion of the sample, patients with a Type2Bb fistula were over 
three times more likely to experience failure of fistula closure (RR 3.50, 95%CI: 2.26-5.42) than 
patients without Type2Bb fistulas.   
 
After adjusting for other components of the Tafesse classification system, Class 3 fistulas 
(circumferential and not previously operated) and Class 4 fistulas (both circumferential and 
previously operated), were significantly more likely to not be successfully closed (RR 1.95, 
95%CI: 1.05-3.62 and RR 2.28, 95%CI: 1.27-4.11, respectively).  Patients with fistulas involving 
the urethra but not the middle third had almost twice the risk of failure of fistula closure (RR 
1.86, 95%CI: 1.27-2.74), and those with fistulas completely involving the middle third or 
complete destruction of the urethra had over twice the risk of failure (RR 2.17, 95%CI: 1.10-
4.29).  Finally, women with extensive tissue damage (RR 1.57, 95%CI: 1.21-2.04) or an 
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obliterated vagina (RR 2.64, 95%CI: 2.17-3.21) had greater risk of repair failure than women 
with minimal tissue damage. 
 
After adjusting for other components of the Goh classification system, urethral length and 
scarring independently predicted failure to close the fistula, and were scored.  Urethral length 
2.5-3.5 centimeters was associated with twice the risk of failure (RR 2.04, 95%CI: 1.60-2.61), 
with a slightly lower effect for urethras 1.5-2 centimeters long (RR 1.68, 95%CI: 1.07-2.66), and 
a slightly stronger effect for urethras less than 1.5 centimeters long (RR 2.21, 95%CI: 1.33-3.67).  
A greater than moderate degree of scarring or a small bladder was associated with almost twice 
the risk of failure to close the fistula (RR 1.77, 95%CI: 1.19-2.64).  
 
In the model representing WHO’s classification system, having greater than one urinary fistula, 
scarring, involvement of the urethra / continence mechanism, extensive tissue damage and 
having had a prior repair were all independent predictors of failure to close the fistula.  Women 
with more than one urinary fistula had almost twice the risk of repair failure compared with 
women with a single fistula (RR 1.96, 95%CI: 1.24-3.06).  Patients with involvement of the 
urethra / continence mechanism had over one and a half times the risk of failure to close the 
fistula than women without (RR 1.65, 95%CI: 1.28-214).  Finally, women with extensive tissue 
loss had almost twice the risk of experiencing failure to close the fistula compared to women 
with no or minimal tissue loss (RR 1.72, 95%CI: 1.17- 2.54).  
  
Finally, we developed a new multivariate model, based on factors found to be significant 
predictors of failure to close the fistula in other classification systems, and other factors not 
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included in other classification systems that were found to predict failure to close the fistula at a 
p-value less than 0.20 in bivariate analysis (Table 3.3).  Due to the high inter-correlation between 
duration of fistula and prior repair, the inclusion of the latter factor (rather than duration of the 
fistula) in existing classification systems, and fewer missing observations (three as opposed to 
367) we included prior repair rather than duration of fistula repair in our model.  Similarly, 
moderate and extensive tissue loss and moderate and extensive scarring were highly correlated in 
our dataset; we included “moderate or extensive scarring” in our final model, as it may be more 
objectively measured than loss of tissue,  and unlike tissue loss, has been evaluated in prior 
studies.  We also excluded involvement of the closing mechanism: first, this variable was 
collinear with the variables partial and complete urethral involvement; secondly, “closing 
mechanism” is not a commonly used anatomical term, and may be understood as damage to the 
urethral sphincter, or to the combination of anatomical structures that contribute to continence, 
including a functioning urethral sphincter, quiescent bladder, and functioning musculofascial 
supports.31  Thus, it is possible that some surgeons in our study may not have characterized a 
woman as having a damaged closing mechanism if the urethral sphincter was intact but other 
components of the continence mechanism were damaged, leading to an underestimate of this 
measure.  We also excluded helminthiasis, since presence of this comorbidity was elicited 
through an open-ended question about other comorbidities at baseline, and was only reported in 
one country.  Other variables included in this model were fistula size, the presence of necrotic 
tissue, lack of visibility of the cervix, bladder size, and the component of Waaldijk’s 
classification system “ureteric and other exceptional fistulas.”  After removing variables that did 
not retain statistical significance after adjusting for other factors, the final model contained 
greater than one fistula (RR 2.05, 95%CI: 1.28-3.29), moderate or severe scarring (RR 1.57, 
  
76
95%CI: 1.12-2.19), partial urethral involvement (RR 1.39, 95%CI: 1.05-1.84), and complete 
destruction of the urethra or transection / circumferential injury (RR 2.37, 95%CI: 1.80-3.11) 
(Table 3.4).   
 
Validation and comparison of complexity scores 
Based on the above models, and adjusted RRs generated for the individual classification system 
components, we created a scoring system for each classification system.  These scores were 
applied to the validation cohort in order to plot ROC curves (Figure 3.1) and derive 
corresponding AUCs (Table 3.5).  The Waaldijk classification had a 51% probability of correctly 
distinguishing patients whose fistula failed to close from those whose fistula were successfully 
closed (95%CI: 0.49-0.52). The Tafesse, Goh and WHO systems, and the proposed empirically-
derived score had similar (p=.47) discriminatory values:  AUC 0.60 (95%CI: 0.55-0.65), AUC 
0.62 (95%CI: 0.57- 0.68), AUC 0.63 (95%CI: 0.57-0.68), and AUC 0.62 (95%CI: 0.56-0.67), 
respectively. 
 
Discussion 
 
We transformed four existing classification systems into prognostic scores in order to compare 
their discriminatory value for fistula prognosis.   Few components of the Lawson classification 
system predicted repair outcomes, suggesting that fistula location alone may have limited 
prognostic utility.  The Waaldijk system fared less well than those of Tafesse, Goh and WHO in 
terms of predicting fistula closure.  However, our ability to test Waaldijk’s classification system, 
and particularly to test the influence of Type 2 fistulas and corresponding subcategories, was 
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limited by the small number of patients meeting the criteria of “closing mechanism 
involvement.”  Indeed, the small proportion of women with involvement of the closing 
mechanism found in this study is in stark contrast to the majority of patients categorized as 
having Type 2 fistulas in other studies,11, 12 and may result from varying definitions of “closing 
mechanism” across surgeons.  However, unlike the study of the Waaldijk classification system 
conducted by Raassen and colleagues, which found no significant predictors of failure to close 
the fistula 14 days following surgery,12 we found that Type2aa and Type2Bb fistulas 
significantly predicted repair failure.   
 
The scores derived from Tafesse’s, Goh’s and WHO’s classification systems demonstrated 
stronger discriminatory ability in our dataset, though our analyses indicated potential for 
simplification.  As categorized in the Tafesse classification system, the four “Class” 
subcomponents imply that the joint effect of prior repair and circumferential injury on repair 
outcome differs from the independent effects of each of these factors.  However, this did not 
appear to be the case in our dataset: when we tested for evidence of multiplicative interaction the 
cross-product term for prior repair and circumferential fistula was not significant, and the effect 
estimate for the variable representing “Class 4” fistulas (the joint effect of both factors) is not 
consistent with the effect that would be expected if the joint effect of both factors was either 
super-additive or super-multiplicative.  Thus, it may be sufficient to account only for the 
independent effects of prior repair or circumferential fistula, as is done in the classification 
system presented by the WHO.  Similarly, the Tafesse, Goh and WHO systems have components 
with potential for overlap.  For instance, each includes the presence of a circumferential fistula 
and urethral involvement as unique components of the system, though circumferential fistulas 
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are a subtype of urethral involvement.  Similarly, the WHO classification system component 
“non-VVF” overlaps with the components measuring urethral involvement and location of the 
ureters, since the latter are consistent with urethral and ureteric fistulas.   The Goh classification 
includes ureteric involvement as a special consideration, though ureteric fistulas may also be 
captured as under the “Type 1” component, since they are further than 3.5 centimeters from the 
external urinary meatus. Such redundancies could be eliminated for the purpose of predicting 
repair prognosis. 
 
In addition, several components of the above classification systems did not independently predict 
fistula closure.  Ureteric involvement, fistula diameter, and mixed RVF/VVF or cervical fistulas 
were not statistically significant, and prior repair was only marginally significant.  No other 
studies have evaluated the independent influence of ureteric involvement on repair outcomes.  
Two studies examining the association between fistula size and fistula closure failed to detect a 
significant association,12, 32 and the only study to examine the influence of mixed RVF/VVF on 
fistula closure similarly found no association.12   Previous studies have failed to detect an 
independent association between prior repair and repair outcomes; however these studies 
examined either residual incontinence following successful repair or any incontinence, rather 
than fistula closure, as an outcome17, 19, 21, 22 and thus may not be directly comparable.  Similarly, 
scarring did not achieve statistical significance after controlling for other components of the 
WHO classification system; this is likely due to the high degree of correlation between scarring 
and extensive tissue loss, another component of the system, and the fact that the category 
includes “mild scarring,” which may not influence repair outcomes.   
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Measures of urethral involvement (including circumferential defects) and tissue loss or scarring 
were independent predictors of failed closure in the Tafesse, Goh and WHO systems.  An 
association between both circumferential fistulas and urethral involvement and fistula closure 
has been reported in another large study: Nardos and colleagues found that women with 
circumferential or urethral fistulas had 1.56 times the odds of closure failure (95%CI: 0.94-2.59) 
compared to those without, and women with complete urethral destruction had 2.29 times the 
odds (95%CI: 1.06-4.75) of failure to close the fistula compared to those without complete 
destruction.20  Similarly, extensive tissue loss predicted failure to close the fistula in both the 
WHO and Tafesse systems, and the model representing Tafesse’s system revealed a dose-
response relationship, whereby a higher degree of loss was associated with greater risk of failure.  
While no other studies have examined the association between tissue loss and repair outcomes, 
tissue loss leads to scarring, which has been found to be associated with fistula closure in 
previous studies.16, 20 Goh’s Type ii category, defined here as either moderate or severe scarring 
or small bladder, similarly predicted failure to close the fistula.  The component “greater than 
one fistula” was unique to WHO’s classification system, and was found to be significant after 
adjusting for other factors in that system.  Only one other study has examined the relationship 
between having multiple fistulas present and fistula closure, and no association was found.20 
 
Our empirically-derived prognostic score achieved a discriminatory value similar to the Tafesse, 
Goh and WHO systems.  Our system was informed by these systems; however, it includes fewer 
components than are included in the existing classification systems evaluated.  Moreover, its 
components are non-overlapping and objectively measured, thereby improving likelihood of 
inter-observer reliability.  For instance, in contrast to the Tafesse and Goh classification systems, 
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which measures both circumferential fistula and urethral involvement, we measured “partial 
urethral involvement” and “circumferential fistula or complete destruction of the urethra” 
separately, ensuring no overlap between these components.  Similarly, we included measures of 
the presence of scarring rather than the loss of tissue, since it may be easier to measure presence 
of a factor than its absence.  Finally, it is important to remember that while for comparison 
purposes it was necessary to transform existing classification systems into scores, no existing 
classification systems are currently scoring systems.   A prognostic score that is simple and easy 
to recall, such as the one proposed here, can be used in the clinical setting, to assist surgeons in 
planning a repair and making decisions about patient triage.  Such a score can also be used for 
research purposes, to facilitate the statistical adjustment for confounding by prognosis of repair, 
and enable comparison of results across intervention studies.   
 
None of the systems evaluated here had high predictive accuracy.  The highest AUCs observed 
in this study ranged from 0.60-0.63; while the discriminatory ability of the systems evaluated is 
still greater than chance, an AUC greater than 0.70 is typically considered to represent good 
discriminatory value.  The low AUCs in this study indicate that factors in the causal pathway 
between fistula characteristics and fistula closure, such as surgeon skill or peri-operative 
procedures used, may be equally or more important in determining fistula closure. 
 
There are some limitations to this study.  We tested the extent to which loss-to-follow-up may 
have biased our results by deriving and testing the same classification systems using fistula 
closure at discharge from the facility, rather than fistula closure at the 3-month follow up visit 
(Appendix E).  This analysis generated different results than those obtained examining fistula 
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closure at follow-up.  Similarly to the results reported above, there was overlap in the confidence 
intervals across the three AUCs compared.  However, the components of existing systems that 
met criteria for inclusion in a scoring system varied (with neither the Waaldijk nor Goh systems 
containing sufficient operating points for the construction of an ROC curve), as did the weights 
assigned to components previously included.  Our proposed prognostic score contained one new 
component (bladder size) and no longer included partial urethral involvement.   Nonetheless, it is 
important to note that prevalence of failure to close the fistula at discharge (15.3%) was lower 
than at 3-months following surgery (18.4), and therefore these analyses may have had decreased 
statistical power for detecting small differences.  Moreover, overall retention in the study was 
high, decreasing the chances of biased results, and long-term surgical outcomes may provide 
better indication of the quality of the repair.  Secondly, the measures collected in this study are in 
some cases approximations of measures included in various classification systems, which may 
affect our ability to accurately assess the ability of the individual components of these 
classification systems to predict fistula closure.  Nonetheless, we attempted to approximate these 
measures to the best of our ability.  Thirdly, we found that model performance declined in the 
validation cohort compared to the derived cohort.  This may be the result of the relatively small 
number of failures to close the fistula in the two cohorts, and thus unstable estimates.  Finally, 
unlike the other systems tested, the classification system presented by WHO has not explicitly 
been stated to have prognostic value (no narrative accompanied the presentation of this system); 
if this was not the intended purpose of this system, our test of this system’s prognostic value 
would lack construct validity. 
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This study also has important strengths.  It represents the first attempt to empirically evaluate the 
discriminatory value of existing systems for classifying the prognosis of fistula repair, using data 
collected from a heterogeneous sample of patients across several countries and multiple study 
sites.  It is also the first attempt to both derive and validate a prognostic score using 
epidemiological data.  To-date only one other scoring system (containing two parameters: degree 
of scarring and extent of urethral damage33) for fistula prognosis has been developed; this score 
was developed as an informal exercise, and the authors characterize its utility as limited due to 
small sample size and the limited number of components examined.  The current study’s large 
sample size enabled the use of a split-sample design, used to validate the prognostic models on a 
dataset independent of the one used to create the models, thereby decreasing the likelihood of 
biased measures of classification system performance.34  Further, its prospective nature allowed 
for the assessed of both short-term and long-term repair outcomes. 
 
We have demonstrated that while many of the components comprising existing classification 
systems predict repair outcomes, existing systems can be considerably simplified for prognostic 
purposes.  Further, we have proposed an empirically-derived prognostic score which combines 
elements of the two most discriminatory systems into a single simple and more objective 
measure.  These results thus represent an important step towards the development of a single 
standardized fistula classification system.  Further research is warranted to validate our findings 
among other populations of fistula patients, compare the inter-rater and intra-rater reliability of 
the above systems, and to evaluate additional classification systems whose components we were 
not able to measure.  
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Table 3.1: Comparison of derived and validation cohort on baseline characteristics and 
repair outcome 
 
                         Total       Derived cohort     Validation cohort 
                        N    (%)        N    (%)             N    (%) 
 
Total                   1274  ( 100)         637  ( 100)         637  ( 100)    
 
Rural residence         1088  (86.1)         546  (86.4)         542  (85.8) 
 
Mean age                28.2  (11.0)        28.2  (11.1)        28.1  (11.0) 
 
> Primary education      267  (21.0)         120  (18.9)         147  (23.1)   * 
 
Years with fistula       3.3  ( 5.5)         3.4  ( 5.6)         3.2  ( 5.4)   * 
 
Previous repair y/n      294  (23.1)         149  (23.4)         145  (22.9) 
  
Type of fistula reported 
 VVF only               1229  (97.1)         622  (98.3)         607  (95.9)   ** 
 RVF and VVF              37  ( 2.9)          11  ( 1.7)          26  ( 4.1) 
 
Current marital status 
 single                   23  ( 1.8)          10  ( 1.6)          13  ( 2.1) 
 married / as if married 830  (66.1)         403  (64.4)         427  (67.8) 
 widowed                  61  ( 4.9)          34  ( 5.4)          27  ( 4.3) 
 divorced or separated   341  (27.1)         178  (28.4)         163  (25.9) 
 other                     1  ( 0.1)           1  ( 0.2)           0  ( 0.0) 
 
Parity                   3.4  ( 2.9)         3.3  ( 2.9)         3.4  ( 2.9) 
 
Commodities in residence 
 piped water             288  (22.7)         129  (20.3)         159  (25.0)   **  
 flush toilet             46  ( 3.6)          24  ( 3.8)          22  ( 3.5) 
 electricity             256  (20.1)         119  (18.7)         137  (21.5) 
 radio                   881  (69.2)         438  (68.8)         443  (69.5) 
 TV                      199  (15.7)          94  (14.8)         105  (16.5) 
 mobile phone            457  (36.0)         221  (34.7)         236  (37.2) 
 land line phone          24  ( 1.9)          12  ( 1.9)          12  ( 1.9) 
 refrigerator             49  ( 3.9)          22  ( 3.5)          27  ( 4.2) 
 
Current ability to meet basic needs 
 can easily meet needs   327  (25.8)         153  (24.2)         174  (27.4) 
 can somewhat meet needs 660  (52.1)         336  (53.1)         324  (51.0) 
 can barely satisfy need 281  (22.2)         144  (22.7)         137  (21.6) 
Closed at discharge     1058  (84.7)         534  (85.6)         524  (84.3) 
Closed at 3 mth visit   1041  (81.6)         519  (81.5)         522  (82.0) 
*p-value <.05 
**p-value <.20 
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Table 3.2: Derivation of scoring systems for existing classification systems 
 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI)vi Score
vii 
Lawson 
 Juxta-urethral 24  (20.5) 105  (20.4) 1.16 (0.85-1.60) 0.95 (0.61-1.46) - 
 Mid-vaginal 20  (17.1) 172  (33.2) 0.57 (0.37-0.89)** 0.55 (0.33-0.90)** -2 
 Juxta-cervical 20  (17.1) 87  (16.9) 0.94 (0.61-1.46) 0.81 (0.56-1.18) - 
 Vault 2  ( 1.7) 17  ( 3.3) 0.66 (0.34-1.26)** 0.57 (0.27-1.20)* - 
 Massive combination  2  ( 1.7) 5  ( 1.0) 1.78 (0.70-4.45) -- - 
Waaldijk 
 Type 1  Not involving 
closing mechanism 
101  (84.9) 490  (94.8) Ref Ref - 
 Type 2 Involves closing 
mechanism 
18  (15.3) 27  ( 5.2) 2.42 (1.85-3.15)** Ref - 
 Type 2Aa  Without 
(sub)total urethra 
involvement without 
circumferential defect 
8  ( 6.8) 9  ( 1.7) 2.42 (1.48-4.00)** 2.70 (1.79-4.08) ** 3 
 Type 2Ab  Without 
(sub)total urethra 
involvement with 
circumferential defect         
6  ( 5.1) 13  ( 2.5) 1.89 (0.85-4.19)* 1.67 (0.82-3.37)* - 
 Type2Ba With (sub)total 
urethra involvement 
without circumferential 
defect 
1  ( 0.9) 3  ( 0.6) 1.63 (0.71-3.75) 1.69 (0.70-4.08) - 
 Type2Bb With (sub)total 
urethra involvement with 
circumferential defect 
2  ( 1.7) 1  ( 0.2) 3.73 (2.77-5.04)** 3.50 (2.26-5.42)** 4 
 Type 3  Ureteric and other 
exceptional fistulasviii 
39  (33.1) 128  (24.7) 1.41 (0.90-2.21)* 1.31 (0.82-2.12)* - 
 Small <2 27  (23.7) 143  (29.1) Ref Ref - 
 Medium 2-3 49  (42.6) 254  (51.7) 0.91 (0.62-1.37) 0.95 (0.65-1.38) - 
 Large 4-5 31  (27.0) 75  (15.3) 1.59 (1.06-2.38)** 1.38 (0.97-1.97)* - 
 Extensive> 6 7  ( 6.1) 22  ( 4.5) 1.20 (0.54-2.69) 1.17 (0.61-2.23) - 
Tafesse 
 Class 1  Non-
circumferential, not 
previously operated 
50  (42.4) 352  (67.8) Ref Ref - 
 Class 2  Non-
circumferential, previously 
operated 
28  (23.7) 98  (18.9) 1.63(0.97-2.73)** 1. 73 (0.93-3.23)* - 
 Class 3  Circumferential, 
not previously operated 
29  (24.6) 57  (11.0) 2.58 (1.44-4.63)** 1. 95 (1.05-3.62)** 2 
 Class 4  Circumferential, 
previously operated 
11  ( 9.3) 12  ( 2.3) 3.14 (1.85-5.35)** 2. 28 (1.27-4.11)** 2 
 I    No urethral 
involvement (urethral 
length>4cm) 
12  (11.9) 116  (25.4) Ref Ref - 
 II  Urethra involved but not 
middle 1/3 (2.7-3.9 cm) 
47  (46.5) 182  (39.9) 2.56 (1.39-4.72)** 1.86(1.27-2.74)** 2 
                                                 
vi
 Risk ratios are adjusted for all other components of classification system tested 
vii
 Scores were derived by rounding adjusted risk ratio to nearest whole number 
viii
 This category includes mixed vesicovaginal and rectovaginal fistula, cervical and ureteric fistula.  Urethral fistula are excluded 
from this category since these are measured by other components, and uniquely rectovaginal fistula are excluded since our 
analyses examine closure of urinary fistula 
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 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI)vi Score
vii 
 III Middle 1/3 partly 
involved (1.4-2.6 cm)  
34  (33.7) 142  (31.1) 2.60 (1.26- 5.36)** 1.35 (0.67-2.72) - 
 IV-V  Middle 1/3 
completely involved or no 
urethraix 
8  ( 7.9) 16  ( 3.5) 4.46 (1.99-9.98)** 2.17 (1.10-4.29)** 2 
 b-c Longitudinal diameter 
of bladder < 7 cmx 
44  (40.7) 119  (24.4) 1.99 (1.23-3.22) ** 1.19 (0.78-1.80) - 
 < 50% of anterior vagina 
involved  
34  (28.8) 292  (56.5) Ref Ref - 
 > 50% of the anterior 
vagina wall involved  
53  (44.9) 190  (36.8) 1.56 (0.99-2.48)** 1.57 (1.21-2.04)** 2 
 Obliterated vagina  31  (26.3) 36  ( 7.0) 3.16 (1.99-5.02)** 2.64 (2.17-3.21)** 3 
Goh 
 Type 1  Distal edge of the 
fistula >3.5 cm from 
external urinary meatus 
(EUM) 
20  (18.3)         165  (32.9) Ref Ref - 
 Type 2  Distal edge of the 
fistula 2.5-3.5 cm from EUM 
47  (46.5)         180  (39.5) 2.58 (1.43- 4.65)** 2.04 (1.60-2.61)** 2 
 Type 3  Distal edge of the 
fistula 1.5-<2.5 cm from 
EUM 
27  (26.7)         120  (26.3) 2.43 (1.18-  5.03)** 1.68 (1.07-2.66)** 2 
 Type 4  Distal edge of the 
fistula <1.5 cm from EUM 
15  (14.9)          37  ( 8.1) 4.03 (1.90-  8.57)** 2.21 (1.33-3.67)** 2 
 a           Size <1.5 cm  21  (18.4)         107  (21.7) Ref Ref - 
 b           Size 1.5-3 cm  49  (43.0)         273  (55.5) 0.88 (0.57-1.37) 0.74 (0.48-1.12) - 
 c           Size >3 cm  44  (38.6)         112  (22.8) 1.58 (0.95-2.64)* 0.91 (0.63-1.33) - 
 i.           None or only mild 
fibrosis, and/or vaginal 
length >6cm, normal 
bladder capacity 
Ref Ref Ref Ref - 
 ii.          Moderate or 
severe fibrosis, and/or 
reduced vaginal length 
and/or bladder capacity 
75  (63.6)         216  (41.6)    1.98 (1.22-3.23)** 1.77 (1.19-2.64)** 2 
 iii.         Special 
considerations, e.g. post-
radiation, ureteric 
involvement, 
circumferential fistula, 
previous repair  
73  (61.9)         218  (42.0)    1.83 (1.04-3.21)** 1.49 (0.86-2.57) - 
WHO 
 >1 fistula  16  (13.6) 24  ( 4.6) 2.12 (1.38-3.26)** 2.13 (1.27-3.56) 2 
 Site (mixed vvf rvf or 
cervical fistulaxi) 
8  ( 6.8) 47  ( 9.1) 0.74 (0.53-1.04)* 0.83 (0.57-1.21) - 
 Size (diameter >4 cm) 38  (33.3) 95  (19.3) 1.66 (1.10-2. 50)** 1.13 (0.85-1.51) - 
                                                 
ix
 Categories IV (Middle 1/3 completely involved but some urethral tissue remains (urethral length <1.4 cm)) and V (no urethra) 
were collapsed due to the presence of only 1 woman in the latter category 
x
 Categories b (Longitudinal diameter 4-7 cm) and c (Longitudinal diameter <4 cm) collapsed and equated with “small” or “no 
bladder” in our dataset 
xi
 In this category are included mixed vesicovaginal and rectovaginal fistula and cervical fistula.  Urethral fistula are excluded 
from this category since these are measured by the component “involvement of the urethra / continence mechanism.” Ureteric 
fistula are excluded as they are measured through the variable “ureter involvement” and uniquely rectovaginal fistula are 
excluded since our analyses examine closure of urinary fistula 
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 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI)vi Score
vii 
 Involvement of the 
urethra / continence 
mechanism 
72  (61.0) 192  (37.1) 2.04 (1.52-2.76)** 1.80 (1.28-2.54)** 2 
 Scarring   94  (79.7)         386  (74.5) 1.30 (0.94-1.80)* 0.99 (0.66-1.48)  
 Circumferential defectxii 40  (33.9) 69  (13.3) 2.32 (1.64-3.30)**   
 Extensive tissue loss 31  (26.3) 35  ( 6.8) 2.64 (1.83-3.80)** 1.90 (1.38- 2.62)** 2 
 Ureter involvementxiii 32  (27.4) 87  (16.9) 1.64 (0.97-2.76)* 1.12 (0.73-1.73) - 
 Previous repair  39  (33.1) 110  (21.2) 1.43 (1.01- 2.04)** 1.38 (0.96-1.98)*  
**p-value <.05 
*p-value <.20 
 
Table 3.3: Additional variables for consideration in a prognostic classification system 
Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) 
Patient characteristics 
Age > 25 65  (55.1) 241  (46.4) 1.10 (0.77-1.56) 
Duration of fistula (average years, 
sd)  
5.5  ( 8.3) 3.0  ( 4.7) 1.04(1.03-1.06)** 
Comorbidities present at baseline 
Genital cutting  35  (29.7) 99  (19.2) 1.31 (0.88-1.95) 
Malnutrition 8  ( 6.8) 31  ( 6.0) 1.01 (0.46-2.22) 
Anemia 9  ( 7.6) 36  ( 6.9) 0.88 (0.62-1.24) 
UTI 0  ( 0.0) 2  ( 0.4) - 
HIV 0  ( 0.0) 2  ( 0.4) - 
Malaria 1  ( 0.8) 3  ( 0.6) 0.93 (0.33-2.66) 
Helminthiasis 20  (16.9) 54  (10.4) 1.21 (1.10-1.33)** 
Fistula characteristics not included in above classification systems  
Necrotic tissue present 16  (13.7) 46  ( 8.9) 1.33 (0.61-2.86) 
No or mild scarring 51  (43.2) 356  (68.7) Ref 
Moderate scarring 43  (36.4) 133  (25.7) 1.74 (1.08-2.82)** 
Severe scarring 24  (20.3) 29  ( 5.6) 3.27 (1.91-5.68)** 
No urethral involvement 46  (39.0) 326  (62.9) Ref 
Partial urethral involvement 30  (25.4) 119  (23.0) 1.52 (1.12-2.07)** 
Complete destruction or 
transection / circumferential injury 
41  (35.0) 72  (14.0) 2.65 (1.87-3.76)** 
Non-vvf (ureteric, urethral, 
rectovaginal, cervical fistula) 
78  (66.7) 266  (51.6) 1.71 (1.19-2.44)** 
Cervix not visible 27  (22.9) 79  (15.4) 1.43 (0.89 -2.72)* 
**p-value <.05 
*p-value <.20 
 
Table 3.4: Proposed fistula prognostic score 
Component ARR (95% CI) Score 
>1 urinary fistula 2.05 (1.28-3.29) 2 
Moderate or severe scarring 1.57 (1.12-2.19) 2 
Partial urethral involvement 1. 39 (1.05-1.84) 1 
Complete destruction or 
transection / circumferential injury 
2.37(1.80-3.11) 2 
                                                 
xii
 This variable was not included in multivariate analysis since circumferential fistulas are a type of urethral involvement, 
captured by another component of the system 
xiii
 This variable is a proxy for the WHO variable “ureters draining into the vagina or at edge of the fistula”: non-specified 
ureteric involvement was included here to avoid overlap with the variable “non-vvf” 
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Table 3.5: Performance of selected classification systems 
 Derived cohort Validation cohort 
Scoring 
system 
Proportion failed 
closures 
C-statistic 
(95%CI) 
Proportion failed 
closures 
C-statistic 
(95%CI) 
Waaldijk  0.53 (0.51-  0.56)  .51 (0.49-0.53) 
0 108/616 (17.53%)  110/616 (17.83%)  
3 8/17 (47.06%)  3/12 (25.00%)  
4 2/3 (66.67%)  2/5 (40.00%)  
Tafesse  0.66 (0.61- 0.71)  .60  (0.55-0.65) 
0 16/184 (8.70%)  16/188 (8.51%)  
2 38/253 (15.02%)  47/224 (20.98%)  
3 64/200 (32.00%)  52/225   (23.11%)  
Goh  0.62 (0.57-0.67)  0.62 (0.57- 0.68) 
0 14/141 (9.93%)  18/141 (12.77%)  
2 44/275 (16.00%)  33/274 (12.04%)  
4 60/221 (27.15%)  64/222 (28.83%)  
WHO  0.69 (0.64-0.74)  .63 (0.57-0.68) 
0 32/337 (9.5%)  44/351 (12.54%)  
2 54/233 (23.18%)  44/215 (20.47%)  
4 32/67 (47.76%)  27/71 (38.03%)  
Proposed  0.70 (0.65-0.75)  .62 (0.56-0.67) 
0 23/277 (8. 30%)  32/271 (11.81%)  
1 10/78 (12. 82%)  16177 (20.78%)  
2 29/121 (23.97%)  24/147 (16. 33%)  
3 56/161 (34.78%)  43/142 (30.28%)  
 
Figure 3.1: ROC curves - derived cohort 
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Figure 3.2: ROC curves – validation cohort  
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Chapter 4 : The influence of route of repair and duration of catheterization on urinary 
fistula repair outcomes 
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Abstract 
 
Few studies have examined the comparative effectiveness of different peri-operative procedures 
on urinary fistula surgery outcomes.  Abdominal (versus vaginal) route of repair and longer 
duration of catheterization are of particular importance given their potential association with 
longer-term hospitalization, hospital-associated infection, and increased financial and human 
resource requirements.  Using data collected from 1274 women with urinary fistula who 
presented for repair at 11 study sites in sub-Saharan Africa and Asia, we used standard 
multivariable regression and propensity score matching to examine 1) factors influencing route 
of repair and the duration of catheterization, 2) the influence of route of repair and duration of 
catheterization on fistula closure three months following surgery independent of indication for 
repair or repair prognosis, and 3) whether indication for the procedure or fistula prognosis 
moderates the influence of each of these procedures on repair outcomes.   Indication for an 
abdominal route of repair (limited vaginal access due to extensive scarring or tissue loss, genital 
infibulation, ureteric involvement, or trigonal, supra-trigonal, vesico-uterine or intracervical 
location, or other abdominal pathology) was independently associated with abdominal route of 
repair (adjusted risk ratio (ARR) 13.33, 95%CI: 4.61-38.56); the majority of women undergoing 
abdominal repair met common indications for such an approach.  Each unit increase in 
prognostic score was associated with 1.07 times higher likelihood of catheterization > 14 days 
(95%CI: 1.00-1.13), after adjusting for facility, surgeon experience, other fistula characteristics 
and route of repair.  Vaginal route of repair was independently associated with increased risk of 
failure to close the fistula, relative to abdominal route of repair (ARR 1.42, 95%CI: 1.11-1.81); 
however, stratified analyses suggested that risk may be elevated among women who meet 
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common indications for abdominal route of repair.  Duration of catheterization > 14 days was 
associated with failure to close the fistula, after adjusting for severity/repair prognosis and 
surgeon experience (ARR 1.62, 95%CI: 1.16-2.26); this association persisted in the propensity 
score-matched sample.  Residual confounding by indication and reverse causation cannot be 
excluded as explanations for this finding. 
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Introduction 
 
Vaginal fistula is predominantly a childbirth-associated morbidity, whereby the pressure of the 
fetus’s head during obstructed labor creates an abnormal passage between vagina and bladder or 
between the vagina and rectum, resulting in urinary or fecal incontinence, or both.  Fistulas 
resulting in urinary incontinence are most common, and are often referred to as urinary fistulas.  
While the majority (80-95%) of urinary fistulas can be closed surgically,1 the success of repair 
depends on characteristics and severity of the fistula, surgeoni skill, and likely the surgical 
methods used.  Most fistula surgeons have developed their own methods through experience;2 
thus, pre-, intra- and post-operative procedures vary widely across surgeons and facilities.  Few 
studies have examined the comparative effectiveness of different peri-operative interventions 
related to the surgical management of urinary fistulas.3-13   Two procedures in particular, 
abdominal route of repair and extended duration of catheterization following repair, are of 
critical research interest:  each of these procedures is associated with longer-term hospitalization, 
and therefore a potentially elevated risk of nosocomial infection, particularly urinary tract 
infection (UTI), and increased financial and human resource requirements.3 
 
Recommendations vary with regard to whether a vaginal or abdominal surgical approach should 
be used for fistula repair.  Vaginal approaches are generally thought to be appropriate for any 
fistula located between the bladder and the vagina,14, 15 with some full-time fistula surgeons 
claiming to be able to repair all fistulas by the vaginal route.16  However, abdominal approaches 
are also often considered to be most appropriate for “complex” fistulas,17-19 with published 
indications for an abdominal route of repair including the following: a small capacity or poorly 
                                                 
i
 The term “surgeon” is used here to refer to the individual conducting the surgery, rather than the individual’s 
medical training 
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compliant bladder which requires bladder augmentation;15, 17, 18 fistulas involving or close to the 
ureteric orifice (particularly if ureteric reimplantation is required);15, 17, 18 vaginal stenosis or 
other factor inhibiting adequate vaginal exposure of the fistula;15, 17, 18 size;18  trigonal or 
supratrigonal location;18 intracervical location;16 and concomitant abdominal pathology.17  
However, the choice of surgical approach remains to some extent a matter of surgeon preference 
or training,17, 20 and experience of the surgical team.18   
 
Three studies,5, 9 all retrospective study designs, have examined the association between route of 
surgery and repair outcomes.  Kriplani and colleagues9 found a significantly higher proportion of 
success among fistulas repaired vaginally in their sample of 34 women.  Chigbu and colleagues,5 
in their sample of 78 women with juxta-cervical fistulas (which can be approached either 
vaginally and abdominally5), found a higher proportion of success among women repaired 
abdominally (84.3%) compared to vaginally (77.8%); however, this difference was not 
statistically significant.  Finally, Morhason-Bello and colleagues21 found no statistically 
significant differences in continence (closed fistula with no residual incontinence) across 71 
cases of mid-vaginal fistula (with no fibrosis or evidence of infection, urethral or bladder neck 
involvement and without more than one previous repair) repaired either abdominally or 
vaginally; continence rates were 78.3% versus 80.0%, respectively. All three studies were likely 
underpowered to detect small differences, and examined only unadjusted associations (though 
the latter two studies restricted the sample by type of fistula).  Only Morhason-Bello and 
colleagues examined indications for vaginal versus abdominal or mixed vaginal and abdominal 
route of repair, though these were limited due to the strict inclusion criteria employed.  No 
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studies have examined the association of route of repair on repair outcomes after adjusting for a 
range of patient and fistula characteristics. 
 
Similarly, evidence to support the benefit of either short or long-term catheterization following 
urinary fistula repair surgery is lacking.  The bladder is often anecdotally considered to heal 
better “at rest” (i.e. when it is not filling and emptying),3, 22 which may justify implementing 
longer catheterization for cases with worse prognosis.  However, the duration of catheterization 
is informed by convention rather than empirical evidence: no studies have demonstrated the 
benefit of any duration of catheterization with regard to bladder healing following urinary fistula 
repair surgery, or indeed, any type of gynecological surgery, and no basic physiologic studies on 
the dynamics of wound healing in the bladder after fistula repair have been published. In 
practice, duration of catheterization following pelvic surgery varies widely: a recent survey of 40 
fistula surgeons23 found that catheterization durations ranged from 5 to 21 days.  To date, only 
one study has been published on duration of catheterization following obstetric fistula surgery 
and repair outcomes;3 this was a retrospective record review.  While the authors found no 
difference in the proportion of repair breakdown across patients catheterized for 10, 12, and 14 
days, the conclusions that can be drawn from this study are limited, as duration was 
demonstrated to be influenced by severity / complexity of the fistula, only bivariate analyses 
were conducted, and the study was likely underpowered to detect significant differences. 
 
A shared limitation of the studies examining route of repair and duration of catheterization was 
the lack of adjustment for the potential imbalance of a range of prognostic features across 
comparison groups, also termed “confounding by indication.”  In an observational study, the 
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indication for a treatment may act as a confounder.24  For instance, a patient’s urinary fistula may 
have certain characteristics which indicate the need for an abdominal route of repair, and these 
characteristics may also be associated with a poor repair prognosis.  Similarly, the severity or 
prognosis of a patient’s condition may lead a medical provider to assign more vigorous therapy 
(e.g. longer duration of catheterization).  Consequently, treatments reserved for those with a poor  
prognosis will be statistically associated with worse outcomes, even when the treatment itself is 
beneficial.25  While observational studies typically rely on methods such as statistical adjustment 
to minimize differences between comparison groups, such selection bias may be less amenable to 
standard ways of accounting for confounding.25  Methods of controlling for non-comparability of 
comparison groups, such as disease severity scores, may not encompass the totality of factors 
(including a provider’s clinical intuition) that may influence both a provider’s decision to 
administer treatment, as well as eventual repair outcomes.  This would result in incomplete 
adjustment and residual confounding.   
 
Propensity score matching has been proposed as a method particularly suited for the control of 
confounding by indication.  These methods are used to approximate the context of a randomized 
trial, insofar as treatment groups are comparable on measured confounding factors.  Propensity 
score matching may thus minimize selection bias, since it maximizes the comparability of  
individuals on a set of observed variables that may influence the provider’s decision to 
administer the treatment.26  Importantly, however, propensity score matching cannot ensure 
comparability on unmeasured confounding factors.   
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Against this background, we used data from a multi-country observational cohort study to 
elucidate the relationship between route of repair and duration of catheterization on fistula 
closure.  Our first aim was to evaluate which factors predicted both route of repair  and duration 
of catheterization, including the extent to which the choice to undertake these procedures is 
influenced by either indication for, or prognosis of, repair.  Secondly, we aimed to examine the 
influence of route of repair and duration of catheterization on fistula closure, using both 
propensity score matching and standard multivariable regression analysis to account for potential 
confounding.  Our third and final aim was to evaluate whether the effect of each of these 
procedures on fistula closure varied by fistula prognosis or indication.   
 
Methods 
 
Study participants 
Between September 2007 and September 2010, 1,389 women presenting for fistula repair 
services at 11 study sites in Uganda, Guinea, Niger, Nigeria and Bangladesh were enrolled in the 
study, 1329 of whom underwent urinary fistula repair.  Of the women who did not undergo 
urinary fistula repair, 25 underwent repair for rectovaginal fistula only (and were therefore 
excluded from these analyses), and 35 women were referred to other facilities, did not have 
surgery for medical/safety reasons, or were treated by catheterization; these women were evenly 
distributed across all facilities.  Retention was high, with 95.9% of women returning for a 
follow-up visit; the 1274 women retained constituted the study sample for these analyses.   The 
study received national institutional review board (IRB) approval in Nigeria, Uganda, Guinea, 
and Niger; local (facility-based) ethical review was conducted at two of three facilities in 
  
100
Bangladesh.ii  All patients provided informed consent (consent was signed or indicated via 
thumbprint if the patient was not literate). 
 
Study procedures  
Prior to surgery, women reported on sociodemographic characteristics and obstetric history.  
Information was also collected on comorbidities and any medical care provided for these 
comorbidities.  At the time of surgery, detailed information was collected about characteristics of 
the fistula, intra-operative procedures performed and surgical outcomes.  Following the surgery 
but prior to discharge, women were queried about post-operative care provided, and at discharge, 
information about surgical outcomes was once again collected.  Participants were asked to return 
three months following the surgery, at which point a clinical evaluation was conducted to assess 
surgical outcomes. 
 
Measures  
Aim 1.  Our first aim was to evaluate which factors independently predicted both route of repair 
and duration of catheterization.  The primary outcome measures for this aim were surgical route 
and duration of catheterization.  Three possible surgical routes can be used: vaginal, abdominal, 
or combined.  Since we were interested in abdominal route of repair, irrespective of whether it 
was used in combination with a vaginal approach, this variable was dichotomized as either 
“abdominal / combined abdominal and vaginal” (hereafter referred to as “abdominal”) or 
“vaginal;” results of analyses excluding those with a combined route of repair are shown in 
Appendix J.  Duration of bladder catheterization was measured by subtracting the recorded date 
                                                 
ii
 The Bangladesh Medical Research Council (BMRC) did not deem it necessary to review the protocol given the 
study’s observational nature.  One of three study sites was not interested in subjecting the study protocol to ethical 
review. 
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of catheter removal from the date of the surgery; duration of catheterization was first categorized 
as <14 days, 14-21 days, and >21 days.  Due to homogenous effects in the two longer duration 
categories, these categories were collapsed, and we present analyses with catheterization 
duration categorized dichotomously (<14 days or >14 days). 
 
The potential predictors of both abdominal route of repair and duration of catheterization 
included patient characteristics, fistula characteristics, surgeon experience, pre- and intra-
operative procedures and site.  Patient characteristics assessed included age (reference=25 years 
or less), years living with the fistula, marital status (currently married versus unmarried), rural 
residence, education (reference=less than primary education), parity (reference=3 or less) and 
whether or not the patient had previously undergone surgery for the fistula.  Comorbidities 
assessed included malnutrition (as determined through either skin-fold measurement, body mass 
index or visual assessment), anemia (as determined through either hemoglobin level, hematocrit 
or visual assessment), UTI (measured using clinician report), urine-induced contact dermatitis, 
fever, foot drop, and type of female genital cutting (FGC) present, if any.   
 
Fistula characteristics assessed included bladder size, fistula size, and location.  Bladder size was 
dichotomized as small versus normal or distended (as defined subjectively by the surgeon), and 
fistula size was dichotomized at 4 centimeters or greater.  A composite variable representing 
ureteric involvement was created, and defined as ureteric or uretero-vaginal location, or if ureters 
were described to be draining into the vagina or at the edge of the fistula.   Urethral involvement 
was categorized as “partial” (urethra involved but not completely destroyed or transected), and 
“complete destruction or transection.”  
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For analyses examining predictors of route of repair only, we evaluated the influence of fistula 
location in particular on choice of surgical route.   Locations assessed included vesico-uterine, 
mid-vaginal, juxta-cervical, intra-cervical, trigonal, supra-trigonal, and vault.  Based on 
published indications for abdominal route of repair and factors plausibly indicative of limited 
vaginal access and significantly associated with abdominal route of repair in our data, we created 
a composite variable representing “abdominal repair indicated.” Specifically, this variable 
comprised the following indications:  presence of extensive scarring or tissue loss, ureteric 
involvement, trigonal, supra-trigonal, intra-cervical or vesico-uterine location), concomitant 
abdominal pathology, and female genital infibulation.   
 
For analyses of duration of catheterization only, we examined the influence of fistula repair 
prognosis, measured using a prognostic score described in detail in Chapter 3.  In brief, the score 
comprises the following variables, all independent predictors of fistula closure: presence of 
scarring, partial urethral damage, complete urethral damage / transection, and greater than 1 
fistula.  Each variable / component was assigned a weight, corresponding to its adjusted risk ratio 
in the final multivariate regression model used to predict fistula closure.   The values of the score 
range from 0-3, with a higher score representing worse prognosis.  In addition, the individual 
components of the score were also individually assessed.   
 
Surgeon experience was measured by the number of complex repairs the surgeon reported ever 
conducting; complex was defined subjectively, and the number of such repairs was dichotomized 
at 200 complex repairs or greater.  Variables related to the context of the repair included whether 
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the repair was conducted as part of a training session and whether it was conducted as part of 
outreach or within a camp.  The 11 sites were collapsed into 7 categories to help ensure against 
sparse cell sizes.  Thus, a site in Bangladesh conducting only 5 repairs was combined with 
another site in the same country which had conducted 48 repairs.  Similarly, each of the sites in 
Niger were combined with sites in Nigeria: site E (n=72) was combined with sites G (n=57)  and 
I (n=151), and site F (n=93) was combined with site H (n=208); this was done because the high 
collinearity between individual sites and the primary procedures of interest (e.g. no participants 
at sites E, F, I, and C underwent abdominal route of repair, and no participants at sites E and G 
were catheterized for 14 days or less) inhibited the estimation of effects for these sites.  The 
remaining 5 sites were examined as individual units. 
 
Aim 2.  Our second aim was to examine the influence of route of repair and duration of 
catheterization on fistula closure.  The primary exposure measures for our second aim were route 
of repair and duration of catheterization, as described above.  The primary outcome measure for 
both analyses was fistula closure three months following the surgery, whereby the fistula was 
characterized dichotomously as either “closed” or “open.”  The main mechanism of assessing 
fistula closure was through a pelvic exam and dye test.  For 186 women (14.6% of cases) in 
which no pelvic exam was conducted, fistula closure was determined using the question “does 
the client have continuous and uncontrolled leakage of urine,” asked of every client at the three-
month follow-up visit; this question has been used in household-based Demographic and Health 
(DHS) surveys27 to differentiate between fistula and other forms of incontinence, which are 
unlikely to be continuous and uncontrolled.  Outcome misclassification was unlikely, since 
women with continued urinary leakage are eager to report their experiences to the surgeon in 
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order for the condition to be rectified; further, all cases where the dry test was negative but the 
patient reported continuous and uncontrolled leakage of urine were verified to exclude the 
possibility of an unclosed ureteric fistula or other outcome misclassification.  At the two sites 
where pelvic exams were not routinely conducted at follow-up, any patient complaining of 
leakage of urine underwent a pelvic exam.  In the event that a participant had multiple fistulas, 
closure refers to closure of all fistulas.  For two women with multiple fistulas, the surgery 
represented the first of a staged repair, and their fistulas were thus considered “closed” despite 
continued leakage from the remaining fistulas.   
 
Potential confounding variables eligible for inclusion in each model were those factors 
associated with the procedures in question as well as fistula closure.  In addition, the propensity 
score models for duration of catheterization matched participants on intra- and post-operative 
procedures.  Intraoperative procedures included use of Martius flap interpositioning, type of 
suturing technique (double versus single-layer bladder suture), and route of repair.   Post-
operative procedures were use of an open versus closed bladder catheter drainage system and 
post-operative prophylactic antibiotic use.    
 
Aim 3.  The third aim assessed whether indication for an abdominal approach is an effect 
modifier of the relationship between route of repair and fistula closure, and whether repair 
prognosis modifies the relationship between duration of catheterization and fistula closure; we 
also show the relationship between route of repair and fistula closure stratified by repair 
prognosis in Appendix I.  For the latter analyses, the prognostic score was dichotomized at a 
score greater than or equal to 1 (reference=<1); the threshold of 1 was chosen as it neared the 
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optimal threshold based on the balance between true and false positives, as calculated by the 
Youden Index,28 (Appendix I) and also represented the median percentile of observations.   
 
All continuous variables that did not have a linear effect with respect to the outcome were 
categorized in a manner that preserved parsimony and ensured homogeneity across strata; these 
variables include duration of bladder catheterization, age, parity, fistula size, and provider 
experience conducting complex repairs, as discussed above.  
 
Statistical analyses 
Bivariate analyses. Patient and site-level correlates of route of repair and catheterization duration 
were compared using t-tests for continuous variables and Chi-square tests or Fisher’s exact tests 
(where cell sizes were less than 5) for ordinal or dichotomous variables.   Risk ratios and 
corresponding 95% confidence intervals (CIs) were generated using the logarithm link function 
and binomial distribution specification in SAS PROC GENMOD.29   
 
Characteristics of patients whose fistulas were closed at the 3 month follow-up visit were 
compared to those whose fistulas were not closed using risk ratios (RRs) and corresponding 95% 
confidence intervals (CIs); these were derived using Generalized Estimating Equations (GEE), 
accounting for clustering of patient outcomes within facilities.   
 
Multivariate analyses.  We first assessed independent predictors of abdominal route of repair, 
and duration of catheterization longer than 14 days, using two separate multivariable models; 
log-binomial models were once again used to generate RRs.  Variables eligible for inclusion in 
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the models were conceptually associated with the procedure and statistically associated (p-value 
<0.20) with the procedure in bivariate analysis.  In the event that variables were too highly 
correlated only one was included.  Thus, parity was measured rather than age, since it could be a 
measure of care-giving burden (and thus related to length of hospital stay), and malnutrition was 
included rather than anemia, since it is a cause of the latter.  Duration of the fistula and bladder 
size were excluded because of their collinearity with variables comprising the prognostic score: 
the prognostic score was chosen over these measures, since information on duration of fistula 
was missing for almost one-third of participants, and bladder size is only an approximation of 
bladder capacity, a more accurate measure.  Finally, site was measured instead of procedures 
(with the exception of the variable route of repair in analyses examining predictors of 
catheterization duration) in multivariate analyses, as we hypothesized that site would better 
encapsulate unmeasured confounding factors at the site level.  Fever and foot drop were not 
included in the model due to sparse cell sizes.   
 
For our second aim, the evaluation of the independent effect of abdominal route of repair and 
duration of catheterization on fistula closure at the three-month follow-up visit, we similarly 
created separate multivariate GEE models for each of these exposures, using the log-binomial 
specification in GENMOD.  Where the log-binomial model failed to converge, SAS PROC 
GENMOD’s Poisson regression capability with a log link function and robust variance was 
used.30  These models adjusted for factors conceptually associated with both procedure and 
outcome, as well as statistically associated (p-value <0.20) with both procedures and outcome in 
bivariate analysis.   
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For our third aim, we first created product terms to assess multiplicative interaction between 
indication for abdominal route of repair and route of repair, and prognosis of the fistula 
(categorized as a dichotomous variable as well as linearly) and duration of catheterization.  
However, since the study was likely insufficiently powered to detect the presence of effect 
modification, we also conducted stratified analyses to visually assess trends in effect sizes across 
levels of the potential effect modifiers.  Analyses of the effect of route of repair on fistula closure 
were stratified by our measure “abdominal approach indicated,” and analyses of the effect of 
duration of catheterization on fistula closure were stratified by prognostic score (greater than or 
equal to 1).  Bivariate GEE models were used to generate unadjusted RRs and corresponding 
95%CIs for these stratified analyses.   
 
Propensity score analysis.   
Predicted probabilities (propensity scores) of abdominal route of repair, and catheterization for 
longer than 14 days, were estimated using two separate multivariable logistic regression models.  
These propensity score models were developed iteratively, until optimal balance on measured 
covariates was achieved.  For route of repair analyses, the first model included a reduced set of 
variables: abdominal route of repair indicated, mid-vaginal fistula, juxta-cervical fistula, partial 
urethral damage and complete urethral damage / transection.  The second model included the 
same measures, in addition to surgeon experience, site, and parity greater than 3.  For duration of 
catheterization greater than 14 days, the first model included a reduced set of variables, including 
patient and fistula characteristics plausibly associated with surgeon prognostic decision-making 
(i.e. age, parity, ureteric involvement, bladder size, prognostic score, anemia, footdrop, 
malnutrition), context of repair (repair conducted as part of training or outreach), as well as intra-
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operative procedures (use of Martius flap interpositioning,31 type of suturing technique) and 
post-operative procedures (open versus closed catheter drainage and whether prophylactic 
antibiotics were administered).  The second expanded model included the above measures as 
well as site and surgeon experience conducting complex repairs in order to improve balance in 
covariates across groups.     
 
For duration of catheterization, probabilities of catheterization ≤14 days were calculated to 
maximize sample size during matching; for route of repair, probabilities of abdominal / mixed 
vaginal and abdominal repair were calculated.  Matching was done using a 1:2 ratio, an 
optimized matching algorithm and an absolute difference in propensity score of 0.1.  Exposed 
individuals for whom no suitable unexposed match could be found were excluded from the 
analysis.  For analyses of the association between route of repair and fistula closure, 11 
participants undergoing abdominal route of repair (19%) were excluded using the reduced 
propensity score model, and 27 (57%) were excluded with the expanded model.  For analyses of 
the association between duration of catheterization and fistula closure, 119 (31%) participants 
catheterized for 14 days or less were excluded using the reduced model, and 240 (63%) were 
excluded with the expanded model.  All statistical analyses were conducted using SAS version 
9.2, and statistical significance is two-sided at p <0.05 unless stated otherwise. 
 
Results 
 
Sample characteristics 
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Sample characteristics are shown in Table 4.1.  Patients included had a median age of 25 
(Interquartile range (IQR) 20-35), and median parity of 2 (IQR 1-5).  Over half (65.1%) of the 
women were currently married, though over a quarter (27.1%, not shown) were divorced or 
separated from their husbands.  The majority of women were from rural areas, and one-fifth had 
at least a primary education.  Almost three quarters of the women with obstetric fistulas had 
labored at home greater than 24 hours, and over one-third ultimately delivered via cesarean 
section.  The mean number of years women had lived with their fistula was 3.3, and almost one-
quarter of the women had previously undergone surgery to repair their fistula.  One-fifth of the 
women presented with signs of FGC, the majority of these were cases were Type II (excision of 
the clitoris with partial or total removal of labia minora) or III (genital infibulation).  The 
proportion of patients whose fistulas were closed at follow-up was 81.6%.   
 
Predictors of route of repair 
Abdominal route of repair was rare, occurring in only 57/1273 (5%) cases; information on route 
of repair was missing for one study participant.   Use of vaginal compared to an abdominal route 
of repair differed by both facility- and individual-level factors (Table 4.2).  Two of the facilities 
were more likely than the others to use abdominal route of repair, and likelihood of abdominal 
repair was inversely associated with surgeon experience conducting complex repairs (adjusted 
risk ratio (ARR) 0.36, 95%CI: 0.13-0.97).  Patients undergoing vaginal route of repair were 
significantly more likely to have a parity of 3 or more (ARR 1.83, 95%CI: 1.03-3.25).  Patients 
with fistulas meeting indications for abdominal repair had a greater than 13-fold risk (ARR 
13.33, 95%CI: 4.61-38.56) of having an abdominal repair.  Conversely, fistulas that were mid-
vaginal were significantly less likely to be repaired abdominally (ARR 0.25, 95%CI: 0.07-0.81), 
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and fistulas involving the urethra were marginally less likely to be repaired abdominally.  Having 
greater than a primary education and a fistula with juxta-cervical location did not independently 
predict abdominal route of repair. 
 
Predictors of bladder catheterization duration 
A minority of women (383/1271, or 30.4%) were catheterized for less than or equal to 14 days; 
information on catheterization duration was unavailable for 13 participants.  The median 
duration of catheterization in this sample (not shown) was 21 days (IQR 14-27).  As with route 
of repair, duration of catheterization was independently associated with both facility-level factors 
and fistula characteristics (Table 4.3).  Duration of catheterization was significantly influenced 
by site: only 6 of the 11 sites catheterized women for both less than or equal to 14 days or greater 
than 14 days, with the remainder of sites (with the exception of 1 site with 5 women) 
catheterizing women for longer than 14 days (Table 4.3; see Appendix C for the distribution by 
individual site). Catheterization duration greater than 14 days was also associated with surgeon 
experience conducting complex repairs (ARR 1.22, 95%CI: 1.00-1.49). Each unit increase in the 
prognostic score was associated with 1.07 times the risk of long-term catheterization (ARR 1.07, 
95% CI: 1.00-1.13). Parity, rural residence, primary education, malnutrition, and vaginal route of 
repair were not significantly associated with duration of catheterization. 
 
Influence of route of repair on fistula closure  
Almost one-fifth (18.8%) of those repaired vaginally experienced repair failure, compared to 
10.5% of those repaired abdominally.  In bivariate analysis, vaginal route of repair was 
associated with 1.42 (95%CI: 1.11-1.81) times the risk of failure to close the fistula compared to 
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abdominal route.  After adjusting for indication for abdominal route of repair, surgeon 
experience conducting complex repairs and mid-vaginal location, the risk of vaginal route of 
repair relative to abdominal route decreased to 1.40 (95%CI: 1.05- 1.87).   Product terms for the 
interaction between vaginal route of repair and indication for abdominal route were not 
statistically significant.  Analyses conducted in the propensity score matched sample, in which 
propensity scores were created using a reduced set of predictors, found a stronger magnitude of 
effect compared to the fully adjusted multivariate model; while analyses conducted using the 
expanded propensity score model found an effect similar to the fully adjusted multivariate 
model. (Table 4.6)  In analyses stratified by indication, among women with fistula meeting 
indications for abdominal repair, women repaired vaginally had twice the risk of failure 
compared to those repaired abdominally (RR 1.97, 95%CI: 1.03-3.79); effect estimation among 
women where an abdominal approach was not indicated was not possible due to sparse cell sizes 
(no women who underwent abdominal route of repair who did not meet indications for such a 
repair experienced repair failure). (Table 4.7)  
 
Influence of duration of catheterization on fistula closure 
Just over one-fifth (21.4%) of women catheterized for longer than 14 days experienced repair 
failure, compared to 11.5% of women catheterized for 14 days or less.  In bivariate analysis, 
duration of catheterization for 14 days or longer was associated with a 2-fold increased risk of 
failure to close the fistula compared to those catheterized for fewer than 14 days (ARR 2.04, 
95%CI: 1.16-3.59).  This risk decreased after adjusting for fistula prognosis and surgeon 
experience conducting complex repairs (ARR 1.62, 95%CI: 1.16-2.26) (Table 4.8), with 
propensity score analysis generating similar results.  Product terms for the interaction between 
  
112
catheterization duration and prognostic score were not significant.  However, in stratified 
analysis (Table 4.9), among women with a prognostic score greater than 1, catheterization for 14 
days or longer was associated with twice the risk of failure to close the fistula compared to 
women catheterized for less than 14 days (RR 1.95, 95%CI: 1.19-3.19), while among women 
with a prognostic score less than or equal to 1, catheterization for 14 days or longer was not 
significantly associated with risk of failure to close the fistula (RR 1.28, 95%CI: 0.77-2.11).   
 
Discussion 
 
Both route of repair and duration of catheterization were influenced by a combination of patient 
and fistula characteristics, as well as facility-level factors.  Not surprisingly, published 
indications for abdominal route of repair appeared to influence the decision to undertake an 
abdominal route of repair, and location of the fistula in an area accessible through the vagina, 
such as urethral and mid-vaginal location, was protective of an abdominal route of repair.  Most 
women undergoing abdominal repair met the typical indications for an abdominal repair.  Those 
women who did not may have exhibited other unmeasured characteristics which prompted the 
surgeon to undertake an abdominal repair, or may have been repaired abdominally as a matter of 
surgeon preference.  On the other hand, the vast majority of women who met the indications for 
an abdominal route of repair were in fact repaired vaginally.  Indeed, both site and surgeon 
experience conducting complex repairs were highly predictive of surgical approach used.  It is 
notable that surgeon experience conducting complex repairs was inversely associated with the 
decision to undertake an abdominal repair.  In a subanalysis (not shown), we evaluated whether 
more experienced surgeons were less likely to subjectively classify a repair to be “complex,” 
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controlling for fistula prognosis.  This did not appear to be the case.  Thus, a more likely 
explanation is that more experienced surgeons are better able to access a range of fistulas 
vaginally.  Finally, parity greater than three was associated with abdominal route of repair.  
Reasons for this are unclear, though this finding is consistent with Morhason-Bello and 
colleagues’ finding that women repaired abdominally had a significantly higher number of 
deliveries than those repaired vaginally.21   
 
Similar to route of repair, duration of catheterization was influenced by both fistula 
characteristics as well as facility-level factors.  Fistula prognosis independently predicted 
duration of catheterization after adjusting for other fistula characteristics, surgeon experience, 
route of repair and site.  Thus, it appeared that surgeons were in fact assigning vigorous therapy 
when a patient’s prognostic outlook appeared poor.  Our study thus confirms Nardos et al.’s 
findings that duration of catheterization is influenced by severity of the fistula.3 However, site 
was strongly associated with catheterization for longer than 14 days, independent of fistula 
severity.  Therefore, while some sites choose to catheterize women for a specified duration as 
standard practice, it appears that in sites where duration of catheterization varies, fistula 
prognosis influences duration of catheterization.   
 
Vaginal route of repair was associated with increased risk of failure to close the fistula, relative 
to abdominal route of repair, after adjusting for other factors.  This finding is surprising, as one 
might expect that fistulas repaired abdominally would be more complex cases, and therefore 
have a worse prognosis.  Indeed, our results contradict those of Kriplani and colleagues,9 who 
found that vaginal route of repair was protective against incontinence (defined as residual 
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incontinence or failure to close the fistula).  However, these results must be interpreted with 
caution.  First, it is possible that the types of fistulas that are more likely to be repaired 
abdominally (i.e. ureteric, trigonal or supratrigonal) are in fact more likely to have a better repair 
prognosis than fistulas more likely to be repaired vaginally (i.e. urethral fistulas), or that 
abdominal route of repair is only undertaken for those cases which surgeons deem to be likely to 
be successfully repaired.  Alternatively, it is possible that the abdominal route of repair is in fact 
beneficial in certain circumstances, such as cases in which the fistula is difficult to access 
vaginally.  Indeed, unadjusted stratified analyses suggested that the risk of failure among women 
repaired vaginally may be elevated for those women in whom an abdominal repair was indicated 
compared to those where an abdominal repair was not.  However, there were few women who 
underwent abdominal repair when it was not indicated, resulting in potentially unstable 
estimates.   
 
The practical implications of a potentially beneficial effect of an abdominal surgical approach 
are limited.  Abdominal approach of repair is primarily performed under general anesthesia; use 
of general anesthesia requires additional skill on the part of clinicians, is more expensive than the 
local anesthetics used for a vaginal route of repair,21 and may not be routinely available in low-
resource settings.  Moreover, abdominal repairs have been found to be associated with increased 
blood loss,18, 21 UTI21 and longer hospital stay compared to vaginal repairs.18  This more invasive 
procedure may also increase risk of surgical site infection, especially in poorly-resourced 
surgical settings.  Further research evaluating which fistula characteristics do in fact indicate the 
need for an abdominal approach, and the effect of vaginal route of repair across substrata of 
patients defined by fistula characteristics, is warranted.  Any recommendations that women 
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meeting published indications for abdominal repair undergo abdominal route of repair would be 
premature at this time. 
 
Longer duration of catheterization was independently associated with failure to close the fistula 
in our study.  There are three potential explanations for this finding.  The first explanation is that 
longer term catheterization inhibits bladder healing.  A recent study by Boruch and colleagues 
(2010) evaluating the effects of long-term catheterization on extracellular matrix (ECM) 
biological scaffold remodeling following partial cystectomy in canines, found that early bladder 
filling (i.e. shorter duration of catheterization) mediated a constructive remodeling response.32  
While biologic scaffolds composed of ECM are a cutting-edge innovation not feasible for fistula 
repair in developing countries, the results of this study nonetheless provide some preliminary 
evidence that removing the catheter early and allowing the bladder to begin filling and emptying, 
may be beneficial, rather than harmful, to bladder healing.  However, an equally plausible 
explanation is that these results are indicative of residual confounding by indication.  We 
adjusted for fistula characteristics using traditional multivariate techniques as well as through 
propensity score matching; both methods resulted in a decreased strength of effect of duration of 
catheterization on repair outcome.  Moreover, stratified analyses suggested that risk of failure to 
close the fistula was particularly elevated among women with a poor prognosis.  However, it is 
possible that there were also unmeasured factors that influenced a surgeon’s decision to 
catheterize a woman for a longer duration of time.   
 
The most likely explanation for our finding that longer-term catheterization predicts failure to 
close the fistula is that of reverse causation.  It is possible that the decision to catheterize a 
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woman for a longer period of time was made upon initial discovery that the fistula was not 
closed: the catheter may have been left in longer as a final effort to facilitate healing of the 
fistula.   Further research examining the influence of catheterization duration on repair outcomes 
is warranted; experimental designs that are able to establish temporality and preclude the 
possibility of confounding by indication would be of particular benefit. 
   
In addition to our inability to exclude reverse causation as an explanation for the association 
between duration of catheterization and failure to close the fistula, our study has several other 
limitations.  In this multi-country observational study, peri-operative procedures were highly 
collinear within sites, and varied substantially across sites (Appendix F).  In such a context, it is 
possible that at one or more levels of confounding variables, no one was observed at one or more 
levels of the exposure;33  this problem is termed a violation of positivity34, 35 or “off-support”36 
data.  As Oakes and colleagues note, use of regression models in the context of lack of positivity 
means that comparisons are based on very sparse or model-dependent data; while results from 
such analyses may be correct, they rely on “heroic modeling assumptions.”37  Propensity score 
methods can minimize violations of positivity, in that patients who do not match on probability 
of exposure are excluded from data analysis.  Results obtained using multivariate modeling were 
similar to those obtained using propensity score matching, increasing our confidence that our 
findings were not solely based on statistical extrapolation.  Another limitation of this study is that 
the small number of repairs conducted via the abdominal route may have prohibited the detection 
of small, significant effects.  Finally, a related limitation is that we were underpowered to test the 
presence of effect modification; nonetheless, stratified analyses demonstrated trends in the 
directions anticipated.   
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Despite its limitations, this study represents the only comprehensive evaluation of factors that 
influence the choice of route of repair and duration of catheterization for urinary fistula surgery.  
It is the largest collection of data assessing predictors of fistula repair outcomes to date, and the 
only study of this scale to systematically follow women after discharge from the facility in order 
to determine the long-term effects of the procedures studied on fistula repair outcomes.  The 
provision of fistula care and treatment services in developing countries is fraught with many 
challenges.  In a context which has limited human and infrastructural capacity for meeting high 
demand for repair services, finding ways of providing services in a cost-effective manner, 
without compromising surgical outcomes and the overall health of the patient is critical.  
Additional cohort studies that are adequately powered to test hypotheses of effect modification 
are warranted to confirm whether abdominal route of repair is indeed beneficial for certain 
patient populations.  A randomized controlled trial assessing the relationship between 
catheterization and repair outcome would provide evidence with the potential to improve both 
clinical practice and access to fistula repair services for thousands of women.    
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Table 4.1: Sample characteristics  
Patient characteristics N (%) 
Median parity (IQR) 2 (1-5) 
Median age (IQR) 25 (20-35) 
Currently married 830  (65.1) 
Rural residence 1088  (86.1) 
> Primary education 265  (20.8) 
Labored at home > 24 hours during 
causative delivery 
614  (72.7) 
Delivered via c-section during 
causative delivery 
481  (38.9) 
Years with fistula (mean, sd) 3.3  ( 5.5) 
Previously repaired 295  (23.2) 
Female genital cutting 
None 
Type Iiii 
Type IIiv 
Type IIIv 
Other 
 
1012  (79.6) 
  33  ( 2.6) 
 124  ( 9.8) 
  97  ( 7.6) 
   5  ( 0.4) 
Comorbidities 
Malnutrition 
Anemia 
Fever 
UTI 
Footdrop 
 
76  ( 6.0) 
91  ( 7.1) 
21  ( 4.6) 
2  ( 0.2) 
64  ( 5.0) 
Commodities and utilities in household 
Piped water      
Flush toilet     
Electricity      
Radio            
TV               
Mobile phone     
Land line phone  
Refrigerator     
 
288  (22.7)  
 46  ( 3.6)  
256  (20.1)  
881  (69.2)  
199  (15.7)  
457  (36.0)  
 24  ( 1.9)  
 49  ( 3.9) 
Average prognostic score (sd) 1.24 (1.4) 
Met indications for abdominal route of 
repair 
400  (31.7) 
Surgical approach 
Vaginal 
Abdominal 
Mixed 
 
1216 (95.52) 
47   (3.69) 
10   (0.79) 
Catheterized < 14 days 383 (30.4%) 
Surgical outcomes 
Fistula closed at discharge 
Fistula closed at 3 month visit 
 
1058  (84.7) 
1039  (81.6) 
 
 
 
 
 
                                                 
iii
 Excision of prepuce, with or without excision of clitoris, or part of clitoris 
iv
 Excision of the clitoris with partial or total removal of labia minora 
v
 Excision of part of all or the external genitalia and narrowing of vaginal opening 
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Table 4.2: Predictors of vaginal versus abdominal route of repair  
 Abdominal / 
combined     
N (%) 
Vaginal 
 
N (%) 
Unadjusted RR 
(95% CI) 
Adjusted RR (95% 
CI)vi 
Total (n=1273) 57 1216   
Patient characteristics at baseline 
Parity > 3 34  (61.8) 410  (34.9)    2.87 (1.68-4.88) ** 1.83 (1.03-3.25)** 
Age > 25 41  (71.9) 566  (46.5)    2. 81 (1.59-4.96) ** -- 
Currently married 36  (63.2)          793  (65.2) 0.92 (0.54-1.55)  
Rural residence 52  (91.2)         1035  (85.8) 1.68 (0.68-4.16)  
> Primary education 19  (33.3) 246  (20.3)    1.90 (1.11-3.23) ** 1.17 (0.63-2.19) 
Average years with fistula (sd) 4.1  ( 6.5) 3.2  ( 5.4) 1.02 (0.98-1.07)  
Malnutrition 3  ( 5.3)           72  ( 5.9) 0.89 (0.28-2.77)  
Anemia 6  (10.5)           84  ( 6.9) 1.55 (0.68-3.51)  
Fever 0  ( 0.0)                   20  ( 4.7) --  
UTI 0  ( 0.0)                   2  ( 0.2) --  
Footdrop 0  ( 0.0)           64  ( 5.3)    --  
Female genital infibulation 11  ( 9.3)           40  ( 7.8) 2.42 (1.69-3.47)**  
Prior repair  14  (24.6)          281  (23.2) 1.08 (0.60-1.94)  
Fistula characteristics 
Abdominal repair indicatedvii 52  (91.2)          447  (37.2) 15.76 (2.34-106.06)  13.33 (4.61-38.56)** 
Fistula size > 4 cm 8  (15.7)          248  (21.3) 0.70 (0.33-1.46)  
Small bladder 12  (23.5) 326  (28.8) 0.77 (0.41-1.45)  
Extensive scarring 2  ( 3.5)           93  ( 7.7) 0.45 (0.11-1.82)  
Extensive tissue loss 8  (15.4)          127  (10.5) 1.52 (0.73-3.17)  
Extent of urethral damage 
 No damage 
 Partial damage 
Complete transection or         
destruction 
 
48  (87.3) 
3  ( 5.5) 
4  ( 7.4) 
 
710  (58.5)    
278  (22.9)    
222  (18.4)    
 
Ref 
0.17 (0.05-0.55)** 
0.28 (0.10-0.78)** 
 
Ref 
0.40 (0.12-1.36)* 
0.48 (0.15-1.47)* 
Mid-vaginal location 3  ( 5.4)          366  (30.2)    0.14 (0.04-0.44) ** 0.25 (0.07-0.81)** 
Trigonal location 6  (10.5)           60  ( 5.0)    2.13 (0.95-4.79)*  
Supratrigonal location 7  (12.3)           25  ( 2.1)    5.39 (2.65-10.94)**  
Juxta-cervical location 5  ( 8.9)          219  (18.2)    0.45 (0.18-1.13)* 0.60 (0.23-1.60)  
Intracervical location 7  (12.5)           74  ( 6.1)    2.08 (0.97-4.45)*  
Vesico-uterine location 10  (17.9) 11  ( 0.9) 12.85 (7.56-21.84)**  
Vault location 3  ( 5.3)           32  ( 2.7) 1.15 (0.29-4.50)  
Ureter involvement 25  (43.9)          183  (15.2) 3.96 (2.40-6.54)**  
Concomitant abdominal 
pathology 
1  ( 1.8)            1  ( 0.1)    11.35 (2.77-46.45)**  
Facility level factors / characteristics 
                                                 
vi
 Each variable for which effect estimates are reported in the column below was adjusted for the other variables for 
which effect estimates are reported in the column 
vii
 Female genital infibulation, extensive scarring, extensive tissue loss, trigonal, supratrigonal, intracervical, vesico-
uterine location, ureter involvement or concomitant abdominal pathology 
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Site 
A  (n=70) 
B and C (n=53) 
D (n=246) 
E, G, and I (n=266) 
F and H (n=276) 
J (n=159) 
K (n=203) 
   
  9  (12.9) 
   2  ( 4.2) 
   8  ( 3.3) 
   1  ( 1.9) 
   1  ( 0.4) 
 26  (16.4) 
  10  ( 4.9) 
 
61  (87.1)       
51  (96.2)       
238  (96.8)       
265 (99.6)   
275  (99.6)   
133  (83.7)      
193  (95.1)   
 
2.61 (1.11-6.16) * 
0.77 (0.17-3.39)  
0.66(0.27-1.64)  
0.08 (0.01-0.59) ** 
0.07 (0.01-0.57) ** 
3.32 (1.65-6.68) ** 
Ref 
 
2.02 (0.67-6.11) 
0.69 (0.14-3.41) 
0.21 (0.07-0.65)** 
0.13 (0.01-1.14)* 
0.18 (0.02-1.57) 
1.76 (0.66-4.70) 
Ref 
Surgeon performed over 200 
complex repairs                   
7 (12.3) 404 (35.0) 0.27 (0.12-0.59)** 0.36 (0.13-0.97)** 
 *p-value<.20 
**p-value<.05 
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Table 4.3: Predictors of catheterization duration < 14 days versus > 14 days 
 < 14 days 
N (%) 
> 14 days 
N (%) 
Unadjusted RR (95% 
CI) 
Adjusted RR (95% 
CI)viii 
Total (n=1261) 383 878   
Patient characteristics at baseline 
Parity > 3 167  (43.6)         275  (31.3)    0.85 (0.79-0.93) ** 0.91 (0.78-1.06) 
Age > 25 219  (57.2)         383  (43.6)    0.85 (0.79-0.91) ** -- 
Rural residence 335  (87.5)         742  (84.5)    0.92 (0.84-1.01) * 1.03 (0.84-1.26) 
Currently married 256  (66.8)         568  (64.7) 0.97 (0.90-1.05)  
Average years with fistula 
(sd) 
3.9  ( 5.9)          3.0  ( 5.2)    0.99 (0.98-1.00) ** -- 
> Primary education 107  (27.9)         156  (17.8)    0.82 (0.74-0.91) ** 0.99 (0.80-1.23) 
Anemia 8  ( 2.1)           81  ( 9.2)    1.34 (1.24-1.44) ** -- 
Malnutrition 5  ( 1.3)           69  ( 7.9)    1.37 (1.27-1.47) ** 1.06 (0.78-1.44) 
Fever 2  ( 1.3)           18  ( 6.0)    1.38 (1.18-1.62)**  
UTI 1  ( 0.3)            1  ( 0.1) 0.72 (0.18-2.87)  
Footdrop 2  ( 0.5)           61  ( 6.9)    1.42 (1.34-1.51) **  
Prior repair  81  (21.1)          212  (24.2) 0.88 (0.72-1.09)  
Fistula characteristics 
Ave. prognostic score 1.0  ( 1.3)          1.4  ( 1.5)    1.05(1.02-1.08) ** 1.07 (1.00-1.13)** 
Extent of urethral damage 
 No damage 
 Partial damage 
Complete transection or         
destruction 
 
263  (69.2) 
81  (21.3) 
36  ( 9.5)          
 
488  (55.6) 
199  (22.7) 
187  (21.4)                  
 
Ref 
1.09 (1.00-1.19)* 
1.28 (1.19-1.38)** 
 
> 1 fistula 22  ( 5.8)           52  ( 5.9) 1.00 (0.86-1.16)  
Moderate or extensive 
scarring 
129  (33.7)         335  (38.2) 1.07 (0.99-1.14)*  
Small bladder 50  (13.6)          283  (35.1)    1.37 (1.28-1.46) ** -- 
Ureteric involvement 55  (14.4)          170  (19.5)    1.11 (1.02-1.20) ** 1.15 (0.95-1.40)* 
Facility level factors / characteristics 
Site 
A  (n=68) 
B and C (n=52) 
D (n=246) 
E, G, and I (n=263) 
F and H (n=271) 
J (n=158) 
K (n=203) 
 
6  ( 8.8)   
32 (61.5)  
120  (48.8)         
1  ( 0.4)   
46  (17.8)  
80  (50.6)  
98  (48.3)          
 
62  (91.2) 
20 (38.5) 
126  (51.2) 
262 (99.6) 
225  (83.0) 
78  (49.3) 
105  (51.7)         
 
1.76 (1.51-2.05) ** 
0.74 (0.51-1.08)  
0.99 (0.83-1.19) 
1.92 (1.69-2.20) ** 
1.61 (1.39-1.85) ** 
0.95 (0.78-1.17) 
 Ref 
 
1.98 (1.34-2.94)** 
0.76 (0.47-1.23) 
1.01 (0.73-1.40) 
2.10 (1.57-2.81)** 
1.51 (1.15-2.00)** 
1.07 (0.77-1.49) 
Ref 
Surgeon performed over 200 
complex repairs                  
90 (24.5) 314 (37.8) 1.19 (1.11-1.28)** 1.22 (1.00-1.49)** 
Vaginal route of repair 353  (92.2)         850  (96.9)    1.49 (1.13-1.97) ** 1.25 (0.83-1.88) 
2-layer bladder suture   161  (44.1)         252  (29.7)    0.82 (0.75-0.89) ** -- 
Martius graft 3  ( 0.8)           40  ( 4.7)    1.35 (1.23-1.47) ** -- 
Open catheter drainage 220  (57.6)         662  (75.9)    1.33 (1.21-1.47)** -- 
Post-op drinking regimen 333  (86.9)         778  (88.8) 1.07 (0.95-1.22)  
Prophylactic antibiotics 312  (81.5)         767  (87.5)    1.18 (1.04-1.34)** -- 
 *p-value<.20 
**p-value<.05 
                                                 
viii
 Each variable for which effect estimates are reported in the column below was adjusted for the other variables for 
which effect estimates are reported in the column 
  
122
Table 4.4: Patient and fistula characteristics by repair outcome 
Characteristics Open 
N (%) 
Closed 
N (%) 
Unadjusted RR (95% 
CI) 
 
Total (n=1274) 233 1041  
Patient characteristics    
Age > 25 129  (55.4)         479  (46.0) 1.07 (0.90-1.26) 
Duration of fistula (average years, sd)  4.7  ( 7.3)          3.0  ( 5.0) 1.03 (1.01-1.04)**  
Greater than high school education 27  (11.7)          238  (22.9) 0.81 (0.60-1.08)* 
Rural residence 199  (86.1)         889  (86.1) 1.10 (0.84-1.43) 
Parity  > 3 83  (37.1)          362  (35.9) 0.92 (0.78-1.09) 
Delivered via c-section 91  (40.4)          390  (38.5) 1.22 (0.84-1.77)  
Prior repair 83  (35.8)          212  (20.4) 1.53 (1.23- 1.90)** 
Currently married 141  (60.5)         689  (66.2) 0.81 (0.63-1.05)* 
Patient comorbidities    
Female genital cutting  65  (27.9)          194  (18.7) 1.19 (0.89- 1.58) 
Malnutrition 18  ( 7.7)           58  ( 5.6) 1.23 (0.66- 2.28) 
Anemia 19  ( 8.2)           72  ( 6.9) 0.99 (0.79-1.23) 
UTI 0  ( 0.0) 2  ( 0.2) - 
HIV 0  ( 0.0) 4  ( 0.4) - 
Malaria 2  ( 0.9) 4  ( 0.4) 1.26 (0.87-1.81)  
Fistula characteristics    
Average prognostic score 2.1  ( 1.7)          1.1  ( 1.3) 1.38 (1.16-1.65)**  
Abdominal route of repair indicated 104  (45.0)         296  (28.8)         1.64 (1.28-2.10)** 
Juxta-urethral 46  (19.8)          230  (22.2) 0.99 (0.77-1.27) 
Mid-vaginal 49  (21.2)          320  (30.9) 0.74 (0.56-0.99)* 
Juxta-cervical 38  (16.5)          187  (18.1) 0.89 (0.68- 1.18) 
Intra-cervical 10  ( 4.3)           71  ( 6.9) 0.69 (0.49- 0.98)** 
Circumferential 71  (30.5)          143  (13.7) 2.02 (1.44- 2.84)** 
Vesico-uterine 2  ( 0.9)           19  ( 1.8) 0.71 (0.27-1.87) 
Ureteric 1  ( 0.4)           19  ( 1.8) 0.26 (0.05-1.37) 
Uretero-vaginal 3  ( 1.3)           12  ( 1.2) 1.38 (0.89-2.14)** 
Trigonal 11  ( 4.8)           55  ( 5.3) 0.74 (0.40-1.37) 
Supra-trigonal 5  ( 2.2)           27  ( 2.6) 0.69 (0.44-1.06)* 
Vault   6  ( 2.6)           29  ( 2.8) 0.95 (0.63-1.44) 
Small bladder 96  (44.9)          242  (25.0) 2.07 (1.52-2.82)**  
Scarring    
No or mild scarring 111  (47.6)         695  (66.9) Ref 
Moderate scarring 82  (35.2)          289  (27.8) 1.55 (1.05-2.29)** 
Severe scarring 40  (17.2)           55  ( 5.3) 2.84 (1.86-4.35)** 
>1 fistula  23  ( 9.9)           52  ( 5.0) 1.68 (1.11-2.52)** 
Cervix not visible 56  (24.1)          157  (15.3) 1.49 (1.00-2.22)* 
*p-value<.20 
**p-value<.05 
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Table 4.5: Context of repair and peri-operative procedures by repair outcome 
 Not closed 
N (%) 
Closed 
N (%) 
Unadjusted RR (95% CI) 
Total (n=1274) 233 1041  
Surgeon experience     
> 200 complex repairs conducted 61  (27.2)          350  (35.5) 1.27 (1.02-1.58)** 
Organization of services    
Site 
A  (n=71) 
B and C (n=53) 
D (n=246) 
E, G, and I (n=266) 
F and H (n=276) 
J (n=159) 
K (n=203) 
 
19  ( 8.2)          
15  ( 6.4)          
61  (26.2)         
72  (30.9)         
41  (17.6)         
20  ( 8.6)         
5  ( 2.1)          
 
52  ( 5.0) 
38  ( 3.7)    
185  (17.8) 
194  (18.6) 
235  (22.6) 
139  (13.4) 
198  (19.0) 
 
10.86 (4.21-28.02)** 
11.49 (4.37-30.18)** 
10.07 (4.12-24.58)** 
10.99 (4.52-26.70)** 
 6.03 (2.43-14.99)** 
5.11 (1.96-13.31)** 
Ref 
Repair conducted in the context 
of training 
120  (51.7)         601  (57.8) 0.84 (0.64-1.11)* 
Repair conducted in context of 
outreach services / camp 
89  (38.2)          388  (37.4) 0.77 (0.44-1.33) 
 
Intra-operative procedures    
Vaginal-only route of repair 227  (97.4)         989  (95.1) 1.42 (1.11-1.81)** 
Single layer suture of bladder 121  (53.1)         677  (67.4) 0.78 (0.57-1.07)* 
Double layer suture of bladder 99  (44.0)          314  (31.3) 1.16 (0.84-1.60) 
Martius flap (with or without labia 
skin) 
12  ( 5.3)           31  ( 3.1) 1.45 (1.10-1.91)** 
Relaxing incision  6  ( 2.7)            10  ( 1.0) 2.09 (1.35-3.25)** 
Post-operative procedures    
Duration of catheterization > 14 
days 
188  (81.7)         690  (66.9) 2.01 (1.11-3.63)**  
 
Open vs closed drainage system 123  (53.2)         768  (74.1) 0.63 (0.51-0.79)**  
Drinking regimen prescribed post-
operatively 
189  (81.5)         941  (90.6) 0.96 (0.31-2.98) 
 
Prophylactic antibiotics provided 
post-operatively 
202  (87.1)         891  (85.7) 1.04 (0.75-1.43)  
*p-value<.20 
**p-value<.05 
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Table 4.6: Association between vaginal route of repair and failure to close the fistula at 
three month follow-up visit 
 Total repaired 
abdominally / both 
abdominally and 
vaginally included in 
analysis 
Total repaired 
vaginally included 
in analysis 
RR (95% CI) 
Unmatched, unadjusted 57 1216 1.42 (1.11-1.81)** 
Unmatched, adjusted for indication 
for abdominal repair 
  1.72 (1.29-2.29)** 
 
Unmatched, adjusted for indication 
for abdominal repair, surgeon 
experience conducting complex 
repairs, mid-vaginal location 
  1.40 (1.05-1.87)** 
Matched sample, reduced 
propensity score model 
46 92 1.98 (1.27-3.07)** 
Matched sample, expanded 
propensity score model 
30 60 1.40 (0.77-2.56) 
 
Table 4.7: The influence of vaginal-only route of repair on repair outcome across levels of 
indication for abdominal repair in the unmatched sample 
 Abdominal approach not 
indicated  
Abdominal approach 
indicated 
 Closed  
N (%) 
Not closed 
N (%) 
Closed  
N (%) 
Not closed 
N (%) 
Vaginal-only route of repair 637 (99.22) 117 (100.00) 339 (88.05) 108 (94.74) 
Abdominal / combined abdominal 
vaginal 
5 (0.78) 0 (00.00) 46 (11.95) 6 (5.26) 
RR (95%CI) -- 1.97 (1.03-3.79) ** 
 
Table 4.8: Association between duration of catheterization greater than 14 days and failure 
to close the fistula at three month follow-up visit 
 Total catheterized < 14 
days included in 
analysis 
Total catheterized 
> 14 days included 
in analysis 
RR (95% CI) 
Unmatched, unadjusted 383 878 2.04 (1.16-3.59)** 
Unmatched, adjusted for prognostic 
score 
  1.65 (1.15-2.35)** 
 
Unmatched, adjusted for prognostic 
score, surgeon experience 
conducting complex repairs, ureteric 
involvement 
  1.62 (1.16-2.26)** 
 
Matched sample, reduced 
propensity score model 
264 542 1.51 (0.93-2.45) 
Matched sample, expanded 
propensity score model 
143 297 1.47 (1.04-2.08) ** 
 
Table 4.9: The influence of duration of catheterization on repair outcome across levels of 
severity in the unmatched sample 
 Prognostic score <1  Prognostic score > 1 
Catheterization for >  14 days vs < 14 days 1.28 (0.77-2.11) 1.95 (1.19- 3.19) ** 
*p-value<.20 
**p-value<.05 
  
125
References 
 
1. Wall LL, Arrowsmith SD, Briggs ND, Browning A, Lassey A. The obstetric 
vesicovaginal fistula in the developing world. Obstet Gynecol Surv. 2005 Jul;60(7 Suppl 
1):S3-S51. 
 
2. Browning A. The circumferential obstetric fistula: characteristics, management and 
outcomes. BJOG. 2007 Sep;114(9):1172-6. 
 
3. Nardos R, Browning A, Member B. Duration of bladder catheterization after surgery for 
obstetric fistula. Int J Gynaecol Obstet. 2008 Oct;103(1):30-2. 
 
4. Rangnekar NP, Imdad Ali N, Kaul SA, Pathak HR. Role of the martius procedure in the 
management of urinary-vaginal fistulas. J Am Coll Surg. 2000 2000;191(3):259-63. 
 
5. Chigbu CO, Nwogu-Ikojo EE, Onah HE, Iloabachie GC. Juxtacervical vesicovaginal 
fistulae: outcome by route of repair. J Obstet Gynaecol. 2006;26(8):795-7. 
 
6. Tomlinson AJ, Thornton JG. A randomised controlled trial of antibiotic prophylaxis for 
vesico-vaginal fistula repair. Br J Obstet Gynaecol. 1998;105(4):397-9. 
 
7. Olusegun AK, Akinfolarin AC, Olabisi LM. A review of clinical pattern and outcome of 
vesicovaginal fistula. J Natl Med Assoc. 2009 Jun;101(6):593-5. 
 
8. Browning A. Lack of value of the Martius fibrofatty graft in obstetric fistula repair. Int J 
Gynaecol Obstet. 2006;93(1):33-7. 
 
9. Kriplani A, Agarwal N, Parul, Gupta A, Bhatla N. Observations on aetiology and 
management of genital fistulas. Arch Gynecol Obstet. 2005;271(1):14-8. 
 
10. Nardos R, Browning A, Chen CC. Risk factors that predict failure after vaginal repair of 
obstetric vesicovaginal fistulae. Am J Obstet Gynecol. 2009 May;200(5):578 e1-4. 
 
11. Browning A. Risk factors for developing residual urinary incontinence after obstetric 
fistula repair. BJOG. 2006;113(4):482-5. 
 
12. Safan A, Shaker H, Abdelaal A, Mourad MS, Albaz M. Fibrin glue versus martius flap 
interpositioning in the repair of complicated obstetric vesicovaginal fistula. A prospective 
multi-institution randomized trial. Neurourol Urodyn. 2009;28(5):438-41. 
 
13. Kirschner C, Yost K, Du H, Karshima J, Arrowsmith S, Wall L. Obstetric fistula: the 
ECWA Evangel VVF Center surgical experience from Jos, Nigeria. International 
Urogynecology Journal.21(12):1525-33. 
  
126
14. Zambon JP, Batezini NS, Pinto ER, Skaff M, Girotti ME, Almeida FG. Do we need new 
surgical techniques to repair vesico-vaginal fistulas? Int Urogynecol J Pelvic Floor 
Dysfunct. 2010 Mar;21(3):337-42. 
 
15. Carr LK, Webster GD. Abdominal repair of vesicovaginal fistula. Urology. 1996 
Jul;48(1):10-1. 
 
16. Hancock B, Browning A. Practical obstetric fistula surgery. London: Royal Society of 
Medicine Press; 2009. 
 
17. Genadry RR, Creanga AA, Roenneburg ML, Wheeless CR. Complex obstetric fistulas. 
Int J Gynaecol Obstet. 2007 Nov;99 Suppl 1:S51-6. 
 
18. Kapoor R, Ansari MS, Singh P, Gupta P, Khurana N, Mandhani A, et al. Management of 
vesicovaginal fistula: An experience of 52 cases with a rationalized algorithm for 
choosing the transvaginal or transabdominal approach. Indian J Urol. 2007 
Oct;23(4):372-6. 
 
19. Creanga AA, Genadry RR. Obstetric fistulas: a clinical review. Int J Gynaecol Obstet. 
2007 Nov;99 Suppl 1:S40-6. 
 
20. Hill EC. Repair of vesico-vaginal fistula. Calif Med. 1962 Oct;97:216-9. 
 
21. Morhason-Bello IO, Ojengbede OA, Adedokun BO, Okunlola MA, Oladokun A. 
Uncomplicated midvaginal vesico-vaginal fistula repair in Ibadan: A comparison of the 
abdominal and vaginal routes Annals of Ibadan Postgraduate Medicine. 2008;6(2):39-43. 
 
22. Shittu OS, Ojengbede OA, Wara LH. A review of postoperative care for obstetric fistulas 
in Nigeria. Int J Gynaecol Obstet. 2007 Nov;99 Suppl 1:S79-84. 
 
23. Arrowsmith SD, Ruminjo J, Landry EG. Current practices in treatment of female genital 
fistula: a cross sectional study. BMC Pregnancy Childbirth. 2010;10:73. 
 
24. Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in 
the use of epidemiologic terminology. Am J Epidemiol. 1999 Jun 1;149(11):981-3. 
 
25. Walker AM. Confounding by indication. Epidemiology. 1996 Jul;7(4):335-6. 
 
26. Hak E, Verheij TJM, Grobbee DE, Nichol KL, Hoes AW. Confounding by indication in 
non-experimental evaluation of vaccine effectiveness: the example of prevention of 
influenza complications. Journal of Epidemiology and Community Health. 2002 
December 1, 2002;56(12):951-5. 
 
27. Johnson K, Peterman A. Incontinence data from the Demographic and Health Surveys: 
comparative analysis of a proxy measurement of vaginal fistula and recommendations for 
  
127
future population-based data collection. Calverton, Maryland, USA: Macro International 
Inc; 2008. 
 
28. Youden WJ. Index for rating diagnostic tests. Cancer. 1950 Jan;3(1):32-5. 
 
29. Carter RE, Zhang X, Woolson RF, C.C. A. Statistical analysis of correlated relative risks. 
Journal of Data Science. 2009;7:397-407. 
 
30. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and 
differences. Am J Epidemiol. 2005 Aug 1;162(3):199-200. 
 
31. Martius H. Die operative Wiederhellstellung der volkonmmen fehlenden Harnrohare und 
des Schlessmuskels derselben. Zentralbi Gynakol. 1928;52:480-86. 
 
32. Boruch AV, Nieponice A, Qureshi IR, Gilbert TW, Badylak SF. Constructive remodeling 
of biologic scaffolds is dependent on early exposure to physiologic bladder filling in a 
canine partial cystectomy model. J Surg Res. 2010 Jun 15;161(2):217-25. 
 
33. Westreich D, Cole SR. Invited commentary: positivity in practice. Am J Epidemiol. 2010 
Mar 15;171(6):674-7; discussion 8-81. 
 
34. Hernan MA, Robins JM. Estimating causal effects from epidemiological data. J 
Epidemiol Community Health. 2006 Jul;60(7):578-86. 
 
35. Cole SR, Hernan MA. Constructing inverse probability weights for marginal structural 
models. Am J Epidemiol. 2008 Sep 15;168(6):656-64. 
 
36. Manski CF. Identification problems in the social sciences. Cambridge, Mass.: Harvard 
University Press; 1995. 
 
37. Oakes JM, Messer LC, Mason S. Messer et al. Respond to “Positivity in Practice”. 
American Journal of Epidemiology. 2010 March 15, 2010;171(6):680-1. 
 
  
128
Chapter 5 :  Conclusion 
  
129
Introduction 
 
Vaginal fistula is a devastating, yet preventable condition.  The ultimate goal of public health 
intervention efforts should be to prevent vaginal fistulas from occurring in the first place: 
specifically, by improving access to emergency obstetric care and the quality of obstetric 
services in developing countries.  However, in the absence of universal access to emergency 
obstetric care, an immediate goal is to facilitate and improve treatment for women who suffer 
from the injury.  There is currently little evidence regarding patient and fistula characteristics 
that influence the prognosis of a fistula repair surgery, as well as the comparative effectiveness 
of various peri-operative procedures on fistula repair outcomes.  While clinicians, program 
implementers and donors alike have called for the development of a standardized system for 
classifying fistula,1-5 the development of such a system cannot advance without evidence 
demonstrating which fistula characteristics are prognostic of repair outcomes and studies which 
compare the discriminatory value of existing systems.  In this dissertation, I sought to fill the 
above research gaps: first, by reviewing published literature regarding the individual and fistula 
characteristics, and peri-operative factors that influence repair outcomes; secondly, by comparing 
existing classification systems with regard to their ability to predict fistula closure, and 
identifying prognostic factors heretofore not included in existing systems; and finally, by 
exploring the influence of two repair procedures, one intra-operative and the other post-
operative, on fistula closure, independent of measured prognostic factors and indication for 
repair.   
 
Summary of findings 
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In Chapter 2, I reviewed the existing literature examining the influence of individual and fistula 
characteristics, and peri-operative procedures, on fistula repair outcomes.  I identified 19 articles 
meeting the inclusion criteria, all but three of which were observational studies.  The surgical 
outcomes examined were fistula closure, residual incontinence following closure, and closure 
with no remaining incontinence.  No studies demonstrated an influence of patient characteristics 
on surgical outcomes.  With regard to fistula characteristics, the presence of scarring and urethral 
involvement was associated with poor prognosis across the range of outcomes, with some 
evidence suggesting an association between greater fistula size and smaller bladder size on poor 
repair prognosis.  Evidence with regard to the role of ureteric involvement and prior repair was 
insufficient.  Most studies examining peri-operative interventions were small, and likely were 
underpowered to detect small differences.  Among the larger studies, results from two RCTs 
examining prophylactic use of antibiotics and repair outcomes were inconclusive, and a large 
study examining the influence of use of the Martius graft may have been subject to confounding 
by indication and provider experience.  Studies examining the influence of route of repair and 
duration of catheterization were likely underpowered and subject to bias resulting from 
confounding by indication. I thus concluded that while scarring and urethral involvement appear 
to be associated with poor repair prognosis, overall there remains insufficient evidence on which 
to base practice.    
 
In Chapter 3, I aimed to advance existing research on the individual patient and fistula 
characteristics that predict fistula closure, as well as to contribute to efforts in developing a 
standardized, evidence-based fistula classification system.  Specifically, I evaluated the 
discriminatory value of five existing classification systems in terms of predicting fistula closure, 
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and proposed an empirically-derived prognostic score, informed by these systems.  The scoring 
systems representing the Tafesse, Goh and WHO classification systems had higher predictive 
values: AUC 0.60 (95%CI: 0.55-0.65), AUC .62 (95%CI: 0.57-0.68) and AUC 0.63 (95%CI: 
0.57-0.68), respectively, compared to the Waaldijk system; it was not possible to develop a score 
for the Lawson system.  However, there was no statistically significant difference in the AUCs of 
these scores.  The empirically-derived prognostic score achieved a similar discriminative ability 
(AUC .62, 95%CI: .56-.67) to the scores representing Tafesse’s, Goh’s and WHO’s systems.  
Importantly, the existing classification systems evaluated contained overlapping or redundant 
components, or components that did not independently predict repair outcomes.  In contrast, the 
empirically-derived score contained a minimally sufficient set of non-overlapping and more 
objectively measured components, and therefore may be simpler to use and have higher 
reliability.  Based on these findings, I concluded that while further evaluation of the reliability 
and validity of these systems is warranted, consideration should be given to a prognostic score 
derived empirically from factors shown to independently predict repair outcomes. 
 
In Chapter 4, I endeavored to enrich the evidence-base regarding the comparative effectiveness 
of peri-operative procedures with regard to surgical repair outcomes by examining two 
procedures in particular: vaginal versus abdominal route of repair, and urinary catheterization 
greater than 14 days compared to 14 days or less.  Having met published indications for an 
abdominal route of repair (e.g. intracervical or supratrigonal location) was indeed independently 
associated with choice of abdominal surgical route (ARR 13.33, 95%CI: 4.61-38.56); few 
women undergoing abdominal repair did not meet the typical indications.  Each unit increase in 
prognostic score was associated with 1.07 times higher likelihood of urinary catheterization >14 
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days (95%CI: 1.00-1.13), after adjusting for facility, provider experience, other fistula 
characteristics and route of repair.  Vaginal route of repair was independently associated with 
increased risk of failure of fistula closure, relative to the abdominal route of repair; however, 
stratified analyses suggested a particularly elevated risk associated with vaginal route of repair 
for women in whom an abdominal repair was indicated (RR 1.97, 95%CI: 1.03-3.79).  Effect 
estimation among women in whom a vaginal approach was not indicated was precluded because 
there were no failed closures among women who underwent abdominal repair despite not 
meeting indications for abdominal route.  Despite adjusting for repair prognosis and provider 
experience, duration of catheterization >14 days predicted failure to close the fistula (ARR 1.62, 
95%CI: 1.16-2.26).  Results for both the influence of route of repair and duration of 
catheterization on fistula closure were similar when analyses were conducted in a propensity 
score-matched sample.   
 
Implications of the findings 
 
The results presented in this dissertation have important implications for clinical practice.  First, I 
have illustrated that a classification system based solely on fistula location, such as Lawson’s 
system, is unlikely to be informative in terms of repair prognosis.  Second, I have demonstrated 
that the Tafesse, Goh and WHO classification systems can be simplified for the purpose of 
predicting fistula closure: redundant measures can be streamlined, and non-predictive 
components could be eliminated from these systems.  Third, I have proposed an empirically-
derived prognostic score which can be used in the clinical setting, as a complement to clinical 
judgment for making to triage decisions.   This score is simple, comprising a minimal number of 
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non-overlapping components, and is easy to calculate.   A threshold value for “poor prognosis” 
of >1 (favoring increased sensitivity over specificity) presented in Chapter 4, is easy to recall.  In 
a context where the availability of surgeons with specialized skills is limited, facilitating triage 
decisions is critical.   
 
It is important to note, however, that the empirically-derived prognostic score presented in this 
dissertation may have some limitations.  For instance, it may not be useful in terms of planning 
the execution of a repair (e.g. determining which procedures should be undertaken).  This was 
clearly illustrated in Chapter 4: indications for abdominal route of repair, all indicators of 
visualization of and access to the fistula through a vaginal approach, were the most important 
predictors of route of repair, while increased prognostic score appeared to be inversely associated 
with an abdominal route of repair.  In addition, and as will be discussed under “Future 
Directions” below, this score would not be useful for counseling a patient with regard to her 
likelihood of return to a more functional state, since residual incontinence may be possible 
despite successful fistula closure.  Perhaps most importantly, this score represents only a proxy 
measure for the difficulty of a fistula repair.  While repair prognosis and difficulty of executing a 
repair are overlapping constructs, difficulty of repair may not necessarily lead to a poor outcome. 
 
The results of this dissertation also have important implications for future research efforts.   The 
above-mentioned prognostic score can be used to facilitate the evaluation of surgical success 
rates and provider performance across facilities, an issue of particular relevance for program 
implementers, including local and national health ministries.  Such a score can also be used to 
evaluate the effects of interventions on surgical outcomes independent of confounding by 
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prognosis, as demonstrated in Chapter 4.  If widely adopted, such a score could facilitate the 
comparative analysis of studies that examine treatment outcomes by ensuring that a standard set 
of components are adjusted for across studies.   
 
Unfortunately, drawing definitive conclusions from the analyses examining the comparative 
effectiveness of abdominal route of repair and catheterization greater than 14 days (presented in 
Chapter 4) may not be possible.  While it appeared as though the risk of failure to close the 
fistula for women repaired vaginally was elevated in women in whom access through the vagina 
was impaired, there were few women in this sample who underwent abdominal repair when it 
was not indicated.  Similarly, residual confounding by indication and reverse causation cannot be 
excluded as explanations for the increased risk of failure to close the fistula among women 
catheterized for longer than 14 days. Nonetheless, these analyses highlighted factors that may 
influence the use of one procedure over another, and confirmed that prognosis of repair and 
duration of catheterization are indeed related. 
 
Finally, the methods used in this dissertation can serve as a model to future investigations 
evaluating the discriminatory value of different classification systems, or studies using a multi-
site observational study design to compare the effectiveness of peri-operative procedures.  This 
study represents the largest collection of data assessing predictors of fistula repair outcomes to-
date, and is the only study designed to follow women after discharge from the facility in order to 
determine longer-term repair outcomes.  The study’s large sample size enabled the use of a split-
sample design to validate the prognostic models on a dataset independent of the one used to 
create the models, thereby deriving less biased measures of classification system performance;6 
future studies evaluating different classification systems should consider this design, or should 
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validate their models in different populations.  The large sample size also enabled evaluation of 
the role of route of repair on fistula closure.  As demonstrated in Chapter 2, few studies 
examining predictors of fistula repair outcomes have been sufficiently powered to demonstrate 
small significant effects.  Finally, propensity score analysis may be a useful tool where 
information on potential prognostic factors is comprehensively collected, or where overlap of 
covariates across comparison groups is questioned.  Notably, where there is little overlap in 
covariates (and therefore fewer possible matches on propensity score across comparison groups) 
and many observations have been discarded, researchers should be cautious about the external 
validity of their results.   
 
Future directions 
 
There are several specific future directions that I would like to highlight.  First, Chapter 2 
demonstrated the range of outcomes studied (fistula closure, residual incontinence, and any 
incontinence), and that this, in concert with the range of predictors studied, has resulted in a lack 
of a unified evidence-base on most predictor-outcome relationships.  It is undoubtedly true that 
from the patient’s standpoint, “any incontinence,” whether it be due to failure to close the fistula 
or residual incontinence, is the most important endpoint.  However, this endpoint does little to 
inform intervention efforts, since the distinct roles different patient or fistula characteristics or 
peri-operative procedures have on fistula closure versus residual incontinence are muddled.  
Thus, I recommend that when possible, future studies examine fistula closure and residual 
incontinence separately, in order to clarify the etiological importance of different characteristics 
and procedures on distinct outcomes.  Similarly, I evaluated the discriminatory value of several 
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classification systems on fistula closure, the immediate goal of a fistula repair.  However, it is 
also important to evaluate the discriminatory value of these systems on residual incontinence.  A 
classification system which is prognostic of residual incontinence could have important value for 
patient counseling, insofar that patients could be given an idea of what their chances of 
functional success are following the surgery. 
 
In addition to testing the discriminatory value of different classification systems with regard to 
residual incontinence, there are a number of additional steps that need to take place to further the 
development of a standardized classification system.  First, the utility of a classification system 
depends not only on its discriminatory ability, but also its ease of use and reliability in a clinical 
setting.   To date, only the Goh classification system has been subjected to tests of inter- and 
intra-rater reliability.  Thus, an important next step would be to test the inter- and intra-rater 
reliability of the classification systems evaluated in Chapter 3.  Most importantly, the acceptance 
of a particular standardized classification system requires input and buy-in from the 
gynecologists, urogynecologists and urologists who are performing fistula surgeries.  These 
analyses thus represent only an initial step towards the development of a standardized, evidence-
based fistula classification system. 
 
Finally, further research is required to evaluate the effectiveness of different peri-operative 
procedures used for fistula repair.  Reducing the duration of post-operative bladder 
catheterization by only four days has been shown to have the potential of increasing the number 
of patients who could receive surgical care by 20% in a high-volume facility,7 and may be 
associated with a decreased incidence of UTIs.8  While further research to evaluate the non-
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inferiority of shorter duration catheterization is critically needed, in Chapter 4 I demonstrated the 
limitations of an observational study design in answering this question.  Future observational 
studies on this issue must carefully establish temporality of the relationship between 
catheterization duration and repair outcome, by recording multiple outcome measurements (dye 
tests as well as any other methods to assess outcome, such as visual inspection of leaking around 
the catheter), and their timing relative to catheter removal.  Nevertheless, confounding by 
prognosis of repair may be difficult to avoid in an observational study, particularly since some 
clinical decisions may be based on factors that are difficult to measure.  The relationship between 
duration of catheterization and repair outcomes would thus be optimally measured within the 
context of a clinical trial, where the process of randomization would ensure that the control and 
intervention groups in the study are, on average, similar with respect to all prognostic factors that 
might confound the association between the intervention and the outcome.  The cost and health 
implications (particularly health-care associated infection) related to longer duration 
catheterization, together with the lack of evidence with regard to the optimal length of 
catheterization following pelvic surgery, recent evidence from a canine model indicating that 
early bladder filling may facilitate bladder healing,9 and the range of catheter durations currently 
prescribed in practice, lend justification to the conduct of such a trial. 
 
Further research is similarly necessary to determine the optimal route of repair for urinary fistula.  
However, an RCT may not be warranted to evaluate the effectiveness of abdominal route of 
repair.  Abdominal approach of repair is primarily performed under general anesthesia, which 
requires additional clinical skills, is more expensive than local anesthetia,10 and may not be 
routinely available in low-resource settings.  Moreover, abdominal repairs have been found to be 
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associated with increased blood loss,10, 11 UTI10 and longer hospital stay compared to vaginal 
repairs.11  Thus, given the decreased likelihood that an RCT would lead to an intervention that 
can be practically implemented, the effectiveness of this intervention would be better studied in 
the context of an observational cohort study.  Such a study would need to be adequately powered 
to test hypotheses of effect measure modification; specifically, whether abdominal route of repair 
is warranted for certain patient populations (defined by fistula characteristics) compared to 
others, or whether the effectiveness of an abdominal route of repair varies by provider 
experience or training.  An opportunity for such large-scale observational research exists in the 
form of the Geneva Foundation for Medical Education and Research (GFMER) web-based data 
entry system,12 which aims to enable the collection and evaluation of prospective data related to 
patient characteristics and peri-operative procedures used, among other objectives.  Because this 
database can be administered and managed from multiple centers, its wide-scale adoption would 
allow for the large-scale collection of data that is needed to examine relatively rare procedures.  
 
Conclusion 
 
This dissertation has contributed to the body of evidence on obstetric fistula care and treatment 
in the following ways: 1) through summarizing what is known with regard to a range of 
predictors of fistula repair outcomes; 2) by comparing the discriminatory value of existing 
classification systems in predicting fistula closure; 3) by identifying a minimally sufficient set of 
patient and fistula characteristics prognostic of fistula closure; 4) by elucidating factors that 
influence abdominal route of repair and duration of catheterization longer than 14 days; and 
finally, 5) through examining the comparative effectiveness of the latter procedures on repair 
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outcomes, and whether outcomes vary by indication for repair and repair prognosis.  The care 
and treatment of fistula patients in developing countries is fraught with many challenges; 
continuing research on this important topic can help to ensure that a lack of an evidence-base is 
not among them.   
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Appendix A: Diagrams of types of urinary fistula i 
 
 
 
Figure A.1: Lateral view of a vesicovaginal fistula 
Reprinted with permission from R. Avritscher and the Radiological Society of North America 
(RSNA) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.2: Left ureterovaginal fistula 
Reprinted with permission from R. Avritscher and the Radiological Society of North America 
(RSNA) 
                                                 
i
 Avritscher R, Madoff DC, Ramirez PT, Wallace MJ, Ahrar K, Morello FA, et al. Fistulas of the Lower Urinary 
Tract: Percutaneous Approaches for the Management of a Difficult Clinical Entity. Radiographics. 2004 October 
1, 2004;24(suppl 1):S217-S36. 
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Appendix B: Glossary  
 
Table B.1: Glossary of key terms and phrases 
Term Definition 
Any incontinence Failure to close the fistula or residual incontinence 
Circumferential fistula Complete separation of the urethra and bladder 
Closing mechanism Variously defined as the urethral sphincter, or continence 
mechanism 
Closure (of the fistula) State in which fistula has been surgically rendered intact, with no 
leakage of urine around the sutures. 
Continence mechanism The combination of anatomical structures that contribute to 
continence, including a functioning urethral sphincter, quiescent 
bladder, and functioning musculofascial supports. 
Intra-cervical fistula Fistula between the bladder and the cervical canal 
Juxta-cervical fistula Fistula located in the region of the cervix 
Juxta-urethral fistula Fistula at the urethro-vesical junction 
Mid-vaginal fistula Small defect 4 cm or more from the external urethral orifice 
Obstetric fistula Vaginal fistula of obstetric etiology 
Recto-vaginal fistula (RVF) Fistulas located between the rectum and the vagina 
Residual incontinence Remaining incontinence (stress incontinence, urge incontinence, 
frequency / urgency syndrome) following successful fistula 
closure 
Urinary fistula Term used to refer to a vaginal fistula which results in urinary 
incontinence 
Vault fistula Fistulas located at the vaginal apex 
Vesico-vaginal fistula 
(VVF) 
Fistulas located between the bladder and the vagina 
Vaginal fistula Abnormal passageway between the vagina and bladder or 
between the vagina and rectum 
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Appendix C: Existing classification systems compared in Chapter 1 
Where possible, we retained the original components of the classification schemes that we tested.  
However, in some cases, it was necessary to approximate the measures, either because we did 
not measure the component exactly, or for analytic purposes.  The original measures and ways in 
which they were operationalized are shown below. 
 
 
Table C.1: Lawson, Waaldijk, Tafesse and Goh classification systems and how they were 
operationalized for analytic purposes 
Classification 
system 
Type and / or description of fistula  How component was 
operationalized  
Lawson 1968 i. Juxta-urethral 
ii. Mid-vaginal 
iii. Juxta-cervical 
iv. Vault 
v. Massive combination fistula 
i. No change 
ii. No change 
iii. No change 
iv. No change 
v. No change  
Waaldijk 1995 Classification 
Type 1  Not involving the closing 
mechanism 
Type 2  Involves closing mechanism 
A          Without (sub)total urethra 
involvement 
B          With (sub)total urethra 
involvement 
a           Without circumferential 
defect 
b           With circumferential defect 
Type 3  Ureteric and other 
exceptional fistulas 
 
Classification 
Type 1  Not involving the closing 
mechanism and not 
involving complete 
destruction of bladder neck 
Type 2  Involves closing mechanism 
or destruction of bladder 
neck 
A          Intact or partially damaged 
urethra (no change) 
B          Completely destroyed urethra 
(no change) 
a           No change 
b           No change 
Type 3  Mixed vesicovaginal and 
rectovaginal fistulas, cervical 
and ureteric fistulas 
Size 
Small <2 
Medium 2-3 
Large 4-5 
Extensive> 6 
Size 
No change 
No change 
No change 
No change 
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Classification 
system 
Type and / or description of fistula  How component was 
operationalized  
Tafesse 2008 Class 1  Non-circumferential, not 
previously operated 
Class 2  Non-circumferential, 
previously operated 
Class 3  Circumferential, not 
previously operated 
Class 4  Circumferential, previously 
operated 
Class 1  No change 
Class 2  No change 
Class 3  No change 
Class 4  No change  
 
Urethral involvement 
I            No involvement (urethral 
length>4cm) 
II           Urethra involved but not 
middle 1/3 (urethral length 
2.7-3.9 cm) 
III         Middle 1/3 partly involved 
(urethral length 1.4-2.6 cm) 
IV         Middle 1/3 completely 
involved but some urethral 
tissue remains (urethral 
length <1.4 cm) 
V           No urethra 
Urethral involvement 
I            No change  
II          No change  
III         No change  
IV         Collapsed categories IV and 
V 
Bladder size 
a            Longitudinal diameter >7 cm 
b            Longitudinal diameter 4-7    
cm 
c            Longitudinal diameter <4 cm 
Bladder size 
a           “Normal” bladder  
b            Small bladder 
c            Small bladder 
 
Anterior vaginal tissue loss 
1 Less than 50% of anterior 
vagina is involved (>3.5 cm 
of healthy vagina remains) 
2 More than 50% of the 
anterior vagina wall is 
involved (<3.5 cm of health 
vagina remains) 
3 Obliterated vagina (vagina 
cannot admit more than 1 
finger) 
Anterior vaginal tissue loss 
1 Minimal tissue loss 
2 Moderate tissue loss 
3 Extensive tissue loss or 
obliterated vagina 
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Classification 
system 
Type and / or description of fistula  How component was 
operationalized  
Goh 2004  Type 1  Distal edge of the fistula >3.5 
cm from external urinary 
meatus 
Type 2  Distal edge of the fistula 2.5-
3.5 cm from external urinary 
meatus 
Type 3  Distal edge of the fistula 1.5-
<2.5 cm from external 
urinary meatus 
Type 4  Distal edge of the fistula <1.5 
cm from external urinary 
meatus 
Type 1  Urethral length > 3.5 cm  
Type 2  Urethral length 2.5-3.5 cm  
Type 3  Urethral length 1.5-<2.5 cm  
Type 4  Urethral length <1.5 cm  
 
 
a           Size <1.5 cm in the largest 
diameter 
b           Size 1.5-3 cm in the largest 
diameter 
c           Size >3 cm in the largest 
diameter 
a           No change  
b           No change 
c           No change 
 
i.           None or only mild fibrosis 
(around fistula and/or vagina) 
and/or vaginal length >6cm, 
normal bladder capacity 
ii.          Moderate or severe fibrosis 
(around fistula and/or vagina) 
and/or reduced vaginal length 
and/or bladder capacity 
iii.         Special considerations, e.g. 
post-radiation, ureteric 
involvement, circumferential 
fistula, previous repair  
 
i.           None or only mild fibrosis 
and normal bladder capacity 
ii.          Moderate or severe fibrosis 
and small bladder capacity 
iii.         Ureteric involvement, 
circumferential fistula, 
previous repair 
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Table C.2: Classification system presented by WHO and how it was operationalized for 
analytic purposes 
 
Classification 
system 
Type and / or description of fistula  How component was 
operationalized  
WHO Defining 
Criteria 
Simple Complex  
Number of 
fistula 
 single   multiple  No change 
Site  vesico-vaginal 
(VVF)  
 
 All non-VVF 
urinary 
fistula 
 recto-vaginal 
(RVF) 
 mixed 
VVF/RVF 
 involvement 
of cervix 
 non-VVF excludes 
ureteric and 
urethral fistulas 
Size (diameter)  <4cm   >4cm  No change 
Involvement of 
the urethra / 
continence 
mechanism 
 absent  
 
 present  No change 
Scarring of 
vaginal tissue 
 absent   present  No change 
Presence of 
circumferential 
defect* 
 absent  
 
 present  Not included in 
multivariate 
analysis 
Degree of 
tissue loss 
 minimal   extensive  Moderate and 
minimal tissue loss 
considered 
“minimal” 
Ureter/bladder 
involvement 
 
 ureters are 
inside the 
bladder, not 
draining into 
the vagina 
 one or both 
ureters are 
draining into 
the vagina 
 one or both 
ureters are at 
the edge of 
the fistula 
 Created composite 
measure 
representing 
ureteric 
involvement 
(either ureteric 
location or ureters 
draining into 
vagina or at edge 
of vagina) 
Number of 
previous repair 
attempts 
 no previous 
attempt  
 failed 
previous 
repair 
attempts 
 No change 
* Complete separation of the urethra and bladder 
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Appendix D: Comparing discriminatory value of classification systems, accounting for 
clustering by surgeon rather than site  
 
In this appendix, I evaluate the discriminatory value of existing classification systems and 
propose an empirically-derived prognostic score, accounting for provider, rather than site, as the 
clustering variable in my analyses.  The predictive value of existing systems remained the same.  
One variable, partial urethral involvement, in the empirically-derived prognostic score was no 
longer significant.  There were no statistically significant differences in the AUCs in the 
proposed empirically-derived prognostic score, and the scores developed to represent the 
Tafesse, Goh and WHO classification systems.  I present results of analyses accounting for 
clustering by site rather than provider within the body of the manuscript, since site is the higher 
order level of clustering. 
 
Table D.1: Existing classification systems – clustering by provider rather than site 
 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI) Score 
Lawson 
 Juxta-urethral 24  (20.5) 105  (20.4) 1.14 (0.80-1.62) 0.93 (0.60-1.43) - 
 Mid-vaginal 20  (17.1) 172  (33.2) 0.58 (0.36-0.92)** 0.52 (0.32-0.86)** -2 
 Juxta-cervical 20  (17.1) 87  (16.9) 0.93 (0.57-1.52) 0.81 (0.52-1.27) - 
 Vault 2  ( 1.7) 17  ( 3.3) 0.62 (0.24-1.63) 0.52 (0.19-1.46) - 
 Massive combination  2  ( 1.7) 5  ( 1.0) 1.67 (0.74-3.79) - - 
Waaldijk 
 Type 1  Not involving 
closing mechanism 
101  (84.9) 490  (94.8) Ref Ref - 
 Type 2 Involves closing 
mechanism 
18  (15.3) 27  ( 5.2) 2.32 (1.71-3.16)** 
 
Ref - 
 Type 2Aa  Without 
(sub)total urethra 
involvement without 
circumferential defect 
8  ( 6.8) 9  ( 1.7) 2.49 (1.59-3.90)** 2.70 (1.70-4.08)** 
 
3 
 Type 2Ab  Without 
(sub)total urethra 
involvement with 
circumferential defect        
6  ( 5.1) 13  ( 2.5) 1.81 (0.87-3.73)* 1.67 (0.83-3.37)* - 
 Type2Ba With (sub)total 
urethra involvement 
without circumferential 
defect 
1  ( 0.9) 3  ( 0.6) 1.34 (0.44-4.07) 1.69 (0.70-4.08) - 
 Type2Bb With (sub)total 
urethra involvement with 
circumferential defect 
2  ( 1.7) 1  ( 0.2) 3.63 (2.30-5.73) 3.50 (1.26-5.42)** 
 
4 
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 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI) Score 
 Type 3  Ureteric and 
other exceptional 
fistulasii 
39  (33.1) 128  (24.7) 1.39 (0.85-2.30)* 
 
1.31 (0.82-2.12)* - 
 Small <2 27  (23.7) 143  (29.1) Ref Ref - 
 Medium 2-3 49  (42.6) 254  (51.7) 0.91 (0.61-1.34) 0.95 (0.65-1.38) - 
 Large 4-5 31  (27.0) 75  (15.3) 1.62 (1.03-2.56) 1.38 (0.97-1.97)* - 
 Extensive> 6 7  ( 6.1) 22  ( 4.5) 1.31 (0.66-2.58) 1.17 (0.61-2.23) - 
Tafesse 
 Class 1  Non-
circumferential, not 
previously operated 
50  (42.4) 352  (67.8) Ref Ref - 
 Class 2  Non-
circumferential, 
previously operated 
28  (23.7) 98  (18.9) 1.78 (0.97-3.25** 
 
1.73 (0.93- 3.23)* - 
 Class 3  Circumferential, 
not previously operated 
29  (24.6) 57  (11.0) 2.63 (1.43-4.84)** 
 
1.95 (1.05- 
3.62)** 
 
2 
 Class 4  Circumferential, 
previously operated 
11  ( 9.3) 12  ( 2.3) 3.37 (1.94-5.84)** 
 
2.28 (1.27-4.11)** 
 
2 
 I    No urethral 
involvement (urethral 
length>4cm) 
12  (11.9) 116  (25.4) Ref Ref - 
 II  Urethra involved but 
not middle 1/3 (2.7-3.9 
cm) 
47  (46.5) 182  (39.9) 2.27 (103- 5.01)** 1.86 (1.27- 
3.74)** 
 
2 
 III Middle 1/3 partly 
involved (1.4-2.6 cm)  
34  (33.7) 142  (31.1) 2.23 (1.05- 4.74)** 
 
1.35 (0.67-2.72) 
 
- 
 IV-V  Middle 1/3 
completely involved or 
no urethraiii 
8  ( 7.9) 16  ( 3.5) 3.85 (1.59- 9.35)** 
 
2.17 (1.10- 4.29)* 
 
2 
 b-c Longitudinal 
diameter of bladder < 7 
cmiv 
44  (40.7) 119  (24.4) 2.03 (1.19-3.43)** 1.19 (0.78-1.80) 
 
 
- 
 < 50% of anterior vagina 
involved  
34  (28.8) 292  (56.5) Ref Ref - 
 > 50% of the anterior 
vagina wall involved  
53  (44.9) 190  (36.8) 1.65 (1.02- 2.67)** 1.57 (1.21-2.04)** 
 
2 
 Obliterated vagina  31  (26.3) 36  ( 7.0) 3.36 (1.97-5.73)** 2.64 (2.17- 3.21) 3 
Goh 
 Type 1  Distal edge of 
the fistula >3.5 cm from 
external urinary meatus 
(EUM) 
20  (18.3)         165  (32.9) Ref Ref - 
 Type 2  Distal edge of 
the fistula 2.5-3.5 cm 
from EUM 
47  (46.5)         180  (39.5) 2.50 (1.16-  5.30) 1.98 (1.280-
3.05)** 
2 
                                                 
ii
 This category includes mixed vesicovaginal and rectovaginal fistula, cervical and ureteric fistula.  Urethral fistula are excluded 
from this category since these are measured by other components, and uniquely rectovaginal fistula are excluded since our 
analyses examine closure of urinary fistula 
iii
 Categories IV (Middle 1/3 completely involved but some urethral tissue remains (urethral length <1.4 cm)) and V (no urethra) 
were collapsed due to the presence of only 1 woman in the latter category 
iv
 Categories b (Longitudinal diameter 4-7 cm) and c (Longitudinal diameter <4 cm) collapsed and equated with “small” or “no 
bladder” in our dataset 
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 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI) Score 
 Type 3  Distal edge of 
the fistula 1.5-<2.5 cm 
from EUM 
27  (26.7)         120  (26.3) 2.28 (1.07-  4.87) 1.62 (1.01-2.59)** 2 
 Type 4  Distal edge of 
the fistula <1.5 cm from 
EUM 
15  (14.9)          37  ( 8.1) 3.74 (1.75- 7.99) 2.04 (1.17-3.57)** 2 
 a           Size <1.5 cm  21  (18.4)         107  (21.7) Ref Ref - 
 b           Size 1.5-3 cm  49  (43.0)         273  (55.5) 0.90 (0.53-1.53) 0.75 (0.44-1.26) - 
 c           Size >3 cm  44  (38.6)         112  (22.8) 1.69 (1.05-2.70) 0.98 (0.65-1.47) - 
 i.           None or only mild 
fibrosis, and/or vaginal 
length >6cm, normal 
bladder capacity 
Ref Ref Ref Ref - 
 ii.          Moderate or 
severe fibrosis, and/or 
reduced vaginal length 
and/or bladder 
capacity 
75  (63.6)         216  (41.6)    2.07 (1.23- 3.48) 1.74 (1.10-2.77)** 2 
 iii.         Special 
considerations, e.g. 
post-radiation, ureteric 
involvement, 
circumferential fistula, 
previous repair  
73  (61.9)         218  (42.0)    1.87 (0.99-3.54)* 1.55 (0.81-2.96)* - 
WHO 
 >1 fistula  16  (13.6) 24  ( 4.6) 2.26 (1.43-3.56)** 1.83 (1.06- 
3.16)** 
2 
 Site (mixed vvf rvf or 
cervical fistulav) 
8  ( 6.8) 47  ( 9.1) 0.72 (0.40-1.30) 0.78 (0.39-1.56) 
 
- 
 Size (diameter >4 cm) 38  (33.3) 95  (19.3) 1.72 (1.13-2.62)** 1.17 (0.83- 1.66) - 
 Involvement of the 
urethra / continence 
mechanism 
72  (61.0) 192  (37.1) 2.03 (1.52-2.70)** 1.64 (1.20- 
2.24)** 
 
 
2 
 Scarring   94  (79.7)          386  (74.5) 0.86 (0.36-2.09) 0.97 (0.57-1.65) - 
 Circumferential defect 40  (33.9) 69  (13.3) 2.32 (1.60-3.35)** - - 
 Extensive tissue loss 31  (26.3) 35  ( 6.8) 2.75 (1.80-4.18)** 1.89 (1.24-2.86)** 2 
 Ureter involvementvi 32  (27.4) 87  (16.9) 1.67 (1.00-2.80)* 1.13 (0.69-1.86) - 
 Previous repair  39  (33.1) 110  (21.2) 1.57 (1.07-2.31)** 1.43 (0.96-2.13)* - 
 
 
 
 
                                                 
v
 In this category are included mixed vesicovaginal and rectovaginal fistula and cervical fistula.  Urethral fistula are excluded 
from this category since these are measured by the component “involvement of the urethra / continence mechanism.” Ureteric 
fistula are excluded as they are measured through the variable “ureter involvement” and uniquely rectovaginal fistula are 
excluded since our analyses examine closure of urinary fistula 
vi
 This variable is a proxy for the WHO variable “ureters draining into the vagina or at edge of the fistula”: non-specified ureteric 
involvement was included here to avoid overlap with the variable “non-vvf” 
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Table D.2: Additional variables for consideration in a prognostic classification system – 
accounting for clustering by provider rather than site 
Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) 
Patient characteristics 
Age > 25  65  (55.1) 241  (46.4) 1.19 (0.84-1.70) 
Duration of fistula (average 
years, sd)  
5.5  ( 8.3) 3.0  ( 4.7) 1.04 (1.03-1.06)** 
 
Comorbidities present at baseline 
Genital cutting  35  (29.7) 99  (19.2) 1.26 (0.90-1.87) 
Malnutrition 8  ( 6.8) 31  ( 6.0) 1.26 (0.71-2.23) 
Anemia 9  ( 7.6) 36  ( 6.9) 1.14 (0.75-1.74) 
UTI 0  ( 0.0) 2  ( 0.4) - 
HIV 0  ( 0.0) 2  ( 0.4) - 
Malaria 1  ( 0.8) 3  ( 0.6) 0. 59 (0.35-2.58) 
Helminthiasis 20  (16.9) 54  (10.4) 1.23 (0.83-1.82) 
Fistula characteristics not included in above classification systems  
Necrotic tissue present 16  (13.7) 46  ( 8.9) 1.44 (0.64-3.23) 
No or mild scarring 51  (43.2) 356  (68.7) Ref 
Moderate scarring 43  (36.4) 133  (25.7) 1.85 (1.10-3.13)** 
Severe scarring 24  (20.3) 29  ( 5.6) 3.39 (1.98-5.80)** 
No urethral involvement 46  (39.0) 326  (62.9) Ref 
Partial urethral involvement 30  (25.4) 119  (23.0) 1.50 (1.03-2.17)** 
Complete destruction or 
transection / circumferential 
injury 
41  (35.0) 72  (14.0) 2.64 (1.88-3.72)** 
Any ureteric involvement 78  (66.7) 266  (51.6) 1.67 (1.00-2.80)* 
Non-vvf (ureteric, urethral, 
rectovaginal, cervical fistula) 
27  (22.9) 79  (15.4) 1.65 (1.14-2.38)** 
Cervix not visible 65  (55.1) 241  (46.4) 1.37 (0.78-2.44) 
 
 
Table D.3: Proposed fistula complexity scoring system – outcome at follow-up, adjusting 
for clustering by provider 
Component ARR (95% CI) Score 
>1 fistula 2.03 (1.21- 3.39) 2 
Moderate or severe scarring 1.75 (1.14- 2.70) 2 
Complete destruction or 
transection / circumferential 
injury 
2.04 (1.38- 3.02) 2 
 
Table D.4: Comparison of AUCs – clustering by provider 
 Derived cohort Validation cohort 
Scoring 
system 
Proportion failed 
closures 
C-statistic 
(95%CI) 
Proportion failed 
closures 
C-statistic 
(95%CI) 
Waaldijk  0.53 (0.51-0.56)  0.51 (0.49- 0.53) 
0 108/616 (17.53%)  110/617 (17.83%)  
3 8/17 (47.06%)  3/12 (25.00%)  
4 2/3 (66.67%)  2/5 (40.00%)  
Goh  0.62 (0.57- 0.67)  0.62 (0.57- 0.68) 
0 14/141 (9.93%)  18/141 (12.77%)  
2 44/275 (16.00%)  33/274 (12.04%)  
4 60/221 (27.15%)  64/222 (28.83%)  
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 Derived cohort Validation cohort 
Scoring 
system 
Proportion failed 
closures 
C-statistic 
(95%CI) 
Proportion failed 
closures 
C-statistic 
(95%CI) 
Tafesse  0.66 (0.61-0.71)  0.59 (0.54- 0.64)  
0 18/193 (9.33%)  18/193 (9.33%)  
2 37/250 (14.80%)  51/230 (22.17%)  
3 63/194 (32.97%)  46/214 (21.50%)  
WHO  0.69 (0.64-0.74)  0.63 (0.57- 0.68)  
0 32/337 (9.50%)  44/351 (12.54%)  
2 54/233 (23.18%)  44/215 (20.47%)  
4 32/67 (47.76%)  27/71 (38.03%)  
Proposed  0.69 (0.64-0.74)   0.60 (0.55-0.66) 
0 33/355 (9.30%)  48/348 (13.79%)  
2 47/186 (25.27%)  36/194 (18.56%)  
4 3831/96 (39.58%)  31/95 (32.63%)  
 
 
Figure D.1: ROC curves – outcome at discharge, derived cohort 
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Figure D.2: ROC curves – outcome at discharge, validation cohort 
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Appendix E: Comparing discriminatory value of classification systems, where primary 
outcome is fistula closure at discharge from facility 
 
In this appendix, I evaluate the discriminatory value of existing classification systems and 
propose an empirically-derived prognostic score, examining fistula closure at discharge from the 
facility, rather than at the three-month follow-up visit.  This analysis generated different results 
than those obtained examining fistula closure at follow-up.  Specifically, the components of 
existing systems that met criteria for inclusion in a scoring system varied (only one element of 
both the Waaldijk and Goh systems met criteria for inclusion), as did the weights assigned to 
components previously included.  The proposed prognostic score contained one new component 
(bladder size) and no longer included partial urethral involvement.   Further, there was overlap in 
the confidence intervals across the three AUCs compared.  However, prevalence of failure to 
close the fistula at discharge (15.1%) was lower than at 3-months following surgery (18.5%), and 
therefore these analyses may have had decreased statistical power for detecting small 
differences. 
 
 
Table E.1: Derivation of prognostic scores for existing classification systems –outcome at 
discharge 
 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI) Score 
Lawson 
 Juxta-urethral 22  (22.4)         111  (20.2) 1.18 (0.80-1.75) 0.91 (0.53-1.56) - 
 Mid-vaginal 18  (18.4)         176  (31.8) 0.58 (0.30-1.12)* 0.53 (0.26-1.08)* - 
 Juxta-cervical 14  (14.3)          94  (17.1) 0.81 (0.38-1.72) 0.69 (0.35-1.36) - 
 Vault 2  ( 2.0) 18  ( 3.3) 0.68 (0.37-1.26) 0.54 (0.24-1.24)* - 
 Massive combination  2  ( 2.0)   5  ( 0.9) 2.25 (1.01-5.03)** -- - 
Waaldijk 
 Type 1  Not involving 
closing mechanism 
85  (85.9)         520  (93.9) Ref Ref - 
 Type 2 Involves closing 
mechanism 
14  (14.1) 34  ( 6.1) 1.97 (1.26-3.09)** Ref - 
 Type 2Aa  Without 
(sub)total urethra 
involvement without 
circumferential defect 
4  ( 4.0) 
 
15  ( 2.7) 1.32 (0.46-3.79) 1.63 (0.62-4.27) - 
 Type 2Ab  Without 
(sub)total urethra 
6  ( 6.1)  13  ( 2.3) 1.92 (0.89-4.18)* 1.54 (0.77-3.08) - 
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 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI) Score 
involvement with 
circumferential defect        
 Type2Ba With (sub)total 
urethra involvement 
without circumferential 
defect 
1  ( 1.0)   3  ( 0.5) 1.92 (0.82-4.45)* 1.85 (0.71-4.82) - 
 Type2Bb With (sub)total 
urethra involvement with 
circumferential defect 
2  ( 2.0) 
 
  2  ( 0.4) 3.32 (1.70-6.50)** 2.41 (1.07-5.43)** 2 
 Type 3  Ureteric and 
other exceptional 
fistulavii 
37  (37.8)         135  (24.3) 1.73 (1.07-2.80)** 1.53 (0.95-2.49)* - 
 Small <2 20  (21.5)         153  (29.0) Ref Ref - 
 Medium 2-3 38  (40.9)         268  (50.8) 1.09 (0.75-1.58) 
 
1.07 (0.73-1.56) - 
 Large 4-5 29  (31.2)          83  (15.7) 2.11 (1.26-3.53)** 1.63 (0.97-2.75) * - 
 Extensive> 6 6  ( 6.5)            24  ( 4.5) 1.57 (0.73-3.39) 1.33 (0.67-2.62) - 
Tafesse 
 Class 1  Non-
circumferential, not 
previously operated 
44  (44.4)         368  (66.3) Ref Ref - 
 Class 2  Non-
circumferential, 
previously operated 
19  (19.2)         109  (19.6) 1.26 (0.76-2.09) 1.19 (0.64-2.22) - 
 Class 3  Circumferential, 
not previously operated 
28  (28.3)           63  (11.4) 2.65 (1.58-4.44)** 1.74 (0.85-3.58)* - 
 Class 4  Circumferential, 
previously operated 
  8  ( 8.1)          15  ( 2.7) 2.68 (1.63-4.40)** 1.74 (0.83-3.64)* - 
 I    No urethral 
involvement (urethral 
length>4cm) 
21  (22.8)         169  (31.7) Ref Ref - 
 II  Urethra involved but 
not middle 1/3 (2.7-3.9 
cm) 
29  (34.9)         205  (42.4) 1.42 (0.83-2.41)* 1.18 (0.80-1.73) * - 
 III Middle 1/3 partly 
involved (1.4-2.6 cm)  
34  (41.0)         142  (29.3) 2.23 (1.38-3.61)** 1.37(0.77-2.43) - 
 IV-V  Middle 1/3 
completely involved or 
no urethraviii 
  8  ( 9.6)          17  ( 3.5) 3.75 (1.98- 7.13)** 2.14 (1.07-4.30) 
** 
2 
 b-c Longitudinal 
diameter of bladder < 7 
cmix 
37  (43.0)         129  (24.8) 2.17 (1.61-2.93)** 1.13 (0.79-1.63) - 
 < 50% of anterior vagina 
involved  
27  (27.3)         303  (54.9) Ref Ref - 
 > 50% of the anterior 
vagina wall involved  
44  (44.4)         209  (37.9) 1.83 (1.20-2.79)** 1.64 (1.08-2.51) 
** 
2 
 Obliterated vagina  28  (28.3)           41  ( 7.4)    3.97 (2.65-5.94)** 3.16 (2. 02-3.95) 3 
                                                 
vii
 This category includes mixed vesicovaginal and rectovaginal fistula, cervical and ureteric fistula.  Urethral fistula are excluded 
from this category since these are measured by other components, and uniquely rectovaginal fistula are excluded since our 
analyses examine closure of urinary fistula 
viii
 Categories IV (Middle 1/3 completely involved but some urethral tissue remains (urethral length <1.4 cm)) and V (no urethra) 
were collapsed due to the presence of only 1 woman in the latter category 
ix
 Categories b (Longitudinal diameter 4-7 cm) and c (Longitudinal diameter <4 cm) collapsed and equated with “small” or “no 
bladder” in our dataset 
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 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI) Score 
** 
Goh 
 Type 1  Distal edge of 
the fistula >3.5 cm from 
external urinary meatus 
(EUM) 
21  (22.8)         172  (32.3) Ref Ref - 
 Type 2  Distal edge of 
the fistula 2.5-3.5 cm 
from EUM 
29  (34.9)         203  (41.9) 1.44 (0.87-2.38) 1.14 (0.72-1.80) - 
 Type 3  Distal edge of 
the fistula 1.5-<2.5 cm 
from EUM 
27  (32.5)         120  (24.8) 2.13 (1.35-3.35)** 1.52 (0.85-2.72)* - 
 Type 4  Distal edge of 
the fistula <1.5 cm from 
EUM 
15  (18.1)          38  ( 7.9) 3.38 (1.94-5.89) 1.83 (0.83-4.05)* - 
 a           Size <1.5 cm  16  (17.2)         115  (21.8)       Ref Ref - 
 b           Size 1.5-3 cm  36  (38.7)         289  (54.7) 0.95 (0.56-1.59) 0.75 (0.43-1.33) - 
 c           Size >3 cm  41  (44.1)         124  (23.5) 195 (1.11-3.44)** 1.02 (0.57-1.83) - 
 i.           None or only mild 
fibrosis, and/or vaginal 
length >6cm, normal 
bladder capacity 
Ref Ref Ref Ref - 
 ii.          Moderate or 
severe fibrosis, and/or 
reduced vaginal length 
and/or bladder 
capacity 
69  (69.7)         231  (41.6) 2.55 (1.82-3.58)** 2.38 (1.54-3.67)** 2 
 iii.         Special 
considerations, e.g. 
post-radiation, ureteric 
involvement, 
circumferential fistula, 
previous repair  
59  (59.6)         241  (43.4) 1.66 (0.99-2.80)* 1.25 (0.70-2.21) - 
WHO 
 >1 fistula  14  (14.1)          26  ( 4.7) 2.33 (1.68- 3.22)** 2.46 (1.60-3.79)** 2 
 Site (mixed vvf rvf or 
cervical fistulax) 
8  ( 8.1)            48  ( 8.6) 0.94 (0.66-1.34) 0.91 (0.68-1.21) - 
 Size (diameter >4 cm) 35  (37.6)         107  (20.3) 1.90 (1.24-2.91)** 1.13 (0.80-1.61) - 
 Involvement of the 
urethra / continence 
mechanism 
59  (59.6)         213  (38.4) 2.01 (1.36-2.97)** 1.61 (0.99-2.62)* - 
 Scarring  83  (83.8)         409  (73.8) 2.16 (1.54-3.04)** 1.84 (1.03-3.27)** 2 
 Circumferential defectxi 36  (36.4)          78  (14.1) 2.49 (1.76-3.53)** - - 
 Extensive tissue loss 28  (28.3)          40  ( 7.2) 2.90 (2.19-3.84)** 2.03 (1.52- 
2.71)** 
2 
 Ureter involvementxii 29  (29.6)          94  (17.1) 1.82 (1.09-3.06)** 1.25 (0.84-1.86)* - 
                                                 
x
 In this category are included mixed vesicovaginal and rectovaginal fistula and cervical fistula.  Urethral fistula are excluded 
from this category since these are measured by the component “involvement of the urethra / continence mechanism.” Ureteric 
fistula are excluded as they are measured through the variable “ureter involvement” and uniquely rectovaginal fistula are 
excluded since our analyses examine closure of urinary fistula 
xi
 This variable was not included in multivariate analysis since circumferential fistulas are a type of urethral involvement, 
captured by another component 
xii
 This variable is a proxy for the WHO variable “ureters draining into the vagina or at edge of the fistula”: non-specified ureteric 
involvement was included here to avoid overlap with the variable “non-vvf” 
  
157
 Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) ARR (95% CI) Score 
 Previous repair  27  (27.3)         124  (22.3) 1.11 (0.76-1.63) 1.01 (0.70-1.47) - 
 
Table E.2: Additional variables for consideration in a prognostic classification system –
outcome at discharge 
Component Open 
N (%) 
Closed 
N (%) 
RR (95% CI) 
Patient characteristics 
Age > 25 50  (50.5)          266  (47.9) 0.94 (0.59-1.49) 
Duration of fistula (average years, 
sd)  
4.3  ( 7.1) 3.2  ( 5.3) 1.03 (1.01-1.05)** 
 
Comorbidities present at baseline 
Genital cutting  22  (22.2)          113  (20.5) 1.05 (0.61-1.81) 
Malnutrition 13  (13.1)           32  ( 5.8) 1.68 (1.17-2.41)** 
Anemia 12  (12.1)             38  ( 6.8) 1.16 (0.45-3.00) 
UTI 0  ( 0.0)   2  ( 0.4) - 
HIV 0  ( 0.0)   2  ( 0.4) - 
Malaria 1  ( 1.0)   3  ( 0.6) 1.59 (0.89-2.83) 
Helminthiasis 12  (12.1)           62  (11.2) 1.03 (0.95-1.12) 
Fistula characteristics not included in above classification systems  
Necrotic tissue present 15  (15.3)           52  ( 9.5) 1.40 (0.57-3.46) 
No or mild scarring 37  (37.4)          379  (68.4) Ref 
Moderate scarring 40  (40.4)          142  (25.6) 2.33 (1.62-3.37)** 
Severe scarring 22  (22.2)           33  ( 6.0) 4.20 (2.68-6.56)** 
No urethral involvement 40  (40.4)          342  (61.7) Ref 
Partial urethral involvement 22  (22.2)          129  (23.3) 1.42 (1.03-1.95)** 
Complete destruction or 
transection / circumferential injury 
37  (37.4)           81  (14.8) 2.75 (1.84-4.11)** 
Any ureteric involvement 29  (29.6)           94  (17.1) 1.82 (1.09-3.06)** 
Non-vvf (ureteric, urethral, 
rectovaginal, cervical fistula) 
68  (68.7)          285  (51.7) 1.94 (1.28-2.96)** 
Cervix not visible 23  (23.2)           86  (15.7) 1.64 (1.14-2.33)** 
 
Table E.3: Proposed prognostic score – outcome at discharge 
Component ARR (95% CI) Score 
Small bladder 1.21 (1.01- 1.45) 1 
>1 fistula 2.11 (1.41- 3.17) 2 
Moderate or severe scarring 2.02 (1.57- 2.60) 2 
Complete destruction or 
transection / circumferential injury 
2.07 (1.52- 2.83) 2 
 
Table E.4: Performance of selected classification systems – outcome at discharge 
 Derived cohort Validation cohort 
Scoring 
system 
Proportion failed 
closures 
C-statistic 
(95%CI) 
Proportion failed 
closures 
C-statistic 
(95%CI) 
Tafesse  .67 (0.62-0.72)  .66 (0.61-0.71) 
0 23/317 (7.26)  23 / 289 (7.96)  
2 41/244 (16.80)  45 / 262 (17.18)  
3 28 / 75 (37.33)  32 / 85 (37.65)  
WHO  .68 (0.63- 0.74)  .59 (0.54- 0.65) 
0 26/379 (6.86)  45 / 372 (12.10)  
2 37/186 (19.89)  32 / 193 (16.58)  
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 Derived cohort Validation cohort 
Scoring 
system 
Proportion failed 
closures 
C-statistic 
(95%CI) 
Proportion failed 
closures 
C-statistic 
(95%CI) 
4 29/72 (40.28)  23 / 72 (31.94)  
Proposed  .68 (0.63-0.73)  .63 (0.58-0.69) 
0 17/309 (5.50)  27 / 293 (9.22)  
1 3/46(6.52)  13 / 55(23.64)  
2 29/126(23.02)  13 / 127(10.24)  
3 43/156(27.56)  47 / 162 (29.01)  
 
 
Figure E.1: ROC curves –derivation cohort, outcome at discharge 
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Figure E.2: ROC curves –validation cohort, outcome at discharge 
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Appendix F: Distribution of success rates, surgeons, and peri-operative procedures across sites 
 
Table F.1: Distribution of success rates, surgeons, and peri-operative procedures across sites 
 Site N (%) 
Characteristic Total 
(n=1328) 
Site A 
(n=84) 
Site B 
(n=48) 
Site C 
(n=5) 
Site D 
(n=246) 
Site E 
(n=72) 
Site F 
(n=93) 
Site G 
(n=57) 
Site H 
(n=208) 
Site I 
(n=151) 
Site J 
(n=160) 
Site K 
(n=204) 
Number of 
surgeons 
51i 7 5 2 6 6 4 8 2 5 5 10 
Number of 
patients 
returning for 
follow-up visit  
1274 
(95.93) 
71 
(84.52) 
48 
(100.00)    
5 
(100.00)    
246 
(100.00)    
67 
(93.06) 
68 
(73.12) 
53 
(92.98) 
208 
(100.00)    
146 
(96.69) 
159 
(99.38) 
203 
(99.51) 
Successful 
repair at 
discharge  
1104       
(84.47) 
62  
(75.61) 
34  
(70.83) 
5  
(100.00)    
204       
(82.93) 
40       
(59.70) 
72       
(86.75) 
39       
(72.22) 
189       
(90.87) 
115       
(76.16) 
141       
(88.13) 
203      
(100.00) 
Successful 
repair at follow-
up 
1039       
(81.55) 
52 
(73.24) 
34 
(70.83) 
3 (60.00) 185 
(75.20) 
40 
(59.70) 
45 
(66.18) 
37 
(69.81) 
190 
(91.35) 
117 
(80.14) 
138 
(86.79) 
198 
(97.54) 
Repair 
conducted in 
the context of 
training 
(n=1314) 
485       
(36.94) 
3        
(3.61) 
0 
(00.00)     
0 
(00.00)     
246 
(100.00)    
29       
(43.28) 
38       
(42.70) 
7       
(12.73) 
11        
(5.29) 
7        
(4.67) 
26       
(16.25) 
121       
(59.90) 
Repair part of 
outreach 
services / camp 
(n=1313)  
554     
(42.16) 
0 
(00.00)     
36       
(75.00) 
0 
(00.00)     
246 
(100.00)    
45       
(67.16) 
8       
(8.99) 
17       
(30.91) 
6       
(2.88) 
11       
(7.33) 
21      
(13.13) 
164     
(81.19) 
Pre-operative procedures 
Pre-operative  
antibiotics 
administered  
prophylactically 
(n=1314) 
541       
(41.17) 
48       
(57.83) 
48      
(100.00) 
3       
(60.00) 
246      
(100.00) 
2        
(2.99) 
46       
(51.69) 
4        
(7.27) 
9        
(4.35) 
33       
(22.00) 
28       
(17.50) 
74       
(36.27) 
Pre-operative  
antibiotics  
administered 
therapeutically 
(n=1314) 
50        
(3.81) 
11       
(13.25) 
0 
(00.00)     
0 
(00.00)     
0 
(00.00)     
0 
(00.00)     
2        
(2.25) 
3        
(5.45) 
9        
(4.35) 
12        
(8.00) 
12        
(7.50) 
1        
(0.49) 
                                                 
i
 Number of unique surgeons 
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 Site N (%) 
Characteristic Total 
(n=1328) 
Site A 
(n=84) 
Site B 
(n=48) 
Site C 
(n=5) 
Site D 
(n=246) 
Site E 
(n=72) 
Site F 
(n=93) 
Site G 
(n=57) 
Site H 
(n=208) 
Site I 
(n=151) 
Site J 
(n=160) 
Site K 
(n=204) 
Drinking 
regimen 
prescribed pre-
operatively 
(n=1311) 
1053       
(80.32) 
33       
(39.29) 
48      
(100.00) 
0      
(00.00) 
246 
(100.00) 
67      
(100.00) 
0     
(00.00) 
29       
(51.79) 
138       
(66.99) 
150      
(100.00) 
158 
(100) 
187       
(92.12) 
Median liters of 
fluid prescribed 
(IQR) (n=1057) 
5 (4-8) 5 (5-5) 4 (4-4) N/A 4 (3-5) 6 (6-6) N/A 8 (6-8) 10 (7-
10) 
8 (8-8) 3 (3-3) 5 (4-5) 
Intra-operative procedures 
Vaginal route 
(n=1273) 
1253       
(95.29) 
71       
(85.54) 
46       
(95.83) 
5      
(100.00) 
238       
(96.75) 
67      
(100.00) 
89      
(100.00) 
53       
(96.36) 
207       
(99.52) 
151      
(100.00) 
133       
(83.13) 
193       
(95.07) 
Single layer 
suture of 
bladder 
(n=1271) 
820       
(64.52) 
65       
(80.25) 
28       
(59.57) 
5      
(100.00) 
30       
(12.20) 
65       
(97.01) 
26       
(32.91) 
49       
(89.09) 
169       
(84.08) 
92       
(61.33) 
118       
(80.82) 
173       
(89.18) 
Double layer 
suture of 
bladder 
(n=1265) 
428       
(33.83) 
15       
(18.99) 
19       
(40.43) 
0      
(00.00) 
215       
(87.40) 
1        
(1.49) 
53       
(66.25) 
3        
(5.56) 
17        
(8.54) 
58       
(38.67) 
24       
(16.55) 
23       
(11.92) 
Single layer 
suture of 
vaginal mucosa  
(n=1269) 
1076       
(84.79) 
73       
(90.12) 
47      
(100.00) 
5      
(100.00) 
244       
(99.19) 
66       
(98.51) 
29       
(36.71) 
44       
(80.00) 
174       
(87.44) 
132       
(88.00) 
120       
(82.19) 
142       
(73.20) 
Double layer 
suture of 
vaginal mucosa  
(n=1261) 
14        
(1.11) 
1        
(1.27) 
0      
(00.00) 
0      
(00.00) 
1        
(0.41) 
0      
(00.00) 
2        
(2.56) 
1        
(1.85) 
1        
(0.50) 
0      
(00.00) 
3        
(2.07) 
5        
(2.60) 
Martius flap 
(with or without 
labia skin) 
(n=1261) 
43        
(3.41) 
4        
(5.06) 
6       
(12.77) 
0      
(00.00) 
17        
(6.91) 
0      
(00.00) 
0      
(00.00) 
0      
(00.00) 
15        
(7.54) 
0      
(00.00) 
0      
(00.00) 
1        
(0.52) 
Relaxing 
incision 
(n=1261) 
16        
(1.27) 
0      
(00.00) 
2        
(4.26) 
1       
(20.00) 
0      
(00.00) 
0      
(00.00) 
0      
(00.00) 
3        
(5.56) 
6        
(3.02) 
1        
(0.67) 
0      
(00.00) 
3        
(1.56) 
Post-operative procedures 
Open drainage 
system 
(n=1309) 
899      
(68.68) 
0 
(00.00)     
0 
(00.00)     
1       
(20.00 
95       
(38.62) 
67       
(100.00) 
0 
(00.00)     
41       
(74.55) 
203      
(100.00) 
151      
(100.00) 
147       
(91.88) 
194       
(95.57) 
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 Site N (%) 
Characteristic Total 
(n=1328) 
Site A 
(n=84) 
Site B 
(n=48) 
Site C 
(n=5) 
Site D 
(n=246) 
Site E 
(n=72) 
Site F 
(n=93) 
Site G 
(n=57) 
Site H 
(n=208) 
Site I 
(n=151) 
Site J 
(n=160) 
Site K 
(n=204) 
Median days of 
catheterization 
(IQR) 
(n=1261) 
21.00 
(14-27) 
21.00 
(17-21) 
14.00 
(14-20) 
14.00 
(14-14) 
15.00 
(14-21) 
28.00 
(28-28) 
14.00 
(13-15) 
29.00 
(28-34) 
23.00 
(21-28) 
28.00 
(28-28) 
14.00 
(14-21) 
15.00 
(14-16) 
Drinking 
regimen 
prescribed 
post-
operatively 
(n=1304) 
1148      
(88.04) 
60       
(74.07) 
48      
(100.00) 
0 
(00.00)     
246 
(100.00)    
67       
(100.00) 
0 
(00.00)     
7       
(12.96) 
208       
(100.00) 
150       
(100.00) 
160      
(100.00) 
202       
(100.00) 
Median liters of 
fluid prescribed 
(n=1138) 
5 (4-8) 3 (3-5) 4 (4-4) N/A 3 (3-3) 10 (10-
10) 
N/A 6 (6-10) 10 (10-
10) 
8 (8-8) 6 (6-6) 5 (5-5) 
Bladder training 
provided 
(n=1305) 
670       
(51.34) 
23       
(28.40) 
7       
(14.58) 
1       
(20.00) 
79       
(32.11) 
44       
(65.67) 
0 
(00.00)     
28       
(51.85) 
13        
(6.25) 
121       
(80.13) 
159      
(100.00) 
195       
(96.06) 
Prophylactic 
antibiotics 
provided 
(n=1305) 
1122       
(85.98) 
76       
(93.83) 
3        
(6.25) 
2       
(40.00) 
246      
(100.00) 
64       
(96.97) 
83      
(100.00) 
8       
(14.81) 
208       
(100.00) 
151       
(100.00) 
160      
(100.00) 
124       
(61.08) 
Bed-rest 
prescribed > 3 
days 
(n=1328) 
244      
(18.37) 
5       
(5.95) 
0 
(00.00)     
2       
(40.00) 
151    
(61.38) 
0 
(00.00)     
38      
(40.86) 
0 
(00.00)    
3      
(1.44) 
0 
(00.00)     
15       
(9.38) 
30       
(14.71) 
Patient did 
pelvic-muscle 
exercises 
(n=1308) 
1118       
(85.47) 
62       
(73.81) 
12       
(25.53) 
5      
(100.00) 
226       
(91.87) 
48       
(72.73) 
0 
(00.00)     
53       
(96.36) 
202       
(97.12) 
150      
(100.00) 
158       
(98.75) 
202      
(100.00) 
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Appendix G: Propensity score matching for analyses of route of repair and fistula closure 
 
In this appendix, I illustrate the overlap in propensity between participants operated using an 
abdominal / combined route versus vaginal route of repair.  Propensity scores were first 
calculated using a reduced model comprised of fistula characteristics (abdominal route of repair 
indicated, mid-vaginal or juxta-cervical location, partial urethral damage or complete damage / 
transaction of the urethra) only.  Since no individuals undergoing abdominal repair had a 
propensity score <.004, individuals with a propensity score lower than this value were excluded 
from the analyses.  Upon visual examination of p-values and distribution of covariates in Table 
G.2, it appears that covariate balance is somewhat improved (though imbalance remains in terms 
of some patient and fistula characteristics, surgeon skill, and procedures).  Due to this remaining 
imbalance, I matched participants on an expanded set of covariates, including fistula 
characteristics, parity, site, and surgeon skill.  Observations with a propensity score <.0029 or 
>.856 were excluded from the analyses.  Covariate balance was further improved, as shown in 
Table G.4, though some imbalances remained; since a large proportion of the sample had to be 
excluded from the analyses, no further covariates were included.   
 
Table G.1: Overlap in propensity between participants operated using an abdominal / 
combined route vs vaginal route, propensity scores calculated using reduced model  
                      
Route  Obs       N            Mean         Std Dev         Minimum         Maximum 
          ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
 0    1216    1202       0.0334723       0.0706272    1.3590802E-6       0.6996159 
 
 1      57      52       0.2262770       0.1999126       0.0042345       0.6996159 
          ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
 
 
 
 
Figure G.1: Overlap in propensity between participants operated using an abdominal / 
combined route versus vaginal route, propensity scores calculated using reduced model 
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Table G.2: Assessing balance after matching on propensity for abdominal versus vaginal 
route of repair (reduced model) 
 
                         Total       Abdominal/combined       Vaginal 
                        N    (%)        N    (%)             N    (%) 
 
Total                    138  ( 100)          46  ( 100)          92  ( 100)    
 
Site 
 Kumudini                 15  (10.9)           9  (19.6)           6  ( 6.5) 
 Lamb                      4  ( 2.9)           2  ( 4.3)           2  ( 2.2) 
 Kissidougou              36  (26.1)           7  (15.2)          29  (31.5) 
 Maradi                    5  ( 3.6)           0  ( 0.0)           5  ( 5.4) 
 Lamorde                   7  ( 5.1)           0  ( 0.0)           7  ( 7.6) 
 Sokoto                    1  ( 0.7)           1  ( 2.2)           0  ( 0.0) 
 Zamfara                  13  ( 9.4)           1  ( 2.2)          12  (13.0) 
 Kebbi                     5  ( 3.6)           0  ( 0.0)           5  ( 5.4) 
 Kagando                  34  (24.6)          20  (43.5)          14  (15.2) 
 Kitovu                   18  (13.0)           6  (13.0)          12  (13.0) 
 
Age >25                   86  (62.3)          33  (71.7)          53  (57.6)  * 
 
Currently married         86  (62.3)          27  (58.7)          59  (64.1) 
 
Duration of fistula      4.2  ( 6.0)         4.8  ( 6.8)         3.9  ( 5.6) 
 
> Primary education       36  (26.1)          17  (37.0)          19  (20.7)  * 
 
Rural residence          124  (89.9)          42  (91.3)          82  (89.1) 
 
Parity >3                 63  (47.0)          26  (57.8)          37  (41.6)  * 
 
Average prognostic score1.43  ( 1.6)        1.00  ( 1.4)        1.64  ( 1.7)  ** 
 
Previous repaired         35  (25.4)          12  (26.1)          23  (25.0) 
 
Any scarring              63  (45.7)          20  (43.5)          43  (46.7) 
 
> 1 urinary fistula       16  (11.7)           3  ( 6.5)          13  (14.3) 
 
Urethral damage  
 Partial                  22  (16.1)           3  ( 6.5)          19  (20.9)  ** 
 Transection or complete  16  (11.7)           4  ( 8.7)          12  (13.2) 
 
Ureteric involvement      70  (50.7)          23  (50.0)          47  (51.1) 
 
Small bladder             46  (36.5)          12  (29.3)          34  (40.0) 
 
Comorbidities at baseline 
 Helminthiasis            20  (14.5)           1  ( 2.2)          19  (20.7)  ** 
 Malnutrition              7  ( 5.1)           3  ( 6.5)           4  ( 4.3) 
 Anemia                   11  ( 8.0)           5  (10.9)           6  ( 6.5) 
 Urine dermatitis          4  ( 6.9)           0  ( 0.0)           4  (11.8)  * 
 Fever                     0  ( 0.0)           0  ( 0.0)           0  ( 0.0)  * 
 UTI                       0  ( 0.0)           0  ( 0.0)           0  ( 0.0) 
 Foot drop                 3  ( 2.2)           0  ( 0.0)           3  ( 3.3) 
 
Fistula location 
 Juxta-urethral            3  ( 2.2)           1  ( 2.2)           2  ( 2.2)  
 Mid-vaginal              21  (15.2)           3  ( 6.5)          18  (19.6)  ** 
 Juxta-cervical           13  ( 9.4)           5  (10.9)           8  ( 8.7) 
 Intra-cervical           16  (11.6)           7  (15.2)           9  ( 9.8) 
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 Vesico-uterine           13  ( 9.4)           4  ( 8.7)           9  ( 9.8) 
 Circumferential          13  ( 9.4)           4  ( 8.7)           9  ( 9.8) 
 Ureteric                 10  ( 7.2)           6  (13.0)           4  ( 4.3)  * 
 Trigonal                 19  (13.8)           5  (10.9)          14  (15.2) 
 Supra-trigonal           15  (10.9)           5  (10.9)          10  (10.9) 
 Uretero-vaginal          12  ( 8.7)           5  (10.9)           7  ( 7.6) 
 Vault                     6  ( 4.3)           2  ( 4.3)           4  ( 4.3) 
 
Surgical procedure 
 1-layer bladder suture   65  (50.8)          20  (51.3)          45  (50.6) 
 2-layer bladder suture   57  (44.5)          16  (41.0)          41  (46.1) 
 1-layer mucosa suture    98  (77.2)          25  (64.1)          73  (83.0)  ** 
 2-layer mucosa suture     3  ( 2.4)           3  ( 7.7)           0  ( 0.0)  ** 
 Relaxing incision         0  ( 0.0)           0  ( 0.0)           0  ( 0.0)    
 Martius flap              5  ( 3.9)           0  ( 0.0)           5  ( 5.7) 
 
Number of complex repairs performed by surgeon 
 < 50                     56  (42.1)          29  (63.0)          27  (31.0)  ** 
 50-200                   48  (36.1)          11  (23.9)          37  (42.5)  ** 
 200-1000                 16  (12.0)           5  (10.9)          11  (12.6) 
 > 1000                   13  ( 9.8)           1  ( 2.2)          12  (13.8)  ** 
 
 
Table G.3: Overlap in propensity between participants operated using an abdominal / 
combined route versus vaginal route, propensity scores calculated using expanded model  
 
 
              N 
Approach     Obs       N            Mean         Std Dev         Minimum         Maximum 
          ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
0    1216    1098       0.0274832       0.0709935    2.770879E-10       0.8561966 
 
1      57      51       0.4083025       0.3219966       0.0029727       0.9582981 
          ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure G.2: Overlap in propensity between participants operated using an abdominal / 
combined route versus vaginal route, propensity scores calculated using expanded model 
 
  
167
0
10
20
30
40
50
60
70
80
Pe
rc
en
t
0
0 0.06 0.12 0.18 0.24 0.30 0.36 0.42 0.48 0.54 0.60 0.66 0.72 0.78 0.84 0.90 0.96
0
10
20
30
40
50
60
70
80
Pe
rc
en
t
1
Estimated Probability
  
168
Table G.4: Assessing balance after matching on propensity for abdominal versus vaginal 
route of repair (expanded model) 
 
                         Total       Abdominal/combined       Vaginal 
                        N    (%)        N    (%)             N    (%) 
 
Total                     90  ( 100)          30  ( 100)          60  ( 100) 
 
Site 
 Kumudini                 17  (18.9)           6  (20.0)          11  (18.3) 
 Lamb                      4  ( 4.4)           2  ( 6.7)           2  ( 3.3) 
 MCH                       1  ( 1.1)           0  ( 0.0)           1  ( 1.7) 
 Kissidougou              17  (18.9)           8  (26.7)           9  (15.0) 
 Sokoto                    1  ( 1.1)           1  ( 3.3)           0  ( 0.0) 
 Zamfara                   2  ( 2.2)           1  ( 3.3)           1  ( 1.7) 
 Kebbi                     4  ( 4.4)           0  ( 0.0)           4  ( 6.7) 
 Kagando                  32  (35.6)           7  (23.3)          25  (41.7) 
 Kitovu                   12  (13.3)           5  (16.7)           7  (11.7) 
 
Age >25                   65  (72.2)          20  (66.7)          45  (75.0) 
 
Currently married         55  (61.1)          18  (60.0)          37  (61.7) 
 
Duration of fistula      4.3  ( 6.3)         6.0  ( 7.6)         3.5  ( 5.4)  * 
 
> Primary education       23  (25.6)          10  (33.3)          13  (21.7) 
 
Rural residence           82  (91.1)          26  (86.7)          56  (93.3) 
 
Parity >3                 39  (43.3)          14  (46.7)          25  (41.7) 
 
Average prognostic score 1.2  ( 1.4)         1.2  ( 1.5)         1.3  ( 1.3) 
 
Previous repaired         24  (26.7)          10  (33.3)          14  (23.3) 
 
Any scarring              43  (47.8)          14  (46.7)          29  (48.3) 
 
> 1 urinary fistula        5  ( 5.6)           1  ( 3.3)           4  ( 6.7) 
 
Urethral damage  
 Partial                   9  (10.1)           3  (10.0)           6  (10.2) 
 Transection or complete  14  (15.7)           4  (13.3)          10  (16.9) 
 
Ureteric involvement      31  (34.4)          12  (40.0)          19  (31.7) 
 
Small bladder             27  (34.6)          11  (40.7)          16  (31.4) 
 
Comorbidities at baseline 
 Helminthiasis             9  (10.0)           2  ( 6.7)           7  (11.7) 
 Malnutrition             12  (13.3)           2  ( 6.7)          10  (16.7)    
 Anemia                   12  (13.3)           3  (10.0)           9  (15.0) 
 Urine dermatitis          5  (11.6)           0  ( 0.0)           5  (17.2)  * 
 Fever                     1  ( 2.3)           0  ( 0.0)           1  ( 3.4) 
 UTI                       0  ( 0.0)           0  ( 0.0)           0  ( 0.0) 
 Foot drop                 2  ( 2.2)           0  ( 0.0)           2  ( 3.3) 
 
Fistula location 
 Juxta-urethral           12  (13.3)           1  ( 3.3)          11  (18.3)  * 
 Mid-vaginal               8  ( 8.9)           3  (10.0)           5  ( 8.3) 
 Juxta-cervical           13  (14.4)           5  (16.7)           8  (13.3) 
 Intra-cervical           14  (15.6)           5  (16.7)           9  (15.0) 
 Vesico-uterine            9  (10.0)           3  (10.0)           6  (10.0) 
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 Circumferential          14  (15.6)           4  (13.3)          10  (16.7) 
 Ureteric                  2  ( 2.2)           0  ( 0.0)           2  ( 3.3) 
 Trigonal                 10  (11.1)           4  (13.3)           6  (10.0) 
 Supra-trigonal            3  ( 3.3)           2  ( 6.7)           1  ( 1.7) 
 Uretero-vaginal           4  ( 4.4)           2  ( 6.7)           2  ( 3.3) 
 Vault                     9  (10.0)           1  ( 3.3)           8  (13.3) 
 
Surgical procedure 
 1-layer bladder suture   54  (62.8)          14  (48.3)          40  (70.2)  * 
 2-layer bladder suture   30  (34.9)          13  (44.8)          17  (29.8) 
 1-layer mucosa suture    74  (86.0)          20  (69.0)          54  (94.7)  ** 
 2-layer mucosa suture     3  ( 3.5)           2  ( 6.9)           1  ( 1.8) 
 Relaxing incision         0  ( 0.0)           0  ( 0.0)           0  ( 0.0) 
 Martius flap              1  ( 1.2)           0  ( 0.0)           1  ( 1.8) 
 
Number of complex repairs performed by surgeon 
 < 50                     51  (56.7)          13  (43.3)          38  (63.3)  * 
 50-200                   26  (28.9)          12  (40.0)          14  (23.3)  * 
 200-1000                  6  ( 6.7)           3  (10.0)           3  ( 5.0) 
 > 1000                    7  ( 7.8)           2  ( 6.7)           5  ( 8.3) 
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Appendix H: Propensity score matching for analyses of duration of catheterization and 
fistula closure 
 
In this appendix, I illustrate the overlap in propensity between participants catheterized for > 14 
days and < 14 days.  Propensity scores for duration of catheterization analyses were first 
calculated using a reduced model comprised of patient and fistula characteristics, context of 
repair, as well as intra- and post-operative procedures.  Since no individuals catheterized for > 14 
days had a propensity score <.038, and no individuals catheterized for < 14 days had a 
propensity score > .808, individuals with a propensity score lower or higher than those values, 
respectively, were excluded from the analyses.  A comparison of individuals repaired vaginally 
and abdominally by covariates is shown in Table H.2.  To address remaining imbalance in 
patient and facility-level characteristics, I matched participants on an expanded set of covariates, 
including site, and surgeon skill.  For reasons described above, observations with a propensity 
score <.006 or >.895 were excluded from the analyses.  Covariate balance was further improved, 
as shown in Table H.4, though some imbalances remained; since a large proportion of the sample 
had to be excluded from the analyses, no further covariates were included.   
 
Table H.1: Overlap in propensity between participants catheterized <14 days and > 14 
days, propensity scores calculated using reduced model  
 
 
         N 
Grp     Obs    N            Mean         Std Dev         Minimum         Maximum 
           ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
0     400     362       0.4553530       0.1969103       0.0381696       0.8339966 
 
1     894     774       0.2547317       0.1837855     0.000694828       0.8086595 
           ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
 
 
 
 
 
Figure H.1: Overlap in propensity between participants catheterized <14 days and > 14 
days, propensity scores calculated using reduced model  
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Table H.2: Patient characteristics by duration of catheterization (matched sample, reduced 
model) 
 
                         Total          <14 days          >14 days 
                        N    (%)        N    (%)           N    (%) 
 
Total                    806  ( 100)         264  ( 100)         542  ( 100)    
 
Site 
 Kumudini                 22  ( 2.7)           2  ( 0.8)          20  ( 3.7) 
 Lamb                     38  ( 4.7)          21  ( 8.0)          17  ( 3.1) 
 MCH                       4  ( 0.5)           4  ( 1.5)           0  ( 0.0) 
 Kissidougou             164  (20.3)          63  (23.9)         101  (18.6) 
 Maradi                   62  ( 7.7)           0  ( 0.0)          62  (11.4) 
 Lamorde                  47  ( 5.8)          28  (10.6)          19  ( 3.5) 
 Sokoto                   48  ( 6.0)           0  ( 0.0)          48  ( 8.9) 
 Zamfara                  62  ( 7.7)           3  ( 1.1)          59  (10.9) 
 Kebbi                    86  (10.7)           1  ( 0.4)          85  (15.7) 
 Kagando                 120  (14.9)          67  (25.4)          53  ( 9.8) 
 Kitovu                  153  (19.0)          75  (28.4)          78  (14.4) 
 
Age > 25                 401  (49.8)         146  (55.3)         255  (47.0)   ** 
 
Currently married        520  (64.5)         176  (66.7)         344  (63.5) 
 
Duration of fistula      3.4  ( 5.6)         3.7  ( 5.9)         3.3  ( 5.5) 
 
> Primary education      179  (22.3)          76  (28.8)         103  (19.1)   ** 
 
Rural residence          680  (85.1)         230  (88.1)         450  (83.6)   * 
 
Parity > 3               304  (38.5)         113  (43.3)         191  (36.1)   * 
 
Average prognostic score 1.2  ( 1.4)         1.1  ( 1.4)         1.3  ( 1.4)   * 
 
Previously repaired      199  (24.8)          57  (21.6)         142  (26.3)   * 
 
Any scarring             285  (35.4)          95  (36.0)         190  (35.1) 
 
> 1 urinary fistula       55  ( 6.8)          17  ( 6.5)          38  ( 7.0) 
 
Urethral damage 
 Partial                 207  (25.7)          60  (22.7)         147  (27.1)   * 
 Transection or complete 116  (14.4)          35  (13.3)          81  (14.9) 
 
Ureteric involvement     115  (14.3)          41  (15.5)          74  (13.7) 
 
Small bladder            156  (19.4)          44  (16.7)         112  (20.7)   * 
 
Comorbidities at baseline 
 Helminthiasis            92  (11.4)          34  (12.9)          58  (10.7) 
 Malnutrition              6  ( 0.7)           2  ( 0.8)           4  ( 0.7) 
 Anemia                   12  ( 1.5)           4  ( 1.5)           8  ( 1.5) 
 Urine dermatitis         26  (11.1)          10  ( 9.5)          16  (12.3) 
 Fever                     5  ( 2.1)           1  ( 1.0)           4  ( 3.1) 
 UTI                       1  ( 0.1)           1  ( 0.4)           0  ( 0.0) 
 Foot drop                 7  ( 0.9)           2  ( 0.8)           5  ( 0.9) 
  
Fistula location 
 Juxta-urethral          208  (25.8)          63  (23.9)         145  (26.8) 
 Mid-vaginal             234  (29.0)          65  (24.6)         169  (31.2)   * 
 Juxta-cervical          153  (19.0)          58  (22.0)          95  (17.5)   * 
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 Intra-cervical           55  ( 6.8)          19  ( 7.2)          36  ( 6.6) 
 Vesico-uterine           17  ( 2.1)          10  ( 3.8)           7  ( 1.3)   ** 
 Circumferential         106  (13.2)          33  (12.5)          73  (13.5) 
 Ureteric                 11  ( 1.4)           6  ( 2.3)           5  ( 0.9)   * 
 Trigonal                 41  ( 5.1)          15  ( 5.7)          26  ( 4.8) 
 Supra-trigonal           26  ( 3.2)          18  ( 6.8)           8  ( 1.5)   ** 
 Uretero-vaginal           8  ( 1.0)           3  ( 1.1)           5  ( 0.9) 
 Vault                    20  ( 2.5)          12  ( 4.5)           8  ( 1.5)   ** 
 
Surgical procedure 
 Vaginal route           772  (95.8)         245  (92.8)         527  (97.2)   ** 
 1-layer bladder suture  519  (64.4)         164  (62.1)         355  (65.5) 
 2-layer bladder suture  280  (34.7)          98  (37.1)         182  (33.6) 
 1-layer mucosa suture   681  (84.5)         205  (77.7)         476  (87.8)   ** 
 2-layer mucosa suture    11  ( 1.4)           4  ( 1.5)           7  ( 1.3) 
 Relaxing incision         9  ( 1.1)           4  ( 1.5)           5  ( 0.9) 
 Martius flap              8  ( 1.0)           3  ( 1.1)           5  ( 0.9) 
 
Post-operative procedures administered 
 Open catheter drainage  584  (72.5)         181  (68.6)         403  (74.4)   * 
 Drinking regimen        700  (87.0)         231  (87.5)         469  (86.7) 
 Bladder training        487  (60.4)         171  (64.8)         316  (58.3)   * 
 Prophy. antibiotics     666  (82.6)         211  (79.9)         455  (83.9)   * 
 >1 day vaginal pack     268  (33.3)         107  (40.5)         161  (29.7)   ** 
 
Number of complex repairs performed by surgeon 
 < 50                    300  (39.6)         105  (41.8)         195  (38.5) 
 50-200                  236  (31.1)          80  (31.9)         156  (30.8) 
 200-1000                105  (13.9)          35  (13.9)          70  (13.8) 
 > 1000                  117  (15.4)          31  (12.4)          86  (17.0)   * 
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Table H.3: Overlap in propensity between participants catheterized <14 days and > 14 
days, propensity scores calculated using expanded model  
 
 
 
       N 
Grp   Obs       N            Mean         Std Dev         Minimum         Maximum 
           ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
0     400     358       0.6010320       0.1725217       0.0064263       0.8959554 
 
1     894     748       0.1909501       0.2514202     0.000137157       0.9025091 
           ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 
 
 
Figure H.2: Overlap in propensity between participants catheterized <14 days and > 14 
days, propensity scores calculated using expanded model  
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Table H.4: Patient characteristics by duration of catheterization (matched sample, 
expanded model) 
 
                         Total          <14 days          >14 days 
                        N    (%)        N    (%)           N    (%) 
 
Total                    440  ( 100)         143  ( 100)         297  ( 100)   *    
 
Site 
Kumudini                  4  ( 0.9)            2  ( 1.4)           2  ( 0.7) 
 Lamb                     28  ( 6.4)          11  ( 7.7)          17  ( 5.7) 
 MCH                       4  ( 0.9)           4  ( 2.8)           0  ( 0.0) 
 Kissidougou             149  (33.9)          45  (31.5)         104  (35.0) 
 Lamorde                  38  ( 8.6)          20  (14.0)          18  ( 6.1) 
 Zamfara                  15  ( 3.4)           2  ( 1.4)          13  ( 4.4) 
 Kebbi                     2  ( 0.5)           1  ( 0.7)           1  ( 0.3) 
 Kagando                  90  (20.5)          26  (18.2)          64  (21.5) 
 Kitovu                  110  (25.0)          32  (22.4)          78  (26.3) 
 
Age > 25                 258  (58.6)          94  (65.7)         164  (55.2)   ** 
 
Currently married        263  (59.8)          96  (67.1)         167  (56.2)   ** 
 
Duration of fistula      4.1  ( 6.3)         4.3  ( 6.3)         4.0  ( 6.3) 
 
> Primary education      124  (28.2)          36  (25.2)          88  (29.7) 
 
Rural residence          388  (89.0)         124  (87.9)         264  (89.5) 
 
Parity > 3               177  (40.2)          69  (48.3)         108  (36.4)   ** 
 
Average prognostic score 1.5  ( 1.5)         1.4  ( 1.6)         1.5  ( 1.4) 
 
Previously repaired      109  (24.8)          45  (31.5)          64  (21.5)   ** 
 
Any scarring             201  (45.8)          62  (43.4)         139  (47.0) 
 
> 1 urinary fistula       39  ( 8.9)          14  ( 9.8)          25  ( 8.4) 
 
Urethral damage 
 Partial                 105  (23.9)          32  (22.4)          73  (24.6) 
 Transection or complete  92  (20.9)          21  (14.7)          71  (23.9)   ** 
 
Ureteric involvement      97  (22.0)          33  (23.1)          64  (21.5) 
 
Small bladder            129  (29.3)          36  (25.2)          93  (31.3) 
 
Comorbidities at baseline 
 Helminthiasis            79  (18.0)          20  (14.0)          59  (19.9)   * 
 Malnutrition              4  ( 0.9)           1  ( 0.7)           3  ( 1.0) 
 Anemia                    8  ( 1.8)           2  ( 1.4)           6  ( 2.0) 
 Urine dermatitis         10  ( 6.2)           5  ( 9.4)           5  ( 4.6) 
 Fever                     2  ( 1.2)           2  ( 3.7)           0  ( 0.0)   * 
 UTI                       1  ( 0.2)           1  ( 0.7)           0  ( 0.0) 
 Foot drop                 3  ( 0.7)           1  ( 0.7)           2  ( 0.7) 
  
Fistula location 
 Juxta-urethral           95  (21.6)          34  (23.8)          61  (20.5) 
 Mid-vaginal              95  (21.6)          28  (19.6)          67  (22.6) 
 Juxta-cervical           88  (20.0)          31  (21.7)          57  (19.2) 
 Intra-cervical           43  ( 9.8)          12  ( 8.4)          31  (10.4) 
 Vesico-uterine           14  ( 3.2)           8  ( 5.6)           6  ( 2.0)   * 
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 Circumferential          89  (20.2)          19  (13.3)          70  (23.6)   ** 
 Ureteric                  5  ( 1.1)           3  ( 2.1)           2  ( 0.7) 
 Trigonal                 34  ( 7.7)           9  ( 6.3)          25  ( 8.4) 
 Supra-trigonal           17  ( 3.9)           9  ( 6.3)           8  ( 2.7)   * 
 Uretero-vaginal           6  ( 1.4)           3  ( 2.1)           3  ( 1.0) 
 Vault                    18  ( 4.1)           9  ( 6.3)           9  ( 3.0)   * 
 
Surgical procedure 
 Vaginal route           414  (94.1)         130  (90.9)         284  (95.6)   * 
 1-layer bladder suture  232  (52.7)          76  (53.1)         156  (52.5) 
 2-layer bladder suture  203  (46.1)          65  (45.5)         138  (46.5) 
 1-layer mucosa suture   361  (82.0)         109  (76.2)         252  (84.8)   ** 
 2-layer mucosa suture     9  ( 2.0)           3  ( 2.1)           6  ( 2.0) 
 Relaxing incision         4  ( 0.9)           2  ( 1.4)           2  ( 0.7) 
 Martius flap              9  ( 2.0)           3  ( 2.1)           6  ( 2.0) 
 
Post-operative procedures administered 
 Open catheter drainage  269  (61.1)          80  (55.9)         189  (63.6)   * 
 Drinking regimen        396  (90.2)         118  (82.5)         278  (93.9)   ** 
 Bladder training        255  (58.0)          77  (53.8)         178  (59.9) 
 Prophy. antibiotics     372  (84.5)         119  (83.2)         253  (85.2) 
 >1 day vaginal pack     231  (52.5)          72  (50.3)         159  (53.5) 
 
Number of complex repairs 
 < 50                    129  (30.2)          46  (33.3)          83  (28.7) 
 50-200                  167  (39.1)          55  (39.9)         112  (38.8) 
 200-1000                 51  (11.9)          18  (13.0)          33  (11.4) 
 > 1000                   80  (18.7)          19  (13.8)          61  (21.1)   * 
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Appendix I: Analyses conducted to test effect modification 
 
In this appendix, I show additional analyses conducted to support evaluation of effect 
modification by fistula prognosis.  First, I calculated the Youden index, a measure of the optimal 
threshold based on the balance between true and false positives.  Based on these calculations 
(Table I.1), the optimal measure threshold is a score of 3.  However, in my primary analyses I 
chose to use a threshold of 1, corresponding to the median percentile distribution of patients, and 
favoring increased sensitivity over specificity.  In Table I.2, I evaluate the influence of vaginal 
route of repair on repair outcomes stratified by prognosis of repair.  While confidence intervals 
are overlapping, these analyses suggest that among women with a prognostic score >1, vaginal 
route of repair may be less associated with failure to close the fistula compared to the risk of 
vaginal route of repair among women with a low prognostic score.   
 
Table I.1: Calculation of Youden index to determine optimal threshold for measure of 
complexity 
Score 
Not 
closed Closed Sensitivity Specificity Youden 
0 32 239 1 0 0 
1 16 61 0.862661 0.229587 0.092248 
2 24 123 0.793991 0.288184 0.082176 
3 43 99 0.690987 0.40634 0.097327 
 233 1041    
 
 
Table I.2: The influence of vaginal route of repair on repair outcome across levels of repair 
prognosis in the unmatched sample 
 Prognostic score <1  Prognostic score >1 
 Closed  Not closed Closed  Not closed 
Vaginal route of repair 462 (93.90) 55 (98.21) 527 (96.17)  172 (97.18) 
Abdominal / combined abdominal 
vaginal 
30 (6.10) 1 (1.79) 21 (3.83) 5 (2.82) 
RR (95%CI) 1.82 (0.66-5.00) 1.18 (0.67-2.06) 
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Appendix J: Predictors of route of repair, and the influence of route of repair on fistula 
closure, excluding mixed vaginal and abdominal routes of repair 
 
In this appendix, I evaluated whether excluding repairs that were conducted both vaginally and 
abdominally introduced any bias in the results.  I first evaluated whether predictors of 
abdominal-only route of repair varied from the predictors of abdominal-only or combined 
abdominal and vaginal route of repair.  These analyses had less power than the previous 
analyses, and it was not possible to adjust for site, due to zero cell-counts.  Nonetheless, with the 
exception of fistula size greater than or equal to 4, which was significant only in the analyses 
excluding combined route of repair, predictors of abdominal-only route of repair were similar to 
those of abdominal-only or combined route of repair.  In terms of the influence of route of repair 
on repair outcome, results of the analyses excluding combined route of repair demonstrated a 
stronger role of vaginal route of repair in predicting repair failure, even after controlling for other 
factors.  The smaller sample size for these analyses may have resulted in unstable estimates; 
however, these results indicate that while fistulas repaired using a combined approach may be 
different compared to fistulas repaired using an abdominal approach with regard to repair 
outcome, the increased risk of vaginal compared to abdominal repair on repair failure is not an 
artifact of this difference.   
Table J.1: Predictors of vaginal versus abdominal route of repair, excluding mixed vaginal 
and abdominal route of repair 
 Abdominal / 
combined     
N (%) 
Vaginal 
 
N (%) 
Unadjusted RR (95% 
CI) 
Adjusted RR 
(95% CI) 
Total (n=1273) 47 1216   
Patient characteristics at baseline 
Parity > 3 28  (62.2) 410  (34.9)    2.94 (1.63-5.31) ** 1.80 (0.90-3.60)* 
Age > 25 33  (70.2) 566  (46.5)    2.61 (1.41-4.83) ** -- 
Currently married 33  (70.2) 793  (65.2) 1.25 (0.67-2.31)  
Rural residence 43  (91.5) 1035  (85.8) 1.75 (0.63-4.80)  
> Primary education 13  (27.7) 246  (20.3)    1.48 (0.79-2.76) ** 1.13 (0.52-2.44) 
Mean years with fistula (sd) 3.1  ( 5.8) 3.2  ( 5.4) 1.00 (0.94-1.05)  
Malnutrition 2  ( 4.3) 72  ( 5.9) 0.71 (0.18-2.89)  
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Anemia 3  ( 6.4) 84  ( 6.9) 0.92 (0.29-2.91)  
Fever 0  ( 0.0)                   20  ( 4.7) --  
UTI 0  ( 0.0)                   2  ( 0.2) --  
Footdrop 0  ( 0.0)           64  ( 5.3)    --  
Female genital infibulation 6  (12.8) 40  ( 7.8) 1.75 (0.76-4.02)  
Prior repair  12  (25.5) 281  (23.2) 1.13 (0.60-2.15)  
Fistula characteristics 
Abdominal repair indicatedi 43  (91.5)       447  (37.2) 16.63 (6.01-46.04) 14.22 (3.98-
50.84)** 
Fistula size > 4 cm 3  ( 7.1)          248  (21.3) 0.29 (0.09-0.94)** 0.20 (0.04-
0.87)** 
Small bladder 10  (23.3) 326  (28.8) 0.76 (0.38-1.51)  
Extensive scarring 2  ( 4.3)          93  ( 7.7) 0.55 (0.13-2.21)  
Extensive tissue loss 4  ( 9.5) 127  (10.5) 0.90 (0.33-2.49)  
Extent of urethral damage 
 No damage 
 Partial damage 
Complete transection or         
destruction 
 
40  (88.9)  
1  ( 2.2)  
4  ( 9.1) 
 
710  (58.5)    
278  (22.9)    
222  (18.4)    
 
Ref 
0.07 (0.01-0.50) ** 
0.34 (0.12-0.94)** 
 
Ref 
0.16 (0.02-1.23)* 
0.70 (0.19-2.52) 
Mid-vaginal location 2  ( 4.3) 366  (30.2)    0.11 (0.03- 0.45)** 0.32 (0.07-1.46)* 
Trigonal location 6  (12.8) 60  ( 5.0)    2.63 (1.16-5.98)**  
Supratrigonal location 6  (12.8) 25  ( 2.1)    5.77 (2.65-12.57)**  
Juxta-cervical location 3  ( 6.5) 219  (18.2)    0.32 (0.10-1.03)* 0.61 (0.17-2.10) 
Intracervical location 6  (13.0) 74  ( 6.1)    2.20 (0.96-5.02)*  
Vesico-uterine location 10  (21.7) 11  ( 0.9) 16.28 (9.37-28.28)**  
Vault location 2  ( 4.3) 32  ( 2.7) 1.59 (0.40-6.30)  
Ureter involvement 21  (44.7) 183  (15.2) 4.15 (2.38-7.23)**  
Other abdominal pathology 1  ( 2.1) 1  ( 0.1)    13.71 (3.33-56.40)**  
Facility level factors / characteristics 
Site 
A  (n=70) 
B and C (n=53) 
D (n=246) 
E, G, and I (n=266) 
F and H (n=276) 
J (n=159) 
K (n=203) 
   
4  ( 8.5) 
0  ( 0.0) 
8  (17.0) 
1  ( 2.1) 
1  ( 2.1) 
25  (53.2) 
8  (17.0) 
 
61  (87.1)       
51  (96.2)       
238  (96.8)       
265 (99.6)   
275  (99.6)   
133  (83.7)      
193  (95.1)   
 
11.13 (4.30-28.80)** 
11.82 (4.51-31.01) 
9.97 (4.08-24.33) 
10.88 (4.48-26.43)** 
5.97 (2.40-14.84) ** 
4.83 (1.85-12.66)** 
Ref 
 
Surgeon performed over 200 
complex repairs                   
6  (12.8) 404 (35.0) 0.28 (0.12-0.65)** 0.42 (0.13-1.35)* 
 *p-value<.20 
**p-value<.05 
 
Table J.2: Association between vaginal route of repair and failure to close the fistula at 
three month follow-up visit, excluding combined vaginal and abdominal route of repair 
 Not closed Closed RR (95% CI) ARR (95% CI)ii ARR (95% CI)iii 
Vaginal route  227  (98.3)         989  (95.8) 2.19 (0.85-5.64) 2.75 (1.06-7.11) 2.89 (1.12-7.46) 
 
                                                 
i
 Female genital infibulation, extensive scarring, extensive tissue loss, trigonal, supratrigonal, intracervical, vesico-
uterine location, ureter involvement or concomitant abdominal pathology 
ii
 Adjusted for indication for abdominal route of repair 
iii
 Adjusted for indication for abdominal route of repair, surgeon experience conducting complex repairs, mid-
vaginal location 
